Sentence,class,file
"The importance of being aware of patient satisfaction levels has been suggested, Corresponding author: Young Ho Kwak, MD, PhD Department of Emergency Medicine, Seoul Na - tional University Hospital, Seoul National University  College of Medicine, 101 Daehak-ro, Jongno-gu,  Seoul 03080, Korea Tel: +82-2-2072-1629 Fax: +82-2-741-7855,  E-mail: yhkwak@snuh.org Received: 5 September, 2014 Revised: 28 November, 2014 Accepted: 23 January, 2015 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(12):466-471 http://dx.doi.org/10.3345/kjp.2015.58.12.466 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/04/49/kjped-58-466.PMC4705326.pdf
"467 http://dx.doi.org/10.3345/kjp.2015.58.12.466Korean J Pediatr 2015;58(12):466-471 but parental satisfaction in Korea has been addressed only once,  in a single-center study7).",Non-OADS,/arxiv_data1/oa_pdf/04/49/kjped-58-466.PMC4705326.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.466Jang HY, et al.",OADS,/arxiv_data1/oa_pdf/04/49/kjped-58-466.PMC4705326.pdf
469 http://dx.doi.org/10.3345/kjp.2015.58.12.466Korean J Pediatr 2015;58(12):466-471 management” were the five most important elements in patient  satisfaction with an ED14).,Non-OADS,/arxiv_data1/oa_pdf/04/49/kjped-58-466.PMC4705326.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.466Jang HY, et al.",OADS,/arxiv_data1/oa_pdf/04/49/kjped-58-466.PMC4705326.pdf
471 http://dx.doi.org/10.3345/kjp.2015.58.12.466Korean J Pediatr 2015;58(12):466-471 relatives of the child were significantly less likely to be contented  with the delivered PEC.,Non-OADS,/arxiv_data1/oa_pdf/04/49/kjped-58-466.PMC4705326.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.472Park GM, et al.",OADS,/arxiv_data1/oa_pdf/93/a6/kjped-58-472.PMC4705327.pdf
"A Cochrane review of  adherence to ICS in asthmatic patients found that patients took the recommended doses of  medication on 20% to 73% of follow­up days, and the percentage of underuse, which was  defined as taking less than 50% of the prescribed doses, ranged from 24% to 69% among Corresponding author: Jinho Yu, MD Department of Pediatrics, Asan Medical center,  University of Ulsan College of Medicine, 88 Olym - pic-ro 43-gil, Songpa-gu, Seoul 05505, Korea  Tel: +82-2-3010-3922 Fax: +82-2-3010-6978 E-mail: jyu3922@gmail.com Received: 14 July, 2014 Revised: 11 November, 2014 Accepted: 12 December, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrOriginal article Korean J Pediatr 2015;58(12):472-477 http://dx.doi.org/10.3345/kjp.2015.58.12.472 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/93/a6/kjped-58-472.PMC4705327.pdf
473 http://dx.doi.org/10.3345/kjp.2015.58.12.472Korean J Pediatr 2015;58(12):472-477 adults with asthma3).,Non-OADS,/arxiv_data1/oa_pdf/93/a6/kjped-58-472.PMC4705327.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.472Park GM, et al.",OADS,/arxiv_data1/oa_pdf/93/a6/kjped-58-472.PMC4705327.pdf
"475 http://dx.doi.org/10.3345/kjp.2015.58.12.472Korean J Pediatr 2015;58(12):472-477 day 30, 56.2% ±18.4% at day 60, 55.0% ±19.7% at day 90, and 59.1  %±11.4% during the total study period.",Non-OADS,/arxiv_data1/oa_pdf/93/a6/kjped-58-472.PMC4705327.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.472Park GM, et al.",OADS,/arxiv_data1/oa_pdf/93/a6/kjped-58-472.PMC4705327.pdf
477 http://dx.doi.org/10.3345/kjp.2015.58.12.472Korean J Pediatr 2015;58(12):472-477 assessments were provided by a pharmacist.,Non-OADS,/arxiv_data1/oa_pdf/93/a6/kjped-58-472.PMC4705327.pdf
Available from:  http://www.ginasthma.org/documents/4.,OADS,/arxiv_data1/oa_pdf/93/a6/kjped-58-472.PMC4705327.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.478Choi MS, et al.",OADS,/arxiv_data1/oa_pdf/e9/5b/kjped-58-478.PMC4705328.pdf
"The introduction of antimicrobials into clinical practice has improved the prognosis of  lung abscess, but the literature from 1969 to 2005 reported mortality rates ranging from Corresponding author: Sun Hee Choi, MD, PhD Department of Pediatrics, Kyung Hee Hospital at  Gangdong, 892 Dongnam­ro, Gangdong­gu, Seoul  05278, Korea Tel: +82­2­440­6278 Fax: +82­2­440­6295 E­mail: chsh0414@naver.com Received: 15 September, 2014 Revised:  3 December, 2014 Accepted: 12 December, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(12):478-483 http://dx.doi.org/10.3345/kjp.2015.58.12.478 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/e9/5b/kjped-58-478.PMC4705328.pdf
479 http://dx.doi.org/10.3345/kjp.2015.58.12.478Korean J Pediatr 2015;58(12):478-483 2.0%–38.2%5).,OADS,/arxiv_data1/oa_pdf/e9/5b/kjped-58-478.PMC4705328.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.478Choi MS, et al.",OADS,/arxiv_data1/oa_pdf/e9/5b/kjped-58-478.PMC4705328.pdf
481 http://dx.doi.org/10.3345/kjp.2015.58.12.478Korean J Pediatr 2015;58(12):478-483 Two patients in the primary abscess group were improved with  antibiotic therapy alone.,Non-OADS,/arxiv_data1/oa_pdf/e9/5b/kjped-58-478.PMC4705328.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.478Choi MS, et al.",OADS,/arxiv_data1/oa_pdf/e9/5b/kjped-58-478.PMC4705328.pdf
483 http://dx.doi.org/10.3345/kjp.2015.58.12.478Korean J Pediatr 2015;58(12):478-483 and beta-lactam/beta-lactamase complex is regarded as the treat- ment of choice for primary lung abscess20).,Non-OADS,/arxiv_data1/oa_pdf/e9/5b/kjped-58-478.PMC4705328.pdf
Available from: http://cdc.go.kr/CDC/cms/content/  88/1188_view.html.,OADS,/arxiv_data1/oa_pdf/e9/5b/kjped-58-478.PMC4705328.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.484Yun YJ, et al.",OADS,/arxiv_data1/oa_pdf/86/ca/kjped-58-484.PMC4705329.pdf
"However, side effects are commonly observed and include irritability, gastrointestinal Corresponding author: Meerim Park, MD Department of Pediatrics, Chungbuk National  University College of Medicine, 1 Chungdae-ro,  Seowon-gu, Cheongju 28644, Korea Tel: +82-43-269-6338 Fax: +82-43-264-6620 E-mail: ming2a@daum.net Received: 25 February, 2015 Revised: 18 May, 2015 Accepted: 21 May, 2015 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Korean J PediatrOriginal article Korean J Pediatr 2015;58(12):484-490 http://dx.doi.org/10.3345/kjp.2015.58.12.484 pISSN 1738-1061•eISSN 2092-7258",Non-OADS,/arxiv_data1/oa_pdf/86/ca/kjped-58-484.PMC4705329.pdf
"485 http://dx.doi.org/10.3345/kjp.2015.58.12.484Korean J Pediatr 2015;58(12):484-490 distress, sleep disturbance, cushingoid facies, adrenal suppression,  immunosuppression, hypertension, bone demineralization,  cardiomyopathy, and growth retardation2).",Non-OADS,/arxiv_data1/oa_pdf/86/ca/kjped-58-484.PMC4705329.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.484Yun YJ, et al.",OADS,/arxiv_data1/oa_pdf/86/ca/kjped-58-484.PMC4705329.pdf
"487 http://dx.doi.org/10.3345/kjp.2015.58.12.484Korean J Pediatr 2015;58(12):484-490 (range, 6–9) at 1 month, 3 months, 6 months, and 12 months,  respectively.",OADS,/arxiv_data1/oa_pdf/86/ca/kjped-58-484.PMC4705329.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.484Yun YJ, et al.",OADS,/arxiv_data1/oa_pdf/86/ca/kjped-58-484.PMC4705329.pdf
"489 http://dx.doi.org/10.3345/kjp.2015.58.12.484Korean J Pediatr 2015;58(12):484-490 frequent relapses from relatively shorter courses of treatment and  a rapid taper of therapy exist, optimal treatment duration and a  tapering schedule have not yet been defined.",Non-OADS,/arxiv_data1/oa_pdf/86/ca/kjped-58-484.PMC4705329.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.484Yun YJ, et al.",OADS,/arxiv_data1/oa_pdf/86/ca/kjped-58-484.PMC4705329.pdf
"491 http://dx.doi.org/10.3345/kjp.2015.58.12.491Korean J Pediatr 2015;58(12):491-500 Intercontinental comparison of caustic ingestion  in children Mandana Rafeey, MD1, Morteza Ghojazadeh, MD, PhD2, Amir Mehdizadeh, PhD2, Hakimeh  Hazrati2, Leila Vahedi, MD, PhD2 1Division of Gastroenterology, Tabriz Children's Hospital, Tabriz University Medical Sciences, Liver and Gastrointestinal Diseases Research Center, Tabriz, 2Liver and  Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Purpose:  To investigate the caustic ingestion in children among different continents according to  demographic characteristics (core purpose), main symptoms, common caustic agents, signs and  symptoms, management, treatment and complications.",Non-OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
"In Denmark, Corresponding author: Leila Vahedi, MD, PhD Liver and Gastrointestinal Diseases Research Cen - ter, Tabriz University of Medical Sciences, Tabriz,  Iran Tel: +98-914-1042900 Fax:  +98-411-3373741  E-mail: vahedi.l49@gmail.com Received: 18 March, 2014 Revised: 6 August, 2014 Accepted: 29 August, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(12):491-500 http://dx.doi.org/10.3345/kjp.2015.58.12.491 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.491Rafeey M, et al.",OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
493 http://dx.doi.org/10.3345/kjp.2015.58.12.491Korean J Pediatr 2015;58(12):491-500 of review articles were added to the set.,Non-OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.491Rafeey M, et al.",OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
495 http://dx.doi.org/10.3345/kjp.2015.58.12.491Korean J Pediatr 2015;58(12):491-500 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.491Rafeey M, et al.",OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
References of Table 2 can be found via http://www.kjp.or.kr/src/sm/kjp-58-491-s001.pdf as supplementary material.,Non-OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
497 http://dx.doi.org/10.3345/kjp.2015.58.12.491Korean J Pediatr 2015;58(12):491-500 3.,Non-OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.491Rafeey M, et al.",OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
499 http://dx.doi.org/10.3345/kjp.2015.58.12.491Korean J Pediatr 2015;58(12):491-500 in long­term stricture formation with a high morbidity mostly in  gastrointestinal tract13).,Non-OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
Supplementary materials References of Table 2 can be found via http://www.kjp.or.kr/src/ sm/kjp­58­487­s001.pdf as supplementary material.,Non-OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.491Rafeey M, et al.",OADS,/arxiv_data1/oa_pdf/64/f7/kjped-58-491.PMC4705330.pdf
"501 http://dx.doi.org/10.3345/kjp.2015.58.12.501Korean J Pediatr 2015;58(12):501-504 Giant coronary aneurysm caused by Kawasaki  disease: consistency between catheter angio­ graphy and electrocardiogram gated dual­ source computed tomography angiography Eun-Ha Hwang, MD1, Jung-Ki Ju, MD2, Min-Jung Cho, MD1, Ji-Won Lee, MD3, Hyoung-Doo Lee, MD, PhD4 Department of Pediatrics1, Pusan National University Hospital, Busan, Department of Pediatrics2, Good Gang-An Hospital, Busan, Department of Radiology3, Pusan  National University Hospital, Busan, Department of Pediatrics4, Pusan National University Children’s Hospital, Yangsan, Korea We present the case of a 5-year-old child with coronary complications due to Kawasaki disease;  this patient unintentionally underwent both dual-source computed tomography (DSCT) coronary  angiography and invasive coronary angiographic examination in 2 months.",Non-OADS,/arxiv_data1/oa_pdf/dc/bd/kjped-58-501.PMC4705331.pdf
"The fever was not completely Corresponding author: Min-Jung Cho, MD Department of Pediatrics, Pusan National University  Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241,  Korea Tel: +82-51-240-7298 Fax: +82-55-360-2181 E-mail: mjchomd@gmail.com Received: 9 September, 2013 Revised: 15 November, 2013 Accepted: 18 November, 2013 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2015;58(12):501­504 http://dx.doi.org/10.3345/kjp.2015.58.12.501 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/dc/bd/kjped-58-501.PMC4705331.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.501Hwang EH, et al.",OADS,/arxiv_data1/oa_pdf/dc/bd/kjped-58-501.PMC4705331.pdf
503 http://dx.doi.org/10.3345/kjp.2015.58.12.501Korean J Pediatr 2015;58(12):501-504 Coronary CT angiography has the advantages of minimal  invasiveness and rapid assessment of coronary lesions in the  evaluation and follow-up of KD.,Non-OADS,/arxiv_data1/oa_pdf/dc/bd/kjped-58-501.PMC4705331.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.501Hwang EH, et al.",OADS,/arxiv_data1/oa_pdf/dc/bd/kjped-58-501.PMC4705331.pdf
"505 http://dx.doi.org/10.3345/kjp.2015.58.12.505Korean J Pediatr 2015;58(12):505-508 Alveolar rhabdomyosarcoma with massive dis ­ seminated intravascular coagulopathy treated  with systemic chemotherapy  Byung Gyu Yoon, MD1, Hee Jo Baek, MD, PhD1, Burm Seok Oh, MD1, Dong Kyun Han, MD, PhD1, Yoo Duk Choi, MD2, Hoon Kook, MD, PhD1,  Departments of 1Pediatrics and 2Pathology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea  It is uncommon for pediatric patients with rhabdomyosarcoma to present with clinical and/or laboratory  features of disseminated intravascular coagulation (DIC).",Non-OADS,/arxiv_data1/oa_pdf/c0/2b/kjped-58-505.PMC4705332.pdf
"Early administration of chemotherapy and vigorous supportive care  could control the massive bleeding and DIC.Corresponding author: Hee Jo Baek, MD, PhD Department of Pediatrics, Chonnam National Uni ­ versity Hwasun Hospital, Chonnam National Uni ­ versity Medical School, 322 Seoyang ­ro, Hwasun  58128, Korea Tel: +82­61­379­7695 Fax: +82­61­379­7697 E­mail: swan93@lycos.co.kr Received: 25 October, 2013 Revised: 13 May, 2014 Accepted: 16 May, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2015;58(12):505­508 http://dx.doi.org/10.3345/kjp.2015.58.12.505 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/c0/2b/kjped-58-505.PMC4705332.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.505Yoon BG, et al.",OADS,/arxiv_data1/oa_pdf/c0/2b/kjped-58-505.PMC4705332.pdf
507 http://dx.doi.org/10.3345/kjp.2015.58.12.505Korean J Pediatr 2015;58(12):505-508 right axillary space (Fig.,Non-OADS,/arxiv_data1/oa_pdf/c0/2b/kjped-58-505.PMC4705332.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.12.505Yoon BG, et al.",OADS,/arxiv_data1/oa_pdf/c0/2b/kjped-58-505.PMC4705332.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Gene Therapy website (http://www.nature.com/gt)CRISPR/Cas9 DNA cleavage at SNP-derived PAM DG Courtney et al 112 Gene Therapy (2016) 108 –112 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/5c/99/gt201582a.PMC4705418.pdf
"bwh.harvard.edu/pph2/) and SIFT (http://sift.bii.a-star.edu.sg/).Because both algorithms returned predictions that showed some discrepancies, we selected all four missense mutations for functional analyses (Supplementary Table S3).",OADS,/arxiv_data1/oa_pdf/61/3f/leu2015202a.PMC4705429.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)JAK2 mutations in T-cell lymphoblastic lymphoma AM Roncero et al 103 © 2016 Macmillan Publishers Limited Leukemia (2016) 94 –103",Non-OADS,/arxiv_data1/oa_pdf/61/3f/leu2015202a.PMC4705429.pdf
( a) Cross-species alignment for target sequences of the PCBP2- speci ﬁc qPCR assay PCBP2 gene sequences were accessed using the UCSC Genome Browser (http://genome.ucsc.edu; Build GRCh37/hg19) and its Vertebrate Multiz Alignment track.,OADS,/arxiv_data1/oa_pdf/76/29/gt201560a.PMC4705430.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Gene Therapy website (http://www.nature.com/gt)Cross-species duplex qPCR for lentiviral vectors I Christodoulou et al 118 Gene Therapy (2016) 113 –118 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/76/29/gt201560a.PMC4705430.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Replication of V. cholerae inside amoebae C Van der Henst et al 910 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/dd/1a/ismej2015165a.PMC4705440.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/b9/rjv175.PMC4705442.pdf
"For an ex-perimental validation of our theoretical results, we built a libraryofgeneticcircuitsusingthepartsregistryrepository (http://parts.igem.org/Main Page)(21–23).",Non-OADS,/arxiv_data1/oa_pdf/9a/18/gkv1280.PMC4705654.pdf
(2015) http://parts.igem.org/Main Page.,Non-OADS,/arxiv_data1/oa_pdf/9a/18/gkv1280.PMC4705654.pdf
"A web-interface to the au- tomated design method, called the Riboswitch Calculator, is accessibleat http://salislab.net/software .",OADS,/arxiv_data1/oa_pdf/04/10/gkv1289.PMC4705656.pdf
AVAILABILITY Programsandcommandsdevelopedfortheanalysis(Cand Rlanguage) are available here: https://github.com/axelcournac/Repeats elements SUPPLEMENTARY DATA Supplementary Data are available at NAR Online.,OADS,/arxiv_data1/oa_pdf/dc/73/gkv1292.PMC4705657.pdf
"Determination of the sequence conservation levels The SiPhy ( 47) algorithm and software package were used to estimate /H9275, the deviation of the branch length compared to the neutral tree based on the total num- ber of substitutions estimated from the alignment of the region of interest across 29 placental mammals(build hg19, http://hgdownload.cse.ucsc.edu/goldenPath/ hg19/multiz46way/maf/ ).",OADS,/arxiv_data1/oa_pdf/6d/f2/gkv1332.PMC4705665.pdf
SMART has been released as a Pythonpackagecalled‘SMART-BS-Seq’andisfreelyavail-able from the Python Package Index ( https://pypi.python.,OADS,/arxiv_data1/oa_pdf/6d/f2/gkv1332.PMC4705665.pdf
All resources produced in this study are publicly available through the Human Methyla-tion MarkAtlas ( http://fame.edbc.org/methymark ).,OADS,/arxiv_data1/oa_pdf/6d/f2/gkv1332.PMC4705665.pdf
"To facilitate theminingoftheMethyMarksacrosscelltypesandspecies, all of the algorithms used in this procedure were inte-gratedintoaSpecificMethylationAnalysisandReportTool (SMART),whichisavailableat http://fame.edbc.org/smart .",OADS,/arxiv_data1/oa_pdf/6d/f2/gkv1332.PMC4705665.pdf
"An atlas of the cell type-specific methylation marks across human celltypes Using SMART, we further identified the HypoMarks and HyperMarks for each of the 42 human cell types and pre- sentedahumanmethylationmarkatlas,whichisavailableathttp://fame.edbc.org/methymark .",OADS,/arxiv_data1/oa_pdf/6d/f2/gkv1332.PMC4705665.pdf
"An Ensembl transcript ID to Entrez gene ID mapping table was generated using Ensembl’s Biomart tool ( http://www.ensembl.org/biomart/ martview/ ), utilizing Ensembl Genes v76 for Homo Sapi- ens (GRCH38).",OADS,/arxiv_data1/oa_pdf/eb/ea/gkv1460.PMC4705677.pdf
MethylAction is available as an R package at http://jeffbhasin.github.io/methylaction .,Non-OADS,/arxiv_data1/oa_pdf/70/7f/gkv1461.PMC4705678.pdf
"Computational performance comparison Run time and peak RAM usage was measured while run- ning MethylAction, MEDIPS and diffReps using Syrupy (https://github.com/jeetsukumaran/Syrupy ).",OADS,/arxiv_data1/oa_pdf/70/7f/gkv1461.PMC4705678.pdf
Dyna- MIT is freely available at http://cibioltg.bitbucket.org .,OADS,/arxiv_data1/oa_pdf/88/19/gkv807.PMC4705680.pdf
"DynaMIT is imple- mentedasanopen-sourcePythonpackage,andcanbeused stand-alone or easily embedded in complex bioinformaticpipelines; it is freely available at http://cibioltg.bitbucket.",OADS,/arxiv_data1/oa_pdf/88/19/gkv807.PMC4705680.pdf
Installing and running DynaMIT The package can be downloaded from the DynaMIT website ( http://cibioltg.bitbucket.org ) or installed directly through the Python Package Index ( https://pypi.python.,OADS,/arxiv_data1/oa_pdf/88/19/gkv807.PMC4705680.pdf
"Additional annotation A set of annotations, based on the content of the AURA 2d a t a b a s e( 28) are available at http://aura.science.unitn.",OADS,/arxiv_data1/oa_pdf/88/19/gkv807.PMC4705680.pdf
"DynaMIT (with either all or only two motif searchers, namely MEME andGLAM2, and the XXX integration strategy), MEME, GLAM2 andWeederwererunonthesedatasets.TheRNA sequence data sets were composed by including three ran- domly generated sequences sets produced with MotifGen(https://galaxy.cbio.mskcc.org/ ) by implanting the motif of case example 1 or the two 9-nucleotides AU-rich element pattern ( 32).",OADS,/arxiv_data1/oa_pdf/88/19/gkv807.PMC4705680.pdf
http://www.scipy.org .,Non-OADS,/arxiv_data1/oa_pdf/88/19/gkv807.PMC4705680.pdf
"(2014) R:Alanguageandenvironmentforstatistical computing .RFoundationforStatisticalComputing,Vienna, http://www.R-project.org .",Non-OADS,/arxiv_data1/oa_pdf/88/19/gkv807.PMC4705680.pdf
"The raw dataareisomiRsequences.Wereportedexpressionintwoforms: as raw read counts and as counts normalized to reads per million mapped reads (RPM), and we submitted both formsasisomiRandstem-loopexpressiondataarchivesto the TCGA data portal ( https://tcga-data.nci.nih.gov/tcga/ dataAccessMatrix.htm ).",OADS,/arxiv_data1/oa_pdf/df/04/gkv808.PMC4705681.pdf
"For those who wish to apply other profiling pipelines, to identify novel miRNAs, or to do analyses thataddress sequence variants and untemplated additions, we alsosubmittedtocgHub( https://cghub.ucsc.edu )BAM(8) files that contain exact-match, mismatch and unaligned se-quence reads.",Non-OADS,/arxiv_data1/oa_pdf/df/04/gkv808.PMC4705681.pdf
"Because the shortest mature miRNA in miRBase v16 is 15bp,wediscardedanytrimmedreadthatwasshorterthan 15bp.WeusedBWA-MEMwithparameterssamse-n10( 9) to align the remaining reads to a reference genome, which, for most TCGA cancers, was GRCh37 ( http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/df/04/gkv808.PMC4705681.pdf
"Finally, we used an in-house tool based on iterative principal compo- nents analysis to screen samples for lane-wise batch effects (http://www.bcgsc.ca/platform/bioinfo/software/bliss ).",OADS,/arxiv_data1/oa_pdf/df/04/gkv808.PMC4705681.pdf
"AVAILABILITY The profiling pipeline runs on Linux and Unix-like sys- tems and is available at: http://www.bcgsc.ca/platform/ bioinfo/software/mirna-profiling , and the adapter trim- ming software at: http://www.bcgsc.ca/platform/bioinfo/ software/adapter-trimming-for-small-rna-sequencing .",OADS,/arxiv_data1/oa_pdf/df/04/gkv808.PMC4705681.pdf
Bladder and breast can- cerpatientsweregroupedaccordingtohighandlowEPC-1 mRNAlevelsbasedonanexpressionsignaturegeneratedbyusingthecancerbrowser( https://genome-cancer.ucsc.edu ).,OADS,/arxiv_data1/oa_pdf/e8/14/gkv885.PMC4705687.pdf
"To gain further insight into the mechanism by which EPC1 regulates survival of malig- nantcells,sequencemotifanalysis( http://myhits.isb-sib.ch/ cgi-bin/motif scan)wasperformedforfunctionprediction.",Non-OADS,/arxiv_data1/oa_pdf/e8/14/gkv885.PMC4705687.pdf
"Cmr is non-essential for Mtb growth in vitro(32,34,35), but TraSH analysis showed a moderate ef- fect of Cmr on in vivogrowth in a murine model system (http://orca2.tamu.edu/U19/genes/detail/Rv1675c/ ).",Non-OADS,/arxiv_data1/oa_pdf/e9/9b/gkv889.PMC4705688.pdf
ThepredictedHTHregionofCmrisessentialforDNAbind- ing HTH domains are common as DNA binding motifs in many transcription factors and DNA binding proteins.We used a HTH prediction program ( http://npsa-pbil.ibcp.,Non-OADS,/arxiv_data1/oa_pdf/e9/9b/gkv889.PMC4705688.pdf
"In addition, MEME ( http://meme.nbcr.net/meme/cgi- bin/meme.cgi ) was not able to detect a binding motif with high confidence among these enriched DNA regions.",OADS,/arxiv_data1/oa_pdf/e9/9b/gkv889.PMC4705688.pdf
"(B) FunctionalclassificationoftheChIP-seqbindingsitesinvariouscategories,asannotatedinTuberculist( http://tuberculist.epfl.ch/ ).‘Genome’isshownas areferencefortheoveralldistributionofgenesasannotatedintheH37Rvgenome.‘Regions’representsthepercentagescalculatedusingenrichedr egions toaccountfortheeffectsofsiteclustering.‘Bindingsites’referstothedistributionofallsiteswithoutaccountingfortheredundancyduetosit eclustering.",OADS,/arxiv_data1/oa_pdf/e9/9b/gkv889.PMC4705688.pdf
Both the motifs were generated using http://meme.nbcr.net/meme/cgi-bin/meme.cgi .,OADS,/arxiv_data1/oa_pdf/e9/9b/gkv889.PMC4705688.pdf
"154NucleicAcidsResearch,2016,Vol.44,No.1 (28).ImageswereassembledusingImageJ(Rasband,W.S., National Institutes of Health, Bethesda, Maryland, USA; http://rsb.info.nih.gov/ij/ ) and Adobe Photoshop CS5 soft- ware.",OADS,/arxiv_data1/oa_pdf/6a/84/gkv900.PMC4705689.pdf
( B)False-coloredoverviewof1H6immuno-EMnanotomydataofFigure2availableat http://www.nanotomy.org/ .,Non-OADS,/arxiv_data1/oa_pdf/6a/84/gkv900.PMC4705689.pdf
Nanotomy of Figure 2 shown in C’ is available online at http://www.nanotomy.org ).,OADS,/arxiv_data1/oa_pdf/6a/84/gkv900.PMC4705689.pdf
"A high-resolution ‘nanotomy’ digital file of Figure 6, were gold-particles can be detected in a ‘Google-earth’ like analysis, is available online at http://www.nanotomy.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/6a/84/gkv900.PMC4705689.pdf
Enumeration of the number and location of immunogold particles observed by immune-electron microscopy in islet of Langerhans cells of rat pancreas.Resultsofindirectimmunogoldlabelingwith1H6andanIgG2bisotypecontrol(MOPC-141;Sigma).Rawdataofthisexperimentisavailablea s Figure6onlineat: http://www.nanotomy.org/ ).Abbreviations:Exp =experiment;Mab =monoclonalantibodyused;[c] =concentrationofantibodyused forstaininginmicrogram /ml;n=numberofcellsanalyzed;ngold /cell=averagenumberofgoldparticlespercell;Het =numberofgoldparticlespresent in heterochromatin; Eu =number of gold particles present in euchromatin; H /Er a t i o =number of gold particles present in heterochromatin relative to the number of gold particles present in euchromatin; mito =mitochondria; ER =endoplasmatic reticulum; ER cyto =cytoplasmic side of the ER; ER lumen =luminalsideoftheER;ERC /Lr a tio =ratioofthenumberofgoldparticlespresentinthecytoplasmicversustheluminalsideoftheER;ctr = isotypecontrolantibody,OADS,/arxiv_data1/oa_pdf/6a/84/gkv900.PMC4705689.pdf
"NucleicAcidsResearch,2016,Vol.44,No.1 235 bebuilt.Dataprocessingandplottingwereperformedusing Rsoftware,version 3.0.0 ( http://www.r-project.org/ ).",OADS,/arxiv_data1/oa_pdf/a7/a2/gkv997.PMC4705696.pdf
The posteriordistributionswereestimatedusingGibbssamplingsoftware JAGS3.4.0( http://mcmc-jags.sourceforge.net/ ).Additional details areprovided inthe SupplementaryMethods.,OADS,/arxiv_data1/oa_pdf/a7/a2/gkv997.PMC4705696.pdf
Available from: http://www.ghr.,Non-OADS,/arxiv_data1/oa_pdf/ab/f8/IJOrtho-49-589.PMC4705723.pdf
Available  from: http://www.shpr.se/en/Publications/DocumentsReports.,Non-OADS,/arxiv_data1/oa_pdf/d0/7d/IJOrtho-49-595.PMC4705724.pdf
Available from: http://www.surfacehippy.info/athletes.php [Last  accessed 2014 Jun 10].,Non-OADS,/arxiv_data1/oa_pdf/d0/7d/IJOrtho-49-595.PMC4705724.pdf
Available from http://www.new.njrcentre.org.uk/NjrCentre/ Portals/0/Documents/NJR%208th%20Annual%20Report%202011.,Non-OADS,/arxiv_data1/oa_pdf/d0/7d/IJOrtho-49-595.PMC4705724.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/66/bf/IJOrtho-49-602.PMC4705725.pdf
Available from: http://www.orthopaedicscore.com/scorepages/ international_knee_documentation_comitee.html.,Non-OADS,/arxiv_data1/oa_pdf/e3/56/IJOrtho-49-615.PMC4705727.pdf
"Accepted:  2015-08-15 orcid: 0000-0003-4012-7084 (Kevin C. Chan)    doi: 10.4103/1673-5374.169612          http://www.nrronline.org/ Nau AC, Murphy MC, Chan KC (2015) Use of sensory substitution devices as  a model system for investigating cross-modal neuroplasticity in humans.",Non-OADS,/arxiv_data1/oa_pdf/92/3c/NRR-10-1717.PMC4705765.pdf
"Goh)    doi: 10.4103/1673-5374.169607          http://www.nrronline.org/ Chin EW, Goh EL (2015) Studying neurological disorders using  induced pluripotent stem cells and optogenetics.",Non-OADS,/arxiv_data1/oa_pdf/ed/50/NRR-10-1720.PMC4705766.pdf
"Accepted:  2015-08-15 orcid: 0000-0002-9750-9596 (Kazunori Sango)    doi: 10.4103/1673-5374.169611          http://www.nrronline.org/ Sango K, Utsunomiya K (2015) Efficacy of glucagon-like peptide-1 mi - metics for neural regeneration.",OADS,/arxiv_data1/oa_pdf/9c/ff/NRR-10-1723.PMC4705767.pdf
"Accepted:  2015-10-08 doi: 10.4103/1673-5374.170287          http://www.nrronline.org/ Dumpich M, Theiss C (2015) VEGF in the nervous system: an important  target for research in neurodevelopmental and regenerative medicine.",Non-OADS,/arxiv_data1/oa_pdf/12/e5/NRR-10-1725.PMC4705768.pdf
Accepted:  2015-10-08 orcid: 0000-0003-4762-5262 (Guido Hermey)    doi: 10.4103/1673-5374.170288          http://www.nrronline.org/ Hermey G (2015) Intracellular sorting pathways of the amyloid precursor pro - tein provide novel neuroprotective strategies.,Non-OADS,/arxiv_data1/oa_pdf/5e/74/NRR-10-1727.PMC4705769.pdf
"Accepted:  2015-07-15 doi:10.4103/1673-5374.170294          http://www.nrronline.org/ Hajieva P, Moosmann B (2015) Brain protein oxidation: what does it re - flect?",Non-OADS,/arxiv_data1/oa_pdf/14/94/NRR-10-1729.PMC4705770.pdf
Accepted:  2015-07-17 orcid: 0000-0001-5613-5420  (Leyan Xu )  doi:10.4103/1673-5374.165319          http://www.nrronline.org/ Xu L (2015) Animal model of repetitive mild traumatic brain injury for  human traumatic axonal injury and chronic traumatic encephalopathy.,Non-OADS,/arxiv_data1/oa_pdf/06/92/NRR-10-1731.PMC4705771.pdf
"Accepted:  2015-08-03 orcid: 0000-0003-2489-4689 (Antonio Ibarra)    doi: 10.4103/1673-5374.165288          http://www.nrronline.org/ Cruz Y, Suárez-Meade P, Ibarra A (2015) Immunization with Cop-1 promotes  neuroprotection and neurogenesis after ischemic stroke.",Non-OADS,/arxiv_data1/oa_pdf/33/29/NRR-10-1733.PMC4705772.pdf
Geneva: World Health Organization; 2014 (http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/33/29/NRR-10-1733.PMC4705772.pdf
"Accepted:  2015-07-18 orcid: 0000-0003-0197-0503 (Guillermo Garcia-Alias)   doi: 10.4103/1673-5374.165318          http://www.nrronline.org/ García-Alías G, Edgerton VR (2015) Who is who after spinal cord injury  and repair?",Non-OADS,/arxiv_data1/oa_pdf/69/0b/NRR-10-1735.PMC4705773.pdf
"Accepted:  2015-10-14 orcid: 0000-0001-5756-3718 (Jana Glumm)    doi: 10.4103/1673-5374.170295          http://www.nrronline.org/ Pohland M, Glumm J (2015) Propriospinal interneurons in the spotlight for  anatomical and functional recovery after spinal cord injury.",Non-OADS,/arxiv_data1/oa_pdf/c7/31/NRR-10-1737.PMC4705774.pdf
Accepted:  2015-10-15 orcid: 0000-0001-5602-0850 (Jan Hoeber)    doi: 10.4103/1673-5374.170296          http://www.nrronline.org/ Hoeber J (2015) Sensory regeneration in dorsal root avulsion.,OADS,/arxiv_data1/oa_pdf/7f/9a/NRR-10-1739.PMC4705775.pdf
Accepted:  2015-07-27 orcid : 0000-0003-2498-3649 (Francesca Cavallo) doi: 10.4103/1673-5374.165297          http://www.nrronline.org/ Cavallo F (2015) Compliant semiconductor scaffolds: building blocks for  advanced neural in terfaces.,Non-OADS,/arxiv_data1/oa_pdf/9d/36/NRR-10-1741.PMC4705776.pdf
"Accepted:  2015-08-22 orcid: 0000-0003-1951-3175 (Aviva M. Tolkovsky) doi: 10.4103/1673-5374.165298          http://www.nrronline.org/ Brelstaff J, Spillantini MG, Tolkovsky AM (2015) pFTAA: a high affinity  oligothiophene probe that detects filamentous tau in vivo and in cultured neu - rons.",Non-OADS,/arxiv_data1/oa_pdf/b5/f3/NRR-10-1746.PMC4705778.pdf
"Accepted:  2015-08-17 orcid: 0000-0002-4045-8265 (André Toulouse)    doi: 10.4103/1673-5374.169606          http://www.nrronline.org/ Toulouse A, Nolan YM (2015) A role for mitogen-activated protein kinase  phosphatase 1 (MKP1) in neural cell development and survival.",Non-OADS,/arxiv_data1/oa_pdf/75/4f/NRR-10-1748.PMC4705779.pdf
"Accepted:  2015-08-12 orcid: 0000-0002-6731-6187 (Cristina Angeloni)    0000-0003-0349-7772 (Marco Malaguti)   0000-0001-7857-4512 (Silvana Hrelia)    doi: 10.4103/1673-5374.169613          http://www.nrronline.org/ Angeloni C, Malaguti M, Hrelia S (2015) Antiglycative activity of  sulforaphane: a new avenue to counteract neurodegeneration?",Non-OADS,/arxiv_data1/oa_pdf/58/b3/NRR-10-1750.PMC4705780.pdf
Accepted:  2015-07-15 orcid: 0000-0002-4882-4143 (Edgar R. Kramer) doi: 10.4103/1673-5374.165295          http://www.nrronline.org/ Kramer ER (2015) The neuroprotective and regenerative potential of  parkin and GDNF/Ret signaling in the midbrain dopaminergic sys - tem.,OADS,/arxiv_data1/oa_pdf/4c/91/NRR-10-1752.PMC4705781.pdf
"Accepted:  2015-09-25 doi: 10.4103/1673-5374.169609          http://www.nrronline.org/ Hügel HM, Jackson N (2015) Polyphenols for the prevention and  treatment of dementia diseases.",Non-OADS,/arxiv_data1/oa_pdf/41/b0/NRR-10-1756.PMC4705783.pdf
Accepted:  2015-09-15 doi: 10.4103/1673-5374.169610          http://www.nrronline.org/ Xiao J (2015) Perspectives on neuroreparative therapies for treating  multiple sclerosis.,Non-OADS,/arxiv_data1/oa_pdf/df/3b/NRR-10-1759.PMC4705784.pdf
Accepted:  2015-07-20 orcid:  0000-0002-9711-5343 (Dusanka S. Skundric) doi: 10.4103/1673-5374.165294          http://www.nrronline.org/ Skundric DS (2015) Chemotactic signaling and beyond: link between  interleukin-16 and axonal degeneration in multiple sclerosis.,OADS,/arxiv_data1/oa_pdf/5b/3f/NRR-10-1761.PMC4705785.pdf
"Accepted:  2015-08-25 doi: 10.4103/1673-5374.165320          http://www.nrronline.org/ Hebron M, Moussa CEH (2015) Two sides of the same coin: tyrosine  kinase inhibitionin cancer and neurodegeneration.",Non-OADS,/arxiv_data1/oa_pdf/0b/2a/NRR-10-1767.PMC4705787.pdf
"Accepted:  2015-09-06 orcid: 0000-0002-8914-7273 (Wiesław Marcol)    doi: 10.4103/1673-5374.170299          http://www.nrronline.org/ Suszy ński K, Marcol W, Górka D (2015) Physiotherapeutic techniques  used in the management of patients with peripheral nerve injuries.",Non-OADS,/arxiv_data1/oa_pdf/49/69/NRR-10-1770.PMC4705788.pdf
GO-Analysis was per - formed based on Gene Ontology (http://www.geneontology.org/).,OADS,/arxiv_data1/oa_pdf/9a/3b/NRR-10-1799.PMC4705791.pdf
GO-Analysis was performed based on  Gene Ontology (http://www.geneontology.org/).,OADS,/arxiv_data1/oa_pdf/9a/3b/NRR-10-1799.PMC4705791.pdf
GO-Analysis was performed based on Gene Ontology  (http://www.geneontology.org/).,OADS,/arxiv_data1/oa_pdf/9a/3b/NRR-10-1799.PMC4705791.pdf
GO-Anal - ysis was performed based on Gene Ontology (http://www.geneontology.,OADS,/arxiv_data1/oa_pdf/9a/3b/NRR-10-1799.PMC4705791.pdf
"miRNA-GO-network analysis  T o identify the core gene function that is controlled in - tensively by multiple miRNAs, we constructed a miR - NA-GO-network via gene-sets between miRNAs and  significant biological processes using GO-analysis in Cyto - scape software (http://www.Cytoscape.org).",OADS,/arxiv_data1/oa_pdf/9a/3b/NRR-10-1799.PMC4705791.pdf
"Pathway analysis of differentially expressed miRNAs T o further study the functions and underlying mechanisms  of these differentially expressed miRNAs under cerebral isch - emia/reperfusion conditions, KEGG (http://www.genome.",Non-OADS,/arxiv_data1/oa_pdf/9a/3b/NRR-10-1799.PMC4705791.pdf
"Green marked nodes were associated with GO  biological process analysis using Cytoscape software (http://www.cy - toscape.org), and red marked nodes are associated with up-regulated  miRNAs.Figure 9 Molecular function classification in GO analysis of the top  ten down-regulated miRNAs.",OADS,/arxiv_data1/oa_pdf/9a/3b/NRR-10-1799.PMC4705791.pdf
GO-Analysis was performed based on Gene  Ontology (http://www.geneontology.org/).,OADS,/arxiv_data1/oa_pdf/9a/3b/NRR-10-1799.PMC4705791.pdf
"Green marked nodes represent GO biological  process analysis in Cytoscape software (http://www.cytoscape.org), and  red marked nodes represent down-regulated miRNAs.",OADS,/arxiv_data1/oa_pdf/9a/3b/NRR-10-1799.PMC4705791.pdf
"Following GO analysis, the Kyoto Encyclopedia of Genes and Genomes  (KEGG) (http://www.genome.jp/kegg/) was used to analyze the signal - ing pathways of specified miRNA target genes.",OADS,/arxiv_data1/oa_pdf/9a/3b/NRR-10-1799.PMC4705791.pdf
Supplementary data:  Supplementary information is available  at http://www.nrronlin e.org.,OADS,/arxiv_data1/oa_pdf/21/2e/NRR-10-1841.PMC4705799.pdf
"Accepted:  2015-09-02 orcid: 0000-0002-2695-7957 (Jeong Pyo Seo)    doi: 10.4103/1673-5374.170320          http://www.nrronline.org/ Jang SH, Seo JP (2015) Injury of corticoreticular pathway and corti - cospinal tract caused by ventriculoperitoneal shunting.",Non-OADS,/arxiv_data1/oa_pdf/45/f1/NRR-10-1874.PMC4705805.pdf
"Accepted:  2015-10-08 orcid: 0000-0001-6383-5505 (Sung Ho Jang)    doi: 10.4103/1673-5374.170321          http://www.nrronline.org/ Kim JW, Lee HD, Jang SH (2015) Severe bilateral anterior cingulum  injury in patients with mild traumatic brain injury.",Non-OADS,/arxiv_data1/oa_pdf/88/82/NRR-10-1876.PMC4705806.pdf
"Accepted:  2015-09-28 orcid: 0000-0003-0137-6352 (Dong Wang)    doi: 10.4103/1673-5374.170322          http://www.nrronline.org/ Tao JJ, Zhang WJ, Wang D, Jiang CJ, Wang H, Li W, Ji WY, Wang Q (2015)  Susceptibility weighted imaging in the evaluation of hemorrhagic diffuse axo - nal injury.",Non-OADS,/arxiv_data1/oa_pdf/0e/26/NRR-10-1879.PMC4705807.pdf
"Translation 2014; 2:e27694; http://dx.doi.org/10.4161/trla.27694Internal translation initiation from HIV-1  transcripts is conferred by a common RNA  structure Terra-Dawn M Plank1†, James T Whitehurst3†, Regina c encic4, Jerry Pelletier4,5 & Jeffrey s Kieft1,2* 1Department of Biochemistry and Molecular Genetics and University of colorado Denver s chool of Medicine, aurora, c O Usa; 2howard h ughes Medical Institute, University  of c olorado Denver s chool of Medicine, aurora, c O Usa; 3Department of Pharmacology, University of c olorado Denver, s chool of Medicine, aurora, c O Usa; 4Department of  Biochemistry, McGill University, Montreal, Quebec, Q c canada; 5The Rosalind and Morris Goodman c ancer Research c enter, McGill University, Montreal, Q c canada †These authors contributed equally to this article.",Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Supplementary Material Supplementary material may be found here:  https://www.landesbioscience.com/journals/translation/article/27694/ References 1.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Prog Nucleic  Acid Res Mol Biol 1996; 54:1-34; PMID:8768071;  http://dx.doi.org/10.1016/S0079-6603(08)60359-1 2.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Cell 2009; 136:731-45; PMID:19239892;  http://dx.doi.org/10.1016/j.cell.2009.01.042 3.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Biochem Soc  Trans 2005; 33:1231-41; PMID:16246087; http://dx.doi.org/10.1042/BST200512314.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Nat  Rev Microbiol 2007; 5:128-40; PMID:17224922; http://dx.doi.org/10.1038/nrmicro1599 5.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Cold Spring Harb Perspect Biol 2012;  4:4; PMID:22815232; http://dx.doi.org/10.1101/ cshperspect.a011544 6.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
J Cell Biol  1991; 115:887-903; PMID:1955461; http://dx.doi.org/10.1083/jcb.115.4.887 8.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Cell  1986; 44:283-92; PMID:3943125; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Cold Spring Harb Perspect Biol 2013; 5:5; PMID:23378589; http://dx.doi.org/10.1101/ cshperspect.a011569,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Wiley Interdiscip Rev RNA 2012; 3:195- 212; PMID:22215521; http://dx.doi.org/10.1002/ wrna.1105 11.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
J Virol 2001; 75:181-91; PMID:11119587;  http://dx.doi.org/10.1128/JVI.75.1.181-191.2001 12.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Retrovirology 2009; 6:74; PMID:19671151;  http://dx.doi.org/10.1186/1742-4690-6-74 14.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Nucleic  Acids Res 2013; 41:6698-714; PMID:23661682;  http://dx.doi.org/10.1093/nar/gkt358 15.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Nature 2009; 460:711- 6; PMID:19661910; http://dx.doi.org/10.1038/ nature08237 16.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
PLoS Biol 2008; 6:e96;  PMID:18447581; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
J Mol Biol 1993;  229:382-97; PMID:8429553; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
J Biol Chem 2002;  277:19967-75; PMID:11896057; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
J Mol Biol 2004; 336:369- 79; PMID:14757051; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
RNA 2001; 7:143-57; PMID:11214176; http://dx.doi.org/10.1017/ S1355838201001881 21.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
J Am Chem Soc 2005; 127:4223- 31; PMID:15783204; http://dx.doi.org/10.1021/ ja043822v 22.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Curr Opin Struct Biol  2009; 19:267-76; PMID:19362464; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
FEBS J 2012;  279:3098-111; PMID:22759308; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Mol Cell Biol 2003; 23:687- 98; PMID:12509466; http://dx.doi.org/10.1128/ MCB.23.2.687-698.2003 26.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Science 1988; 242:93- 7; PMID:3051379; http://dx.doi.org/10.1126/ science.3051379 27.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Nature 1998; 394:854-9;  PMID:9732867; http://dx.doi.org/10.1038/29703 28.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Nucleic  Acids Res 1984; 12:3873-93; PMID:6328442;  http://dx.doi.org/10.1093/nar/12.9.3873 29.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Cell Cycle 2011; 10:229-40; PMID:21220943;  http://dx.doi.org/10.4161/cc.10.2.14472 30.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Oncogene 2008; 27:1033-5; PMID:17767196; http://dx.doi.org/10.1038/ sj.onc.1210777 31.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Oncogene  2004; 23:3200-7; PMID:15094769; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Nucleic Acids Res  2011; 39:6186-200; PMID:21482538; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
J  Biol Chem 2009; 284:31350-62; PMID:19737937;  http://dx.doi.org/10.1074/jbc.M109.048736 34.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
"J Neuroimmune Pharmacol 2011; 6:308- 21; PMID:21360055; http://dx.doi.org/10.1007/ s11481-011-9265-8 35. de Breyne S, Soto-Rifo R, López-Lastra M, Ohlmann T. Translation initiation is driven by different mecha - nisms on the HIV-1 and HIV-2 genomic RNAs.",Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Virus Res 2013; 171:366-81; PMID:23079111;  http://dx.doi.org/10.1016/j.virusres.2012.10.006 36.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
AIDS Res Hum Retroviruses 1993; 9:331-5; PMID:8512748; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Biochem Soc Trans 2008; 36:690-3; PMID:18631141; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
PLoS One  2013; 8:e68108; PMID:23861855; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Curr  Opin Microbiol 2000; 3:366-70; PMID:10972496;  http://dx.doi.org/10.1016/S1369-5274(00)00106-5 41.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Proc Natl Acad Sci U S A 1998; 95:11089-94; PMID:9736694; http://dx.doi.org/10.1073/ pnas.95.19.11089 42.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Nucleic Acids Res  2011; 39:5232-44; PMID:21393254; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
PLoS One 2013; 8:e68665; PMID:23840900; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Nucleic Acids Res 2013; 41:6286-99; PMID:23630313;  http://dx.doi.org/10.1093/nar/gkt306 48.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
EMBO J 2012; 31:3745-56; PMID:22872150; http://dx.doi.org/10.1038/ emboj.2012.220 49.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
PLoS Pathog 2012; 8:e1002612; PMID:22457629;  http://dx.doi.org/10.1371/journal.ppat.1002612 50.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Biochem  Soc Trans 2010; 38:1548-52; PMID:21118124; http://dx.doi.org/10.1042/BST0381548 51.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
PLoS One  2009; 4:e7997; PMID:19956697; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
J Biol Chem 2009;  284:11364-73; PMID:19204000; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Oncogene 1998; 16:423-8; PMID:9467968; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
RNA 2011; 17:1258-73; PMID:21606179; http://dx.doi.org/10.1261/ rna.2594011 56.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Methods Enzymol 2009; 468:67-89; PMID:20946765; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
RNA 2013; 19:63- 73; PMID:23188808; http://dx.doi.org/10.1261/ rna.036327.112 58.,OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
Science 2011; 334:242-5; PMID:21998393; http://dx.doi.org/10.1126/science.1210460,Non-OADS,/arxiv_data1/oa_pdf/4f/d1/ktrs-02-01-10927694.PMC4705822.pdf
"Translation 2014; 2:e27738; http://dx.doi.org/10.4161/trla.27738AURA 2 Empowering discovery of post-transcriptional networks  erik Dassi*, a ngela Re, s ara Leo, Toma Tebaldi, Luigi Pasini, Daniele Peroni and a lessandro Quattrone* Laboratory of Translational Genomics; c entre for Integrative Biology; University of Trento; Trento, Italy Keywords:  post-transcriptional regulation, UTR, translatome, database, RNA-binding protein, non-coding RNA, regulatory  network, cis-element, RNA modification, CLIP Abbreviations:  AURA, Atlas of UTR Regulatory Activity; PTR, post-transcriptional regulation; UTR, untranslated region  of mRNA; RBP, RNA-binding protein; ncRNA, non-coding RNA; lncRNA, long non-coding RNA; m5C, RNA cytosine  methylation at C5 position; m6A, RNA adenosine methylation at A6 position; SNP, single nucleotide polymorphism; CLIP, cross- linking and immunoprecipitation; REST, Representational State Transfer; API, Application Programming Interface Post-transcriptional regulation (PTR) of gene expression is now recognized as a major determinant of cell phenotypes.",Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
a URa 2 is available at http://aura.science.unitn.it.,Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Supplementary Material Supplementary material may be found here:  http://www.landesbioscience.com/journals/translation/article/27738/ References 1.,Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nature 2011; 473:337-42;  PMID :21593866 ;  http://dx.doi.org/10.1038/nature10098 2.,Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Mol Syst Biol 2010;  6:400;  PMID:20739923 ; http://dx.doi.org/10.1038/ msb.2010.59 3.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
BMC Genomics  2012; 13:220;  PMID:22672192 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Methods 2009; 48:301-5; PMID:19426805 ;  http://dx.doi.org/10.1016/j.ymeth.2009.04.0205.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Methods Enzymol  2010; 470:119-42;  PMID:20946809 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nat Protoc 2006; 1:302-7;  PMID:17406249 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Science 2003; 302:1212- 5; PMID:14615540 ; http://dx.doi.org/10.1126/ science.1090095 8.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Cell 2010;  141:129-41;  PMID:20371350 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nat Struct Mol Biol  2010 ; 17:909-15;  PMID:20601959 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
RNA Biol 2012; 9:1224-32;  PMID:22995832 ; http://dx.doi.org/10.4161/ rna.22035 11.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic Acids Res 2005; 33:7138-50;  PMID:16391004 ; http://dx.doi.org/10.1093/nar/ gki1012 12.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Trends Biochem  Sci 2013; 38:204-9; PMID:23337769 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Genome Res 2012; 22:1173-83;  PMID:22454233 ;  http://dx.doi.org/10.1101/gr.132563.111 15.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic Acids Res 2009; 37:e115; PMID:19561200 ;  http://dx.doi.org/10.1093/nar/gkp542 17.,Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Genome Res 2012; 22:947- 56; PMID:22369889 ; http://dx.doi.org/10.1101/ gr.130559.111 18.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic Acids Res 2013; 41(D1):D43-7;  PMID:23161681 ; http://dx.doi.org/10.1093/nar/ gks1068 20.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic Acids Res 2011; 39(D1):D301-8;  PMID:21036867 ; http://dx.doi.org/10.1093/nar/ gkq1069 21.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nature  2013; 499:172-7;  PMID:23846655 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Cell 2013;  153:654-65;  PMID:23622248 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Genome Res  2012; 22:2208-18;  PMID:22879431 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Proc Natl Acad Sci U S A 2012; 109:E2424-32; PMID:22927429 ; http://dx.doi.org/10.1073/ pnas.120784610925.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic  Acids Res 2008; 36:3707-15; PMID:18480124 ;  http://dx.doi.org/10.1093/nar/gkn248 26.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic Acids Res 2013; 41:3201-16; PMID:23376935 ; http://dx.doi.org/10.1093/nar/ gkt017 27.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Bioinformatics 2010; 26:1772-6; PMID:20547637 ; http://dx.doi.org/10.1093/ bioinformatics/btq285 28.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic Acids Res 2001; 29:308-11;  PMID:11125122 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic  Acids Res 2011; 39(D1):D945-50; PMID:20952405 ;  http://dx.doi.org/10.1093/nar/gkq929 30.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
BMC Bioinformatics  2009; 10:421;  PMID:20003500 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Genome Res 2009; 19:1630- 8; PMID:19570905 ; http://dx.doi.org/10.1101/ gr.094607.109 32.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nat Genet 2013; 45:580-5;  PMID:23715323 ; http://dx.doi.org/10.1038/ ng.2653 33.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Bioinformatics 2009; 25:1974-5; PMID:19398448 ;  http://dx.doi.org/10.1093/bioinformatics/btp250 34.,Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Mol Cell 2012; 47:648-55;  PMID:22841487 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
( http://www.python.org/ ) 39.,Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
( http://www.djangoproject.com/ ) 40.,Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
http://jqueryui.com/ 41.,Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Bioinformatics 2010; 26:2347- 8; PMID:20656902 ; http://dx.doi.org/10.1093/ bioinformatics/btq430 42.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
http://www.gen - enames.org 43.,Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic Acids Res 2013;  41(D1):D885-91;  PMID:23175610 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nat Biotechnol 2010;  28:1248-50;  PMID:21139605 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic Acids Res 2011; 39(D1):D152-7;  PMID:21037258 ; http://dx.doi.org/10.1093/nar/ gkq1027 46.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic Acids Res 2009; 37(D1):D54-60;  PMID:18971253 ; http://dx.doi.org/10.1093/nar/ gkn783 47.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
http://amigo.geneontology.org 48.,Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nucleic Acids Res 2013; 41:6816-27; PMID:23748561 ; http://dx.doi.org/10.1093/nar/ gkt482 49.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nat Methods 2011; 8:559- 64; PMID:21572407 ; http://dx.doi.org/10.1038/ nmeth.1608 50.,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Genes Dev 2011; 25:1915-27;  PMID:21890647 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
Nat Biotechnol 2010; 28:511-5; PMID:20436464 ;  http://dx.doi.org/10.1038/nbt.1621,OADS,/arxiv_data1/oa_pdf/94/94/ktrs-02-01-10927738.PMC4705823.pdf
"Translation 2014; 2:e28586; http://dx.doi.org/10.4161/trla.28586Regulation of translation dynamic and neoplastic  conversion by tRNA and their pieces Renaud Geslain1* and Gilbert e riani2* 1Laboratory of tRNA Biology; Department of Biology; College of Charleston; Charleston, SC USA; 2Architecture et Réactivité de l’ARN, Université de Strasbourg; CNRS; i nstitut  de Biologie Moléculaire et Cellulaire; Strasbourg C eDeX, France Keywords:  transfer RNA, translation, misacylation, tRNA fragments, cancer, oxidative stress, gene regulation Abbreviations:  tRNA, transfer RNA molecule; RNase, ribonuclease; ROS, reactive oxygen species; MetRS, methionyl-tRNA  synthetases; tRFs, tRNA-derived RNA fragments; PBS, primer binding site Research on tRNA (tRNA) has gone a long way since the  existence of this essential adaptor of the genetic code was first  hypothesized five decades ago.",Non-OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nature 1981;  294:626-31; PMID:7312050; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Crit Rev Biochem  Mol Biol 2006; 41:77-102; PMID:16595295; http://dx.doi.org/10.1080/10409230600602634 4.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nucleic Acids Res 2004; 32:255-62;  PMID:14715923; http://dx.doi.org/10.1093/nar/ gkh1825.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
RNA 2002; 8:1189-232; PMID:12403461; http://dx.doi.org/10.1017/ S1355838202022021 6.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nucleic Acids Res 2013; 41:D262-7; PMID:23118484; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
EMBO  J 2011; 30:882-93; PMID:21285948; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nucleic Acids Res 2000; 28:1374-80; PMID:10684932; http://dx.doi.org/10.1093/ nar/28.6.1374 9.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Biochemistry 1999; 38:13338-46; PMID:10529209;  http://dx.doi.org/10.1021/bi991061g 10.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nucleic Acids Res 2006; 34:6137-46;  PMID:17088292; http://dx.doi.org/10.1093/nar/ gkl725 11.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
J Mol Biol 2010; 396:821-31;  PMID:20026070; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Proc Natl Acad Sci U S A 2011; 108:E794-802; PMID:21896722; http://dx.doi.org/10.1073/ pnas.1103698108 14.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
RNA 2012; 18:640-52; PMID:22357911;  http://dx.doi.org/10.1261/rna.030775.111 17.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Biochem Biophys Res Commun 2009; 385:160-4; PMID:19450555; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Proc Natl Acad Sci U S A 2000;  97:12619-24; PMID:11058163; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Proc Natl Acad Sci U S A 2011; 108:6933-8; PMID:21482813; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nucleic Acids Res 2012;  40:10494-506; PMID:22941646; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nature 2009; 462:522-6; PMID:19940929;  http://dx.doi.org/10.1038/nature08576 25.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Annu Rev Genet  2013; 47:121-37; PMID:23988117; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
J Cell Biochem 1999; 76:109- 17; PMID:10581005; http://dx.doi.org/10.1002/ (SICI)1097-4644(20000101)76:1<109::AID- JCB11>3.0.CO;2-K 27.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Genes Dev 2008;  22:2773-85; PMID:18923076; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Proc Natl Acad Sci U S A 2007;  104:18097-102; PMID:17989215; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
BMC Genomics 2008; 9:157; PMID:18402656;  http://dx.doi.org/10.1186/1471-2164-9-157 30.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
J Biol Chem 2005; 280:42744-9; PMID:16272149;  http://dx.doi.org/10.1074/jbc.M510356200 31.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Plant Physiol 2009; 150:378-87; PMID:19261735; http://dx.doi.org/10.1104/ pp.108.134767 32.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nucleic Acids Res  2008; 36:732-41; PMID:18084030; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nucleic Acids Res 2008; 36:6048- 55; PMID:18820301; http://dx.doi.org/10.1093/ nar/gkn596 34.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
RNA 2009; 15:2147-60;  PMID:19850906; http://dx.doi.org/10.1261/ rna.1738409 35.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nucleic Acids Res 2012; 40:6787-99;  PMID:22492706; http://dx.doi.org/10.1093/nar/ gks307 36.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
RNA  2010; 16:673-95; PMID:20181738; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
FEBS Lett 2009; 583:437-42; PMID:19114040; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
J Cell Biol 2009;  185:35-42; PMID:19332886; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
J Biol  Chem 2010; 285:10959-68; PMID:20129916;  http://dx.doi.org/10.1074/jbc.M109.077560 41.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
RNA Biol 2013; 10:553-63; PMID:23563448; http://dx.doi.org/10.4161/rna.24285 42.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
J Cell Biol 2009; 185:43-50; PMID:19332891; http://dx.doi.org/10.1083/jcb.200811119 43.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nucleic Acids Res  2008; 36:2677-89; PMID:18346967; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
RNA 2008; 14:2095-103; PMID:18719243; http://dx.doi.org/10.1261/ rna.1232808 45.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Mol Cell 2011; 43:613-23;  PMID:21855800; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Mol Cell 2009; 36:932- 41; PMID:20064460; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Proc Natl Acad Sci U S A  1988; 85:5507-11; PMID:3041414; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nucleic  Acids Res 2009; 37:6575-86; PMID:19729508;  http://dx.doi.org/10.1093/nar/gkp707 50.,Non-OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
PLoS One  2009; 4:e5908; PMID:19526060; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Dev Cell 2012; 23:251-64;  PMID:22863743; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
Nat Struct Mol Biol 2012; 19:1168- 75; PMID:23064648; http://dx.doi.org/10.1038/ nsmb.2400,OADS,/arxiv_data1/oa_pdf/aa/7d/ktrs-02-01-10928586.PMC4705824.pdf
"Translation 2014; 2:e28109; http://dx.doi.org/10.4161/trla.28109Co-translational mechanisms of quality control   of newly synthesized polypeptides valentina Gandin1,2* and ivan Topisirovic1,2* 1Lady Davis i nstitute for Medical Research; Sir Mortimer B. Davis-Jewish General Hospital; Montréal, QC Canada; 2Department of Oncology; McGill University; Montréal, QC  Canada Keywords:  translation, ribosome, proteasome, folding, chaperones During protein synthesis, nascent polypeptides emerge from  ribosomes to fold into functional proteins.",Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cell 2009; 136:731-45; PMID:19239892 ;  http://dx.doi.org/10.1016/j.cell.2009.01.042 3.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cell Biol Int Rep 1985; 9:463-70;  PMID:4016964 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cell Biol Int Rep  1980; 4:1081-90;  PMID:7460022 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nature 2000; 404:770-4; PMID:10783891 ;  http://dx.doi.org/10.1038/35008096 9.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Science  2000; 289:2117-20;  PMID:11000112 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell 2013; 50:368-78;  PMID:23583076 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Science 1973; 181:223- 30; PMID:4124164 ; http://dx.doi.org/10.1126/ science.181.4096.223 13.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell 2000; 6:1219- 32; PMID:11106759 ; http://dx.doi.org/10.1016/ S1097-2765(00)00118-0 14.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cell 2001; 107:361- 72; PMID:11701126 ; http://dx.doi.org/10.1016/ S0092-8674(01)00541-415.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nat Struct Mol Biol 2010; 17:313- 7; PMID:20139981 ; http://dx.doi.org/10.1038/ nsmb.1756 16.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Curr Opin Struct Biol  1999; 9:102-10;  PMID:10047582 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell  2010; 39:560-9;  PMID:20797628 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Annu Rev Biophys 2011; 40:337- 59; PMID:21370971 ; http://dx.doi.org/10.1146/ annurev-biophys-042910-155338 19.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cell 1992; 71:97-105; PMID:1394434 ;  http://dx.doi.org/10.1016/0092-8674(92)90269-I 22.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cell  2013; 152:196-209;  PMID:23332755 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell Biol  2012; 32:4769-79;  PMID :23007158 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Biol Chem 2000; 275:18985-94;  PMID:10748209 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Mol Biol 2002; 318:1367-79; PMID:12083524 ;  http://dx.doi.org/10.1016/S0022-2836(02)00190-0 32.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nat  Struct Mol Biol 2008; 15:1255-62; PMID:19011634 ;  http://dx.doi.org/10.1038/nsmb.1515 33.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Cell Biol  2010; 189:57-68;  PMID:20368618 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Science 2000; 289:920-30;  PMID:10937990 ; http://dx.doi.org/10.1126/ science.289.5481.920 37.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Protein Sci 2008; 17:1256-63; PMID:18434498 ;  http://dx.doi.org/10.1110/ps.034660.108 38.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nat Commun 2012; 3:868; PMID:22643895 ; http://dx.doi.org/10.1038/ ncomms1850 39.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Biol Chem 2012; 287:34264-72;  PMID:22902621 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell 2013; 50:379-93; PMID:23583075 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Mol Biol  1992; 228:7-12;  PMID:1447795 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Mol Biol  1987; 193:413-7;  PMID:3298659 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Protein Chem 1991; 10:445-53;  PMID:1799404 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Protein Sci 1996; 5:1594-612; PMID:8844849 ;  http://dx.doi.org/10.1002/pro.5560050814 45.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
PLoS Genet  2009; 5:e1000548;  PMID:19578405 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Science 2007; 315:525-8;  PMID:17185560 ; http://dx.doi.org/10.1126/ science.1135308 47.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Pharmacogenomics 2007;  8:1075-80;  PMID:17716239 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Science  2002; 295:2262-4;  PMID:11910110 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Science 2002; 295:2258-61; PMID:11910109 ; http://dx.doi.org/10.1126/ science.1067338 51.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Genes Dev 2007; 21:519-24; PMID:17344413 ;  http://dx.doi.org/10.1101/gad.1490207 52.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
EMBO  J 2005; 24:1584-95; PMID:15933721 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Mol Biol  2008; 384:73-86;  PMID:18822297 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cell 2012; 151:1042- 54; PMID:23178123 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Biol Chem 2013; 288:17832- 43; PMID:23667253 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell 2013;  50:637-48;  PMID:23685075 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
FEBS Lett 1998; 440:387- 92; PMID:9872408 ; http://dx.doi.org/10.1016/ S0014-5793(98)01492-6 60.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nature 1988;  334:362-4;  PMID:2455872 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Biol Chem 2008; 283:7145-54; PMID:18180287 ;  http://dx.doi.org/10.1074/jbc.M708224200 62.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell  2010; 37:196-210;  PMID:20122402 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
EMBO J 2011; 30:1804- 17; PMID:21448132 ; http://dx.doi.org/10.1038/ emboj.2011.93 64.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nat Struct Mol Biol 2011; 18:715- 20; PMID:21623367 ; http://dx.doi.org/10.1038/ nsmb.2057 65.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Arch Biochem Biophys  1984; 234:603-11;  PMID:6568109 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Biochem Biophys  Res Commun 1973; 51:406-13; PMID:4693484 ;  http://dx.doi.org/10.1016/0006-291X(73)91272-268.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Proc Natl Acad Sci U S A  2010; 107:17575-9;  PMID:20876129 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Proc Natl Acad Sci U S A 2010; 107:19242-7; PMID:20974926 ; http://dx.doi.org/10.1073/ pnas.1009599107 70.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell Biol  2005; 25:403-13;  PMID:15601860 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
EMBO Rep 2001; 2:821-8; PMID:11559592 ;  http://dx.doi.org/10.1093/embo-reports/kve184 72.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Struct Biol  2012; 179:78-82;  PMID:22450227 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nature 2001;  414:652-6;  PMID:11740563 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nat Cell Biol 2002; 4:134-9;  PMID:11813000 ; http://dx.doi.org/10.1038/ncb746 77.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
EMBO J  2002; 21:5645-52;  PMID:12411482 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Elife  2013; 2:e00308;  PMID:23358411 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Cell Biol 1989; 108:229-41;  PMID:2645293 ; http://dx.doi.org/10.1083/ jcb.108.2.229 83.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Int J  Biochem Cell Biol 1999; 31:25-9; PMID:10216940 ;  http://dx.doi.org/10.1016/S1357-2725(98)00128-9 84.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell Biol 2002; 22:7405- 16; PMID:12370288 ; http://dx.doi.org/10.1128/ MCB.22.21.7405-7416.2002 85.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Biochem J 2005; 385:371-80; PMID:15355306 ;  http://dx.doi.org/10.1042/BJ20041164 86.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cancer Biol Ther 2006; 5:723-8; PMID:16861899 ; http://dx.doi.org/10.4161/ cbt.5.7.2967 87.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cell  1987; 49:805-13;  PMID:3555844 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Cell Biol  2004; 167:27-33;  PMID :15479734 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nature  2003; 426:895-9;  PMID:14685250 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell 2010;  40:253-66;  PMID:20965420 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell 2013; 49:439-52;  PMID :23290915 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nat Struct Biol 2003; 10:366-70; PMID:12665853 ;  http://dx.doi.org/10.1038/nsb915 96.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cell 2012; 149:274- 93; PMID:22500797 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell Biochem 2002; 234-235:81-90;  PMID:12162463 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Cell Physiol 1991; 148:252- 9; PMID :1880153 ; http://dx.doi.org/10.1002/ jcp.1041480210 99.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Biol Chem 2010; 285:27385-95; PMID:20605781 ;  http://dx.doi.org/10.1074/jbc.M110.120295 100.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mech Ageing Dev 1998; 104:59-73; PMID:9751432 ;  http://dx.doi.org/10.1016/S0047-6374(98)00052-9 101.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
PLoS Genet  2009; 5:e1000486;  PMID:19461873 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cell Stress Chaperones 2002; 7:186-90;  PMID:12380686 ; http://dx.doi.org/10.1379/1466- 1268(2002)007<0186:CCOA>2.0 .CO;2 104.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Curr Opin Cell Biol 1998; 10:205- 19; PMID:9561845 ; http://dx.doi.org/10.1016/ S0955-0674(98)80143-9 106.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell Biol 2006; 26:8901- 13; PMID:17000756 ; http://dx.doi.org/10.1128/ MCB.01156-06 108.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Mol Cell Biol 2013; 33:2510-26; PMID:23608534 ; http://dx.doi.org/10.1128/ MCB.01362-12 110.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nat  Struct Mol Biol 2004; 11:957-62; PMID:15334071 ;  http://dx.doi.org/10.1038/nsmb822 112.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
EMBO Rep 2010; 11:956-61;  PMID:21072063 ; http://dx.doi.org/10.1038/ embor.2010.169113.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Science 2013; 341:1238303; PMID:23869022 ; http://dx.doi.org/10.1126/ science.1238303 114.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Cell 2012; 150:549-62;  PMID:22863008 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
PLoS Genet  2011; 7:e1002119;  PMID:21695230 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Genes Dev 2003; 17:1882-93; PMID:12869585 ; http://dx.doi.org/10.1101/ gad.1107803 117.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Nat Rev Immunol 2003; 3:952-61;  PMID:14647477 ; http://dx.doi.org/10.1038/nri1250 118.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
PLoS One 2012; 7:e51968;  PMID:23251665 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
J Cell Physiol 2003; 195:346- 55; PMID:12704644 ; http://dx.doi.org/10.1002/ jcp.10290,Non-OADS,/arxiv_data1/oa_pdf/d4/b0/ktrs-02-01-10928109.PMC4705825.pdf
Translation 2014; 2:e28387; http://dx.doi.org/10.4161/trla.28387Why is start codon selection so precise   in eukaryotes?,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nature 2002;  418:229-35; PMID:12110899; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell 2002; 108:557- 72; PMID:11909526; http://dx.doi.org/10.1016/ S0092-8674(02)00619-0 3.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Trends Biochem  Sci 2007; 32:20-6; PMID:17157507; http://dx.doi.org/10.1016/j.tibs.2006.11.0074.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Science 2009; 326:688- 94; PMID:19833920; http://dx.doi.org/10.1126/ science.1179700 5.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Environ Microbiol 2005; 7:47-54; PMID:15643935; http://dx.doi.org/10.1111/j.1462-2920.2004.00674.x 8.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Cell Biol 2012; 32:3978-89; PMID:22851688; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem 2013; 288:5316-29; PMID:23293029; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Biochemistry  2013; 52:9510-8; PMID:24319994; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell  2011; 147:789-802; PMID:22056041; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Science 2012;  336:1719-23; PMID:22745432; http://dx.doi.org/10.1126/science.1220270 14.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Proc Natl Acad Sci U S A 1990; 87:7668-72; PMID:2217199; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell 2007; 130:1019- 31; PMID:17889647; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nature  2008; 455:416-20; PMID:18758445; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
PLoS Biol 2011; 9:e1001095;  PMID:21750663; http://dx.doi.org/10.1371/jour - nal.pbio.1001095 20.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell 2005; 121:703- 12; PMID:15935757; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Mol Biol  1999; 290:825-37; PMID:10398584; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
EMBO J 2011; 30:873-81; PMID:21183954; http://dx.doi.org/10.1038/ emboj.2010.343 23.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nat Chem Biol  2013; 9:105-11; PMID:23242255; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Gene  2005; 361:13-37; PMID:16213112; http://dx.doi.org/10.1016/j.gene.2005.06.037 27.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Microbiol 1992; 6:1105-14; PMID:1375309; http://dx.doi.org/10.1111/j.1365-2958.1992.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J  Biol Chem 1999; 274:17924-33; PMID:10364239;  http://dx.doi.org/10.1074/jbc.274.25.17924 29.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell 1991;  65:259-69; PMID:1826635; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
EMBO J 1998; 17:5201- 13; PMID:9724656; http://dx.doi.org/10.1093/ emboj /17.17.5201 33.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Bacteriol 2002;  184:5772-80; PMID:12270836; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem 1998; 273:11815- 25; PMID:9565606; http://dx.doi.org/10.1074/jbc.273.19.11815 37.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem 2000; 275:1269-74; PMID:10625672; http://dx.doi.org/10.1074/ jbc.275.2.126939.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nat Rev Mol Cell Biol 2004; 5:451-63; PMID:15173824; http://dx.doi.org/10.1038/ nrm1403 40.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
RNA  2009; 15:2288-98; PMID:19861425; http://dx.doi.org/10.1261/rna.1662609 42.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Extremophiles 2000; 4:175-9; PMID:10879562;  http://dx.doi.org/10.1007/s007920070032 43.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Mol Biol 2001; 309:347-60;  PMID:11371158; http://dx.doi.org/10.1006/ jmbi.2001.4669 44.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Microbiol  2007; 65:700-13; PMID:17608795; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Microbiol  2003; 50:635-43; PMID:14617185; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
EMBO J 2000; 19:4101-10; PMID:10921890; http://dx.doi.org/10.1093/emboj/19.15.4101 48.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell  1986; 44:283-92; PMID:3943125; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
EMBO J 2008; 27:1609-21; PMID:18464793; http://dx.doi.org/10.1038/emboj.2008.90 52.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Cell Biol 2011; 31:4814- 31; PMID:21930786; http://dx.doi.org/10.1128/ MCB.05819-11 54.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nucleic Acids Res 2011; 39:4220-34;  PMID:21266472; http://dx.doi.org/10.1093/nar/ gkr007,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Science 2013; 341:399- 402; PMID:23744781; http://dx.doi.org/10.1126/ science.1234907 57.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell 2009; 136:731-45; PMID:19239892;  http://dx.doi.org/10.1016/j.cell.2009.01.042 60.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell 2000; 103:781- 92; PMID:11114334; http://dx.doi.org/10.1016/ S0092-8674(00)00181-1 61.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Microbiol 2007; 63:941-50; PMID:17238926; http://dx.doi.org/10.1111/j.1365-2958.2006.05574.x 62.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Genes Dev 2000; 14:2534-46; PMID:11018020;  http://dx.doi.org/10.1101/gad.831800 63.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem 2009;  284:20615-28; PMID:19509420; http://dx.doi.org/10.1074/jbc.M109.007658 64.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nucleic Acids Res 2012; 40:905-13;  PMID:21940399; http://dx.doi.org/10.1093/nar/ gkr772 65.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Genes Dev 1997; 11:2396- 413; PMID:9308967; http://dx.doi.org/10.1101/ gad.11.18.2396 67.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
EMBO J 2005; 24:3588-601; PMID:16193068;  http://dx.doi.org/10.1038/sj.emboj.760082169.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
EMBO J 2007; 26:1602- 14; PMID:17332751; http://dx.doi.org/10.1038/ sj.emboj.7601613 70.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Genes Dev 2010; 24:97- 110; PMID:20048003; http://dx.doi.org/10.1101/ gad.1871910 71.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell 2009; 136:447-60; PMID:19203580; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem 2010; 285:21922-33;  PMID:20463023; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
RNA 2006; 12:751- 64; PMID:16565414; http://dx.doi.org/10.1261/ rna.2263906 77.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell  2002; 111:1015-25; PMID:12507428; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Cell Biol  2013; 33:3540-8; PMID:23836883; http://dx.doi.org/10.1128/MCB.00771-13 79.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
EMBO J 2006; 25:4537-46; PMID:16990799; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Mol Biol 2007; 370:315-30; PMID:17512538; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nature 2010; 465:378-81; PMID:20485439; http://dx.doi.org/10.1038/nature0900382.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Genes Dev  2013; 27:2696-707; PMID:24352424; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Biochemistry 2005; 44:12265-72; PMID:16156639;  http://dx.doi.org/10.1021/bi051271v 84.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
EMBO J 2011; 30:302-16; PMID:21139564; http://dx.doi.org/10.1038/ emboj.2010.312 85.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Biochemistry 2010; 49:8251-65;  PMID:20795652; http://dx.doi.org/10.1021/ bi1008529 86.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Translation 2013; 1:e24038; http://dx.doi.org/10.4161/trla.24038 87.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Cell Biol 2003; 23:5431-45;  PMID:12861028; http://dx.doi.org/10.1128/ MCB.23.15.5431-5445.2003 88.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Cell Biol 2000; 20:468- 77; PMID:10611225; http://dx.doi.org/10.1128/ MCB.20.2.468-477.2000 89.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem 2006;  281:22917-32; PMID:16766523; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem 2013; 288:32932-40;  PMID:24092755; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nat Rev Mol Cell Biol 2011; 12:235-45; PMID:21427765;  http://dx.doi.org/10.1038/nrm3083 92.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell  2006; 125:287-300; PMID:16630817; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
"Science 1997; 275:1468-71; PMID:9045610; http://dx.doi.org/10.1126/ science.275.5305.1468 94. de la Cruz J, Iost I, Kressler D, Linder P. The p20 and Ded1 proteins have antagonistic roles in eIF4E- dependent translation in Saccharomyces cerevi - siae.",OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Proc Natl Acad Sci U S A 1997; 94:5201-6; PMID:9144215; http://dx.doi.org/10.1073/ pnas.94.10.5201 95.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cell 2008; 135:1237-50;  PMID:19109895; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
EMBO J 2012; 31:3745-56; PMID:22872150; http://dx.doi.org/10.1038/ emboj.2012.220 97.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Genes Dev 2007; 21:1280-7; PMID:17545463;  http://dx.doi.org/10.1101/gad.1562707 98.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Microbiol  Mol Biol Rev 2011; 75:434-67; PMID:21885680;  http://dx.doi.org/10.1128/MMBR.00008-11 99.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nature 1998; 394:854-9;  PMID:9732867; http://dx.doi.org/10.1038/29703 100.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
"Genes Dev  2002; 16:2906-22; PMID:12435632; http://dx.doi.org/10.1101/gad.1020902 101 Lomakin, I.",OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Cell 2007; 26:41-50; PMID:17434125; http://dx.doi.org/10.1016/j.molcel.2007.03.018 103.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nat Struct Mol Biol 2013; 20:1015- 7; PMID:23851459; http://dx.doi.org/10.1038/nsmb.2622 104.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Cell 2005; 17:265-75; PMID:15664195; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Genes Dev 2007; 21:1217- 30; PMID:17504939; http://dx.doi.org/10.1101/ gad.1528307 107.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem 2013; In press; http://dx.doi.org/10.1074/jbc.M113.498642.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Mol Biol  2009; 394:268-85; PMID:19751744; http://dx.doi.org/10.1016/j.jmb.2009.09.017 109.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nucleic Acids Res 2012; 40:2898-906; PMID:22156057; http://dx.doi.org/10.1093/nar/gkr1192110.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
EMBO J 1999; 18:1673-88; PMID:10075937; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem 2008; 283:1094-103; PMID:17974565; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nucleic  Acids Res 2009; 37:5167-82; PMID:19561193; http://dx.doi.org/10.1093/nar/gkp519 114.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nat Rev Mol Cell Biol 2010; 11:113-27; PMID:20094052; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Genes Dev 2008; 22:2414-25;  PMID:18765792; http://dx.doi.org/10.1101/ gad.480508 117.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Genes Dev  2001; 15:1593-612; PMID:11445534; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Biochim Biophys Acta 2009; 1789:558-70; PMID:19539793; http://dx.doi.org/10.1016/j.bbagrm.2009.06.001 119.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Genes Dev 2010; 24:1787- 801; PMID:20713520; http://dx.doi.org/10.1101/ gad.1957510 120.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem  2010; 285:26779-87; PMID:20566627; http://dx.doi.org/10.1074/jbc.M110.119693 121.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Proc Natl Acad Sci U S A 2010; 107:18056-60;  PMID:20921384; http://dx.doi.org/10.1073/ pnas.1009269107 122.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Science 2009; 324:218-23; PMID:19213877; http://dx.doi.org/10.1126/science.1168978123.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Mol Cell 2000; 6:1099-108; PMID:11106749;  http://dx.doi.org/10.1016/S1097-2765(00)00108-8 124.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Proc Natl Acad Sci U S A 2004; 101:11269-74; PMID:15277680; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nucleic Acids Res  2002; 30:1154-62; PMID:11861906; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Yeast 2003; 20:97-108;  PMID:12518314; http://dx.doi.org/10.1002/yea.937 128.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Proc Natl Acad Sci U S A 2005; 102:15688-93; PMID:16227438; http://dx.doi.org/10.1073/ pnas.0506791102 129.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Biochem J 2006; 394:227- 36; PMID:16225457; http://dx.doi.org/10.1042/ BJ20050605 130.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Nat Rev Cancer 2010; 10:254- 66; PMID:20332778; http://dx.doi.org/10.1038/nrc2824 131.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem 1997;  272:23477-80; PMID:9295280; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Cancer Lett 2009; 284:86-94; PMID:19446954;  http://dx.doi.org/10.1016/j.canlet.2009.04.019 133.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Blood 2010; 115:3196- 205; PMID:20194897; http://dx.doi.org/10.1182/ blood-2009-10-178129 134.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Semin Hematol  2011; 48:89-96; PMID:21435505; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
PLoS  Biol 2004; 2:E139; PMID:15138505; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
J Biol Chem 2010; 285:32200- 12; PMID:20699223; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Translation 2013; 1:e26402; http://dx.doi.org/10.4161/trla.26402,Non-OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
Genes Dev 1990; 4:1790-800; PMID:1701151;  http://dx.doi.org/10.1101/gad.4.10.1790 139.,OADS,/arxiv_data1/oa_pdf/be/b7/ktrs-02-01-10928387.PMC4705826.pdf
"Translation 2014; 2:e28587; http://dx.doi.org/10.4161/trla.28587An AU-rich instability element in the 3 ' UTR  mediates an increase in mRNA stability in  response to expression of a dhh1 ATPase mutant susanne Kramer† and Mark carrington* Department of Biochemistry; University of c ambridge; c ambridge, UK †current a ffiliation: Biozentrum; Lehrstuhl für Zell- und e ntwicklungsbiologie; Universität Würzburg; am h ubland, Würzburg, Germany Keywords:  Trypanosoma brucei, DHH1, mRNA stability, AU-rich element, 3' UTR The D eaD box RN a helicase D hh1 acts as a general repressor of translation and activator of decapping but can also  act specifically on individual mRN as.",Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
RNA Biol 2013; 10:44- 55; PMID:22995827; http://dx.doi.org/10.4161/ rna.22210 2.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Annu Rev Biochem 2007; 76:23-50; PMID:17506634; http://dx.doi.org/10.1146/annurev.biochem.76.052305.115300 3.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Biochemistry 2009; 48:10679-81;  PMID:19839642; http://dx.doi.org/10.1021/ bi901278p 5.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Nat Struct Mol Biol 2013; 20:127- 33; PMID:23222640; http://dx.doi.org/10.1038/ nsmb.2468 8.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Nucleic Acids Res 1997; 25:965-73; PMID:9023105; http://dx.doi.org/10.1093/nar/25.5.965 9.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
J Biol Chem 2011; 286:27454-70; PMID:21642421;  http://dx.doi.org/10.1074/jbc.M111.220251 10.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Nucleic Acids Res 2006; 34:3082-94;  PMID:16769775; http://dx.doi.org/10.1093/nar/ gkl409 11.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Nucleic Acids Res  2011; 39:7764-74; PMID:21712243; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Mol Cell 2010; 39:773- 83; PMID:20832728; http://dx.doi.org/10.1016/j.molcel.2010.08.025 14.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
EMBO J  2002; 21:2788-97; PMID:12032091; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
RNA  2001; 7:1717-27; PMID:11780629; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Nucleic Acids Res 2004; 32:1325- 34; PMID:14982957; http://dx.doi.org/10.1093/ nar/gkh303 19.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Mol Biol Cell 2009; 20:2464-72;  PMID:19297524; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
J Cell  Biol 2011; 194:527-37; PMID:21844211; http://dx.doi.org/10.1083/jcb.201007151 21.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
PLoS Biol 2012; 10:e1001342; PMID:22719226; http://dx.doi.org/10.1371/jour - nal.pbio.1001342 22.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
J Biol Chem 2007;  282:37389-401; PMID:17942399; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
J Biol Chem 2006; 281:29379-90; PMID:16885161; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
J Biol Chem 2008; 283:28527-35; PMID:18715869; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
BMC Genomics 2009; 10:427; PMID:19747379;  http://dx.doi.org/10.1186/1471-2164-10-427 27.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Nucleic Acids Res 2010; 38:4946-57; PMID:20385579; http://dx.doi.org/10.1093/nar/ gkq237 28.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
BMC Genomics 2009; 10:482; PMID:19840382;  http://dx.doi.org/10.1186/1471-2164-10-482 29.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
BMC Genomics 2009; 10:495; PMID:19857263; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Genes Dev 1993; 7:996- 1007; PMID:8504937; http://dx.doi.org/10.1101/ gad.7.6.996 32.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Genes Dev 1994; 8:491- 501; PMID:7907303; http://dx.doi.org/10.1101/ gad.8.4.491mutation / deletions in the AU-rich region were verified by PCR  and sequencing for correct integration of the plasmid.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Eukaryot Cell 2003; 2:542- 51; PMID:12796299; http://dx.doi.org/10.1128/ EC.2.3.542-551.2003 35.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Trends Parasitol 2011; 27:23- 30; PMID:20609625; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Mol Biochem Parasitol 2012; 181:61-72; PMID:22019385; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Nucleic Acids Res 2002; 30:4040-50;  PMID:12235388; http://dx.doi.org/10.1093/nar/ gkf521 40.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
J Cell Sci  2010; 123:699-711; PMID:20124414; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
PLoS Pathog 2010; 6:e1001090; PMID:20838601;  http://dx.doi.org/10.1371/journal.ppat.100109042.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
J Biol Chem 2000; 275:10218-27; PMID:10744707; http://dx.doi.org/10.1074/ jbc.275.14.10218 43.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Nucleic Acids Res 2002; 30:4414-24; PMID:12384588; http://dx.doi.org/10.1093/nar/ gkf577 44.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Biochem Soc Trans 2008; 36:671-6; PMID:18631138; http://dx.doi.org/10.1042/ BST0360671 45.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Biochem Biophys  Res Commun 2007; 356:1062-7; PMID:17399688; http://dx.doi.org/10.1016/j.bbrc.2007.03.104 47.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Nucleic Acids Res  2013; 41:8591-600; PMID:23877242; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Nucleic Acids Res 2006; 34:5312-24;  PMID:17012283; http://dx.doi.org/10.1093/nar/ gkl598 50.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
J  Biol Chem 2001; 276:34801-9; PMID:11435421;  http://dx.doi.org/10.1074/jbc.M102120200 51.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
Mol Biochem Parasitol 1999; 99:89-101; PMID:10215027; http://dx.doi.org/10.1016/S0166-6851(99)00002-X 52.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
PLoS One 2012; 7:e35167; PMID:22511983;  http://dx.doi.org/10.1371/journal.pone.0035167 53.,Non-OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
J Cell Sci  2008; 121:3002-14; PMID:18713834; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/bb/ktrs-02-01-10928587.PMC4705827.pdf
"Translation 2014; 2:e28935; http://dx.doi.org/10.4161/trla.28935Induction of cap-independent BiP ( hsp-3 )   and Bcl-2 ( ced-9 ) translation in response to eIF4G   (IFG-1) depletion in C. elegans J Kaitlin Morrison1, andrew J Friday1, Melissa a  henderson1,2, enhui h ao1, and Brett D Keiper1,* 1Department of Biochemistry and Molecular Biology; Brody s chool of Medicine at e ast c arolina University; Greenville, N c Usa; 2Department of Biochemistry and Molecular  Biology; Debusk c ollege of Osteopathic Medicine; Lincoln Memorial University; h arrogate, TN U sa Keywords:  germ cell apoptosis; cap-independent translation; eIF4G; BiP; Apaf-1; Bcl-2 Abbreviations:  IRES, internal ribosome entry sites; BiP/HSP-3/4, binding immunoglobulin protein/heat shock protein-3/4; HIF-1,  hypoxia-inducible factor 1; p53/CEP-1, tumor protein 53/ C. elegans  p53-like protein; Bcl-2/CED-9, B-cell lymphoma 2/cell death  abnormality 9; Apaf-1/CED-4, apoptotic protease activating factor 1/cell death abnormality 4; IFG-1, initiation factor 4G gene 1  of C. elegans ; eIF4GI, eukaryotic initiation factor 4G gene 1; p97, human 97 kDa eIF4G-homologous protein; eIF4E, eukaryotic  initiation factor 4E; PABP, poly(A) binding protein; c-Myc, cellular myelocytomatosis; CED-1, cell death abnormality 1; GFP,  green fluorescent protein; RNAi, RNA interference; L3, larval 3 growth stage; UTR, untranslated region; qPCR, quantitative  reverse transcriptase-polymerase chain reaction; GAPDH/GPD-3, glyceraldehyde 3-phosphate dehydrogenase; SL2 trans-splicing,  splice leader 2 trans-splicing; RPA, RNase Protection Assay; 4E-BP, eIF4E binding protein; NGM, normal growth medium;  RT-PCR, reverse transcriptase-polymerase chain reaction; cRT-PCR, circularized reverse transcriptase-polymerase chain reaction;  TAP, tobacco acid pyrophosphatase.",Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Annu Rev Cell Dev Biol  2007; 23:405-33;  PMID:17506698 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
EMBO J 1998; 17:7480-9;  PMID:9857202 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
J Biol Chem  1995; 270:21975-83;  PMID:7665619 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
EMBO J 1997; 16:817-25;  PMID:9049310 ; http://dx.doi.org/10.1093/ emboj/16.4.81 7.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Mol Cell Biol 2000; 20:468- 77; PMID:10611225 ; http://dx.doi.org/10.1128/ MCB.20.2.468-477.200 8.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Int J Biochem Cell Biol  1999; 31:37-41;  PMID:10216942 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
FEBS Lett 1999; 451:332-6; PMID:10371215 ; http://dx.doi.org/10.1016/ S0014-5793(99)00614- 10.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Mol Cell Biol 2000; 20:496-506; PMID:10611228 ;  http://dx.doi.org/10.1128/MCB.20.2.496-506.20013.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Cell Death Differ 2000; 7:1234- 43; PMID:11175261 ; http://dx.doi.org/10.1038/ sj.cdd.440075 14.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
J Biol Chem 2003; 278:3572-9;  PMID :12458215 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
PLoS One  2011; 6:e24444;  PMID:21909434 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Cell Death Differ 2008; 15:1232-42;  PMID:18451872 ; http://dx.doi.org/10.1038/ cdd.2008.4 17.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Oncogene  2004; 23:3189-99;  PMID:15094768 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Nat Rev Mol Cell Biol  2005; 6:318-27;  PMID :15803138 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Nucleic Acids Res 1997; 25:2800-7; PMID:9207027 ;  http://dx.doi.org/10.1093/nar/25.14.280 20.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Methods 2005; 35:373-81; PMID:15804610 ;  http://dx.doi.org/10.1016/j.ymeth.2004.10.01 21.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
J Biol Chem 2004; 279:29066-74;  PMID :15123638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Oncogene 2000; 19:899- 905; PMID:10702798 ; http://dx.doi.org/10.1038/ sj.onc.120340 23.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Cell 2001; 104:43- 56; PMID:11163239 ; http://dx.doi.org/10.1016/ S0092-8674(01)00190- 24.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Nature 1992; 356:494-9;  PMID :1560823 ; http://dx.doi.org/10.1038/356494a 25.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Science  1997; 275:1122-6;  PMID:9027312 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Cell Death Differ 2012; 19:406- 15; PMID:21886181 ; http://dx.doi.org/10.1038/ cdd.2011.10 27.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Comp Biochem Physiol  B 1990; 96:633-7; PMID:2225768 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
DNA  1989; 8:233-43;  PMID:2766926 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
J Biol Chem 2004; 279:29066-74;  PMID :15123638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Cell 2007; 129:465-72;  PMID:17482542 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Mol Biol Cell 2002; 13:1792- 801; PMID:12006670 ; http://dx.doi.org/10.1091/ mbc.02-02-001 35.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
J Biol Chem 2010; 285:29033-8;  PMID:20576611 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Gene 2012; 502:75-86; PMID:22555019 ;  http://dx.doi.org/10.1016/j.gene.2012.04.03 39.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Nucleic Acids Res  1997; 25:395-402;  PMID:9016570 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
J Virol 2010; 84:11479- 86; PMID:20739513 ; http://dx.doi.org/10.1128/ JVI.01330-1Acknowledgments The authors thank the Caenorhabditis  Genetics Center for the  ced-9ts  (n1653) strain.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Radiat Res 1994; 138(Suppl):S60-3;  PMID:8146329 ; http://dx.doi.org/10.2307/357876 42.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Mol Cell Biol 2005; 25:100-13; PMID :15601834 ; http://dx.doi.org/10.1128/ MCB.25.1.100-113.200 44.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Curr Top Microbiol Immunol  1995; 203:117-29;  PMID:7555087 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
J Cell Sci 2009; 122:1529- 39; PMID:19383718 ; http://dx.doi.org/10.1242/ jcs.04677 48.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Cell 1994; 76:665-76;  PMID:7907274 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Cell 1997; 90:405-13; PMID:9267021 ;  http://dx.doi.org/10.1016/S0092-8674(00)80501- 50.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Nature 1995; 376:37-43;  PMID:7596430 ; http://dx.doi.org/10.1038/376037a 51.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Nature 1997; 388:728-9; PMID:9285582 ;  http://dx.doi.org/10.1038/419152.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Cell  1997; 91:479-89;  PMID:9390557 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Nature 2001; 413:70-4; PMID :11544527 ;  http://dx.doi.org/10.1038/3509256 54.,Non-OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
Nucleic Acids Res 2004; 32:e117; PMID :15310838 ;  http://dx.doi.org/10.1093/nar/gnh11 55.,OADS,/arxiv_data1/oa_pdf/45/4e/ktrs-02-01-10928935.PMC4705828.pdf
"Translation 2014; 2:e28174; http://dx.doi.org/10.4161/trla.28174Signaling crosstalk between the mTOR complexes Jianling Xie and Christopher G Proud* Centre for Biological Sciences; University of Southampton; Southampton, UK Keywords:  mTORC1, mTORC2, SIN1, TSC2, protein synthesis, mRNA translation Abbreviations:  4E-BP, eIF4E-binding protein; 5'-TOP, 5'-terminal oligopyrimidines; AL, activation loop; AMPK, 5'-AMP- activated protein kinase; aPKC, atypical PKC; CK1 α, casein kinase 1 α; cPKC, conventional PKC; DEPTOR, dishevelled, eEF,  eukaryotic elongation factors; eEF2K, eEF2 kinase; EGF, epidermal growth factor; EGFR, EGF receptor; egl-10, pleckstrin  domain-containing mTOR interacting protein; eIF, eukaryotic initiation factor; ELT3, Eker rat uterine leiomyoma cell line 3;  ERK, extracellular signal-regulated kinase; Fbw8, F-box 8, also termed as Fbxw8 or Fbx29; FKBP12, FK506-binding protein, 12  kDa; FoxO, forkhead box protein; GAP, GTPase-activating protein; GEF, guanine nucleotide exchange factor; Grb10, growth  factor bound-receptor protein 10; GRp58, 58 kDa glucose-regulated protein; GSK3, glycogen synthase kinase 3; HM, hydrophobic  motif; IGF, insulin-like growth factor; IGF1R, IGF1 receptor; IKK, inhibitor of NF- κB (nuclear factor κ -light-chain-enhancer of  activated B cells) kinase; IMP, IGF2 mRNA-binding protein; InsR, insulin receptor; IRS, insulin receptor substrate; Maf1, matrix  attachment region binding filament–like protein 1 associated factor 1; mNIP7: mammalian nuclear import protein 7; mLST8:  mammalian ortholog of lethal with sec thirteen, also known as G β-like protein or G βL; mTOR: mammalian target of rapamycin;  mTORC1: mTOR complex 1; mTORC2: mTOR complex 2; NBS1: Nijmegen breakage syndrome protein 1; nPKC: novel PKC;  PDCD4: programmed cell death protein 4; PDGF: platelet-derived growth factor; PDK1, phosphoinositide dependent protein  kinase 1; PI3K, phosphatidylinositol 3-phosphate kinase; PIP2, phosphatidylinositol (4,5)-bisphosphate; PIP3, phosphatidylinositol  (3,4,5)-trisphosphate; PKB, protein kinase B; PKC, protein kinase C; PRAS40, Pro-rich Akt substrate of 40 kDa; PROTOR,  protein observed with RICTOR; Rac1, Ras-related C3 botulinum toxin substrate 1; RAPTOR, regulatory-associated protein of  mTOR; Rbx1, RING-box protein 1; rDNA, ribosomal DNA; Rheb, Ras homolog enriched in brain; Rhes, Ras homolog enriched  in striatum; RhoA, Ras homolog gene family, member A; RICTOR, rapamycin-insensitive companion of mTOR; RP, ribosomal  protein; rRNA, ribosomal RNA; RSK, p90 RP S6 kinase; RTK, receptor tyrosine kinase; S6K, p70 RP S6 kinase; SCF βTrCP,  Skp1/Cul1/F box protein adaptor β -transducin repeat-containing protein; SGK, serum- and glucocorticoid-induced protein  kinase; SIN1, stress activated protein kinase interacting protein 1; siRNA, small interfering RNA; TBC1D7, Tre2-Bub2-Cdc16 1  domain family, member 7; Tel2, telomere maintenance 2; TFIIIC, transcription factor 3C; TM, turn motif; 5'-TOP, 5'-terminal  oligopyrimidine tract; Tti1, Tel2 interacting protein 1; VEGFR, vascular epithelial growth factor receptor; XPLN, exchange factor  found in platelets, leukemic, and neuronal tissues mTOR is a protein kinase which integrates a variety of environmental and intracellular stimuli to positively regulate many anabolic  processes of the cell, including protein synthesis.",Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell  2003; 11:895-904;  PMID:12718876 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell 2009 ; 137:873- 86; PMID:19446321 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell 2007 ; 131:1248 -59; PMID:18160036 ;  http://dx.doi.org/10.1016/j.cell.2007.10.0524.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J Biol Chem 2010 ;  285:20109 -16; PMID:20427287 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell Biol   2011 ; 31:1657 -71; PMID:21321085 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell  2011 ; 42:50-61;  PMID:21474067 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell 2002 ; 110:163-75; PMID:12150925 ;  http://dx.doi.org/10.1016/S0092-8674(02)00808-5 8.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell 2002 ; 110:177- 89; PMID:12150926 ; http://dx.doi.org/10.1016/ S0092-8674(02)00833-4 9.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell  2007 ; 25:903- 15; PMID:17386266 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nat Cell Biol  2007 ; 9:316-23; PMID:17277771 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J Biol Chem 2007 ; 282:20036 -44; PMID:17510057 ;  http://dx.doi.org/10.1074/jbc.M702376200 12.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
PLoS One  2007 ; 2:e1217 ;  PMID:18030348 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J Biol Chem 2007 ;  282:24514 -24; PMID:17604271 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Curr Biol   2004 ;  14:1296 -302; PMID:15268862 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell  2006 ; 127:125-37; PMID:16962653 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Genes Dev  2006 ; 20:2820 -32; PMID:17043309 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Curr Biol  2006 ; 16:1865 - 70; PMID:16919458 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Biochem J  2007 ; 405:513- 22; PMID:17461779 ; http://dx.doi.org/10.1042/ BJ2007054019.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
PLoS One  2013 ; 8:e65586 ;  PMID:23762398 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell Signal  2013 ; 25:2239 -45; PMID:23872070 ;  http://dx.doi.org/10.1016/j.cellsig.2013.07.008 22.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell  2006 ; 22:159- 68; PMID:16603397 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Blood  2007 ; 109:3509 -12; PMID:17179228 ;  http://dx.doi.org/10.1182/blood-2006-06-030833 24.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Diabetologia  2012 ; 55:1355 -65; PMID:22314813 ;  http://dx.doi.org/10.1007/s00125-012-2475-7 25.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J Clin Invest 2003 ;  112:1223 -33; PMID:14561707 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nat Cell Biol  2003 ; 5:566-71; PMID:12766776 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell  2003 ; 11:1457- 66; PMID:12820960 ;  http://dx.doi.org/10.1016/S1097-2765(03)00220-X 29.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nat Cell Biol  2002 ; 4:658-65; PMID:12172554 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J Biol Chem 2002 ;  277:35364 -70; PMID:12167664 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nat Cell Biol 2002 ; 4:648-57;  PMID:12172553 ; http://dx.doi.org/10.1038/ncb83933.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nature  1986 ; 320:631-4;  PMID:3010126 ; http://dx.doi.org/10.1038/320631a0 34.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Science  2005 ; 307:1098 - 101; PMID:15718470 ; http://dx.doi.org/10.1126/ science.1106148 36.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nat Neurosci  2012 ; 15:191-3;  PMID:22179112 ; http://dx.doi.org/10.1038/nn.2994 37.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nature  2006 ;  442:1058 -61; PMID:16900101 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Oncogene   2006 ; 25:6384 -91; PMID:17041624 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Proc Natl Acad Sci U S A  2010 ; 107:11823 -8; PMID:20543138 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J Biol Chem 2010 ;  285 :15380 -92; PMID:20233713 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell Cycle  2010 ; 9:953-7; PMID:20038818 ;  http://dx.doi.org/10.4161/cc.9.5.10876 42.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nucleic Acids Res 2012 ; 40:2527 -39;  PMID:22121221 ; http://dx.doi.org/10.1093/nar/ gkr1040 43.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Biochem J  2012 ; 444:141-51; PMID:22428559 ;  http://dx.doi.org/10.1042/BJ20112107 46.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Science  2010 ; 328:1172 -6; PMID:20508131 ;  http://dx.doi.org/10.1126/science.1187532,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Proc Natl Acad Sci U S A 2012 ; 109:8977 -82;  PMID:22611195 ; http://dx.doi.org/10.1073/ pnas.1201689109 48.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell  2013 ; 52:574- 82; PMID:24120665 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell 2009 ; 136:731-45;  PMID:19239892 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nat Rev Mol Cell Biol 2010 ; 11:113- 27; PMID:20094052 ; http://dx.doi.org/10.1038/ nrm2838 51.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Genes Dev 1999 ; 13:1422 - 37; PMID:10364159 ; http://dx.doi.org/10.1101/ gad.13.11.1422 53.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J Biol Chem 2000 ; 275:33836 - 43; PMID:10942774 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell Biol   2000 ; 20:3558 -67; PMID:10779345 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell 1992 ; 69:1227 -36; PMID:1377606 ;  http://dx.doi.org/10.1016/0092-8674(92)90643-Q 58.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
EMBO J 2004 ; 23:1761- 9; PMID:15071500 ; http://dx.doi.org/10.1038/ sj.emboj.7600193 59.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Science   2006 ; 314:467-71; PMID:17053147 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell  2005 ; 123:569-80; PMID:16286006 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Proc Natl Acad Sci U S A 1985 ; 82:7939 - 43; PMID:3906654 ; http://dx.doi.org/10.1073/ pnas.82.23.7939 63.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
EMBO J  2001 ; 20:4370 -9; PMID:11500364 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell Biol  2004 ; 24:2986 - 97; PMID:15024086 ; http://dx.doi.org/10.1128/ MCB.24.7.2986-2997.2004 66.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J Biol  Chem  2011 ; 286:10998 -1002 ; PMID:21310961 ;  http://dx.doi.org/10.1074/jbc.M110.195016 67.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J Biol Chem  2011 ; 286:6128 -42; PMID:21131356 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell 2011 ; 144:757-68; PMID:21376236 ;  http://dx.doi.org/10.1016/j.cell.2011.02.014 69.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Biochem J  2008 ; 416:375-85; PMID:18925875 ;  http://dx.doi.org/10.1042/BJ20081668 70.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
The mammalian target of rapamycin  complex 2 controls folding and stability of Akt  and protein kinase C. EMBO J 2008 ; 27:1932 - 43; PMID:18566586 ; http://dx.doi.org/10.1038/ emboj.2008.120 72.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
EMBO J 2010 ; 29:3939 - 51; PMID:21045808 ; http://dx.doi.org/10.1038/ emboj.2010.271 73.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nat Cell Biol 2004 ; 6:1122 -8;  PMID:15467718 ; http://dx.doi.org/10.1038/ncb118374.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Dev Cell  2010 ; 19:845- 57;  PMID:21145500 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Hum Mol Genet 2009 ; 18:3298 - 310; PMID:19505958 ; http://dx.doi.org/10.1093/ hmg/ddp271 77.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell Biol  2012 ; 32:2203 - 13; PMID:22493059 ; http://dx.doi.org/10.1128/ MCB.06474-11 78.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell  2013 ; 52:574- 82; PMID:24120665 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Dev Cell  2006 ; 11:583- 9; PMID:16962829 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Growth Factors 2012 ; 30:367- 84; PMID:23137199 ; http://dx.doi.org/10.3109/089 77194.2012.734507 81.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell Metab  2013 ; 17:745- 55; PMID:23623748 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Sci  Signal  2013 ; 6:ra2; PMID:23300339 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J Biol Chem 2011 ; 286:39450 - 6; PMID:21956113 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Dev Cell  2006 ; 11:859- 71; PMID:17141160 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
EMBO J 2001 ; 20:4349 -59; PMID:11500362 ;  http://dx.doi.org/10.1093/emboj/20.16.4349 86.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell  2011 ; 44:290-303;  PMID:22017875 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell Biol   2008 ; 28:4104 -15; PMID:18411301 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Dev Cell  2010 ;  18:592-604; PMID:20412774 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Curr Opin Pharmacol  2009 ; 9:753- 62; PMID:19683471 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nature  2004 ; 431:200-5;  PMID:15306821 ; http://dx.doi.org/10.1038/ nature02866 94.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell  2012 ; 48:875-87 ; PMID:23142081 ;  http://dx.doi.org/10.1016/j.molcel.2012.09.029 95.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Science  2011 ; 332:1317- 22; PMID:21659604 ; http://dx.doi.org/10.1126/ science.1199498 97.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Science  2011 ; 332:1322 - 6; PMID:21659605 ; http://dx.doi.org/10.1126/ science.119948498.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Science  2012 ; 335:1638 - 43; PMID:22461615 ; http://dx.doi.org/10.1126/ science.1215135 99.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol  Cancer Res 2010 ; 8:896-906; PMID:20501647 ;  http://dx.doi.org/10.1158/1541-7786.MCR-09-0409 101.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell Biol   2010 ; 30:908-21; PMID:19995915 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Oncogene  2010 ; 29:1003 -16; PMID:19935711 ;  http://dx.doi.org/10.1038/onc.2009.401 103.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Mol Cell   2010 ; 39:797-808; PMID:20832730 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nat Cell Biol 2013 ; 15:1340 -50;  PMID:24161930 ; http://dx.doi.org/10.1038/ncb2860 105.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cell Metab  2013 ; 17:1009 - 20; PMID:23684622 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Nature   2011 ; 474:609-15; PMID:21720365 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Cancer Discov  2011 ; 1:248-59;  PMID:22140653 ; http://dx.doi.org/10.1158/2159- 8290.CD-11-0085 108.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Oncogene  2009 ; 28:1187 - 96; PMID:19151764 ; http://dx.doi.org/10.1038/ onc.2008.490 109.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Sci Signal  2013 ; 6:ra25; PMID:23592840 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Genes Dev 2011 ; 25:1159 -72; PMID:21576258 ;  http://dx.doi.org/10.1101/gad.2042311 111.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Genes Dev  2013 ; 27:301-12; PMID:23388827 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J  Biol Chem  2013 ; 288:27019 -30; PMID:23928304 ;  http://dx.doi.org/10.1074/jbc.M113.498055 114.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Trends Biochem Sci 2013 ; 38:233- 42; PMID:23465396 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
J Biol Chem 2010 ; 285:7866 - 79; PMID:20022946 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
Circulation  2013 ; 128:2132 - 44; PMID:24008870 ; http://dx.doi.org/10.1161/ CIRCULATIONAHA.113.003638 119.,Non-OADS,/arxiv_data1/oa_pdf/43/d4/ktrs-02-01-10928174.PMC4705829.pdf
"Translation 2014; 2:e28968; http://dx.doi.org/10.4161/trla.28968Targeting translation initiation in breast cancer Argun Akcakanat1*, David S Hong1, and Funda Meric-Bernstam1,2 1Department of i nvestigational Cancer Therapeutics; Houston, TX USA; 2Department of Surgical Oncology; The University of Texas MD Anderson Cancer Center;   Houston, TX USA Keywords:  breast cancer, translation initiation, translational control, cell signaling, molecular targeted therapy List of abbreviations: 4E-BP , eukaryotic initiation factor 4E-binding protein; CI, confidence interval; eEF2, eukaryotic elongation factor 2; eEF2K,  eukaryotic elongation factor 2 kinase; eIF, eukaryotic initiation factor; eIF2, eukaryotic initiation factor 2; eIF4A, eukaryotic initiation factor 4A; eIF4E,  eukaryotic initiation factor 4E; eIF4G, eukaryotic initiation factor 4G; HR, hazard ratio; HER2, human epidermal growth factor receptor 2; HR, hazard  ratio; MAPK, mitogen-activated protein kinase; Mnk, MAPK-interacting kinase; mTOR, mammalian target of rapamycin; mTORC1, mTOR complex  1; MUC1, mucin 1; p-4E-BP1, phosphorylated eukaryotic initiation factor 4E–binding protein 1; PI3K, phosphatidylinositol 3-hydroxy kinase; pdcd4, programmed cell death 4; PFS, progression-free survival; S6, ribosomal protein S6; S6K1, S6 kinase 1.",Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Nat Rev Cancer 2010; 10:254- 66; PMID:20332778; http://dx.doi.org/10.1038/nrc2824 4.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Res 2012;  72:3891-900; PMID:22850420; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cold Spring Harb Perspect Biol 2013; 5:5;  PMID:22767671; http://dx.doi.org/10.1101/cshper - spect.a012336 7.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cell 2009; 136:731-45; PMID:19239892; http://dx.doi.org/10.1016/j.cell.2009.01.042 8.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Annu Rev Biochem  1999; 68:913-63; PMID:10872469; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Nat  Rev Clin Oncol 2011; 8:280-91; PMID:21364523; http://dx.doi.org/10.1038/nrclinonc.2011.16 10.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Mol Cell 1998; 2:135-40; PMID:9702200; http://dx.doi.org/10.1016/ S1097-2765(00)80122-7 12.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J  Clin Oncol 2009; 27:2278-87; PMID:19332717; http://dx.doi.org/10.1200/JCO.2008.20.0766 13.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Ann Surg Oncol 2008; 15:2996-7; PMID:18712446; http://dx.doi.org/10.1245/ s10434-008-0116-7 15.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cold Spring Harb Perspect Biol 2012; 4:a013706; PMID:22751155; http://dx.doi.org/10.1101/cshper - spect.a013706 17.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Science  2006; 314:467-71; PMID:17053147; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
EMBO J  2001; 20:4370-9; PMID:11500364; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Trends Genet 2000; 16:469- 73; PMID:11050335; http://dx.doi.org/10.1016/ S0168-9525(00)02106-5 22.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Biol Chem 2004;  279:29066-74; PMID:15123638; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Blood 2006; 107:2507-16; PMID:16293596; http://dx.doi.org/10.1182/ blood-2005-09-3732 24.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Mol Biol Cell 2002; 13:1792-801; PMID:12006670; http://dx.doi.org/10.1091/mbc.02-02-0017 25.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
FEBS Lett 1998; 434:417-20; PMID:9742966; http://dx.doi.org/10.1016/S0014-5793(98)01025-4 26.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Oncogene 2000; 19:4174-7; PMID:10962579; http://dx.doi.org/10.1038/ sj.onc.120376527.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Breast Cancer Res 2012; 14:R138; PMID:23102376; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Clin Invest 2010; 120:2406-13; PMID:20530877; http://dx.doi.org/10.1172/ JCI41680 29.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Biol Chem 2007;  282:5790-800; PMID:17170115; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Clin Cancer Res 2011; 17:4600-9; PMID:21610145;  http://dx.doi.org/10.1158/1078-0432.CCR-10-2591 32.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Mol Biol Cell 2003; 14:3942-51;  PMID:12972576; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Oncogene 2004; 23:3790-801; PMID:15094776; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Am J Pathol 2000; 157:1597- 604; PMID:11073819; http://dx.doi.org/10.1016/ S0002-9440(10)64797-9 35.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Hum Mol Genet 2006; 15:1059- 70; PMID:16497727; http://dx.doi.org/10.1093/ hmg/ddl021 36.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Am J Pathol 1999; 154:1777-83; PMID:10362802;  http://dx.doi.org/10.1016/S0002-9440(10)65433-8 37.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Oncogene 2006; 25:4923-36; PMID:16532022; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Biol Chem 2006;  281:22917-32; PMID:16766523; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Oncogene 2001; 20:5291- 301; PMID:11536042; http://dx.doi.org/10.1038/ sj.onc.1204624 40.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Mol Cell Proteomics 2009; 8:1278-94;  PMID:19329653; http://dx.doi.org/10.1074/mcp.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Oncogene 2013; 32:3598- 605; PMID:22907435; http://dx.doi.org/10.1038/ onc.2012.371 43.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Mol Biol Cell  2000; 11:4005-18; PMID:11071923; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Oncogene 2010; 29:4080- 9; PMID:20453879; http://dx.doi.org/10.1038/ onc.2010.152 45.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Int J Cancer 1997; 71:396-401; PMID:9139875; http://dx.doi.org/10.1002/(SICI)1097- 0215(19970502)71:3<396::AID-IJC16>3.0.CO;2-E 48.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Oncogene 2004; 23:5739-47; PMID:15221004; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Nat Rev Cancer 2009; 9:874-85;  PMID:19935676; http://dx.doi.org/10.1038/ nrc2761 50.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Oncogene 2013;  32:2179-88; PMID:22689062; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Blood 2009; 113:4656-66; PMID:19190247; http://dx.doi.org/10.1182/ blood-2008-09-175430 53.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Exp Med 2011;  208:1799-807; PMID:21859846; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Biol Chem  1995; 270:14597-603; PMID:7782323; http://dx.doi.org/10.1074/jbc.270.24.14597 56.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Cell 2004; 5:553-63; PMID:15193258; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Oncogene  2004; 23:3189-99; PMID:15094768; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Cell Biol 2008; 181:51-63; PMID:18391071; http://dx.doi.org/10.1083/ jcb.200707018 60.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Biol Chem 2003; 278:3015-22;  PMID:12441348; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Biol Chem 1995; 270:21176-80; PMID:7673150; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Mol Cancer Ther  2012; 11:1051-61; PMID:22572598; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Res 2007; 67:6814-24;  PMID:17638893; http://dx.doi.org/10.1158/0008-5472.CAN-07-0752 66.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Nat Med  2004; 10:484-6; PMID:15098029; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Res  2011; 71:4068-73; PMID:21498638; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
"Ann Surg 2002; 235:732- 8, discussion 738-9; PMID:11981220; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Surgery  2009; 146:220-6; PMID:19628077; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Surg Res  2009; 156:265-9; PMID:19665145; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Res 2009; 69:3866-73;  PMID:19383915; http://dx.doi.org/10.1158/0008- 5472.CAN-08-3472 74.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Br J Cancer 2009; 100:1393-9; PMID:19367274;  http://dx.doi.org/10.1038/sj.bjc.6605044 75.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Mol Cell 2007; 28:501-12; PMID:17996713;  http://dx.doi.org/10.1016/j.molcel.2007.10.019 76.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Biol Chem 2013; 288:23225- 33; PMID:23814053; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Cell Biol 2008; 181:293-307; PMID:18426977;  http://dx.doi.org/10.1083/jcb.200710215 79.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Nat Cell Biol 2009; 11:903-8; PMID:19525934;  http://dx.doi.org/10.1038/ncb1900 80.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Prog Mol Biol Transl Sci  2009; 90:53-107; PMID:20374739; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Res 2006;  66:3015-23; PMID:16540650; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Int J Cancer 1997; 73:678- 83; PMID:9398045; http://dx.doi.org/10.1002/ (SICI)1097-0215(19971127)73:5<678::AID- IJC11>3.0.CO;2-2 84.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Res 2011; 71:2654-63; PMID:21307130;  http://dx.doi.org/10.1158/0008-5472.CAN-10-2889 86.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Res 2005; 65:3806-10;  PMID:15867377; http://dx.doi.org/10.1158/0008- 5472.CAN-04-4036 88.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Br J Cancer 1999; 79:59-64; PMID:10408694; http://dx.doi.org/10.1038/sj.bjc.6690012 90.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
PLoS One 2012; 7:e41171;  PMID:22911754; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Oncogene 2001; 20:669-76; PMID:11314000; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Mol Cell Biol  2003; 23:26-37; PMID:12482958; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Res 2008; 68:1254-60; PMID:18296647;  http://dx.doi.org/10.1158/0008-5472.CAN-07-1719 95.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Methods Enzymol 2011; 490:333- 56; PMID:21266259; http://dx.doi.org/10.1016/ B978-0-12-385114-7.00019-2 96.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Science 2005; 309:1573- 6; PMID:16081698; http://dx.doi.org/10.1126/science.1115079 99.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Mol Cancer Ther  2008; 7:1782-8; PMID:18644990; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Clin Invest 2007;  117:2638-48; PMID:17786246; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Clin Cancer Res 2011; 17:6582-91; PMID:21831956; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0430 103.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT01234038 NLM identifier: NCT1234038.104.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT01234025 NLM identifier: NCT01234025.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
ACS Chem  Biol 2009; 4:367-77; PMID:19351181; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Blood  2009; 114:257-60; PMID:19433856; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Leukemia 2011;  25:1197-200; PMID:21455212; http://dx.doi.org/10.1038/leu.2011.57 109.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Available from: http://clinicaltrials.gov/ct2/show/ NCT01056757 NLM identifier: NCT01056757.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
RNA  2005; 11:1505-13; PMID:16131589; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
RNA 2005; 11:1238-44;  PMID:16043507; http://dx.doi.org/10.1261/ rna.2930805 113.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Curr Biol  2000; 10:793-6; PMID:10898981; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Cell Sci 2005; 118:1385-94; PMID:15769855;  http://dx.doi.org/10.1242/jcs.01716 115.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Clin Cancer Res 2009; 15:4336-47;  PMID:19458052; http://dx.doi.org/10.1158/1078- 0432.CCR-08-2924,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cell 2007; 128:257-67; PMID:17254965;  http://dx.doi.org/10.1016/j.cell.2006.11.046 117.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Proc Natl Acad Sci U S A 2005; 102:10460-5; PMID:16030146; http://dx.doi.org/10.1073/ pnas.0504249102 119.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Chem  Biol 2006; 13:1287-95; PMID:17185224; http://dx.doi.org/10.1016/j.chembiol.2006.10.005 120.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
"Potent in vitro and in vivo antican - cer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A. Mol Cancer Ther 2009; 8:1250-60;  PMID :19417157; http://dx.doi.org/10.1158/1535-7163.MCT-08-1026 121.",Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
PLoS One 2009; 4:e5223; PMID:19401772; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Nat Chem  Biol 2006; 2:213-20; PMID:16532013; http://dx.doi.org/10.1038/nchembio776 123.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Biochem Pharmacol 2011; 81:713-22;  PMID:21219881; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Biochim Biophys  Acta 1996; 1310:119-26; PMID:9244184; http://dx.doi.org/10.1016/0167-4889(95)00165-4 125.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Int J Cancer 2002; 100:491-8; PMID:12115536; http://dx.doi.org/10.1002/ijc.10515 126.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Int J Cancer 2010; 127:2467-77; PMID:20225320; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cell Biochem Funct  2007; 25:109-14; PMID:16850525; http://dx.doi.org/10.1002/cbf.1351128.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Blood  2009; 114:3064-73; PMID:19589922; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Res 2008;  68:2934-43; PMID:18413763; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Mol Biol 2009; 389:146-56; PMID:19362093;  http://dx.doi.org/10.1016/j.jmb.2009.04.005 134.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Curr Pharm  Des 2011; 17:59-64; PMID:21294709; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cell Signal 2009; 21:656-64; PMID:19166931;  http://dx.doi.org/10.1016/j.cellsig.2009.01.004 136.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Clin Cancer Res 2004; 10:7031-42;  PMID :15501983 ; http://dx.doi.org/10.1158/1078- 0432.CCR-04-0361 137.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
N Engl J Med 2007; 356:2271-81; PMID:17538086; http://dx.doi.org/10.1056/ NEJMoa066838 138.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Lancet 2008; 372:449-56; PMID:18653228; http://dx.doi.org/10.1016/ S0140-6736(08)61039-9 139.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
N Engl J Med 2011; 364:514-23; PMID:21306238; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Lancet 2013; 381:125-32; PMID:23158522;  http://dx.doi.org/10.1016/S0140-6736(12)61134-9141.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Lancet 2013; 381:817-24; PMID:23312829; http://dx.doi.org/10.1016/S0140-6736(12)61767-X 142.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Clin Oncol 2009; 27:4536-41; PMID:19687332; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Clin Cancer Res 2005; 11:5319-28; PMID:16033851;  http://dx.doi.org/10.1158/1078-0432.CCR-04-2402 144.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Clin Oncol 2012; 30:2718-24; PMID:22565002; http://dx.doi.org/10.1200/ JCO.2011.39.0708 145.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Clin Oncol 2009; 27:2630-7; PMID:19380449; http://dx.doi.org/10.1200/JCO.2008.18.8391 146.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
N Engl J Med 2012; 366:520-9; PMID:22149876; http://dx.doi.org/10.1056/ NEJMoa1109653 147.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Future Oncol 2012; 8:651- 7; PMID:22764762; http://dx.doi.org/10.2217/fon.12.49 148.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Clin Oncol 2013; 31:195- 202; PMID:23233719; http://dx.doi.org/10.1200/ JCO.2011.38.3331 149.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Res 2011; 71:4573-84; PMID:21602434; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Pharmacol Exp Ther  2010; 334:830-8; PMID:20522531; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Res 2008; 68:8022-30; PMID:18829560;  http://dx.doi.org/10.1158/0008-5472.CAN-08-1385 152.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Nat Cell Biol 2002; 4:648-57;  PMID:12172553; http://dx.doi.org/10.1038/ncb839 153.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Science 1987; 235:177- 82; PMID:3798106; http://dx.doi.org/10.1126/ science.3798106 156.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Curr Biol  2008; 18:1269-77; PMID:18722121; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cancer Epidemiol Biomarkers Prev 2012; 21:1203-12; PMID:22564867; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
J Clin Oncol 2009; 27:3297- 302; PMID:19487376; http://dx.doi.org/10.1200/ JCO.2009.19.6410163.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Cell Cycle 2009; 8:909- 15; PMID:19221498; http://dx.doi.org/10.4161/ cc.8.6.7933 164.,OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Breast Cancer Res Treat 2012; 135:639- 46; PMID:22847511; http://dx.doi.org/10.1007/ s10549-012-2170-x 166.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Breast Cancer Res Treat 2012; 135:821- 30; PMID:22933030; http://dx.doi.org/10.1007/ s10549-012-2223-1 167.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
Clin Lymphoma Myeloma Leuk 2013; 13:584- 91; PMID:23787123; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/b5/0f/ktrs-02-01-10928968.PMC4705830.pdf
"It was noted early in the characterization of Nrf2 that the protein displays a reduced mobility  on Tris-glycine gels, migrating at a rate of just over 100 kDa despite its molecular weight of  This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ 2Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/ac/17/nihms748068.PMC4705856.pdf
"Results in HepG2, a tumor- derived human liver endothelial cell line ( Knowles et al., 1980 ), were compared to those in  the HaCaT cell line, a spontaneously transformed human normal keratinocyte cell line  (Boukamp et al., 1988 ), and the THLE-2 cell line, which is derived from normal human liver  ihttp://www.abcam.com/nrf2-antibody-ep1808y-ab62352.html  Page last accessed on June 11, 2015.Kemmerer et al.",Non-OADS,/arxiv_data1/oa_pdf/ac/17/nihms748068.PMC4705856.pdf
"Markers were visualized by fluorescence and overlaid above sample bands at  40% opacity using ImageJ (Rasband, W.S., ImageJ, U. S. National Institutes of Health,  Bethesda, Maryland, USA, http://imagej.nih.gov/ij/ , 1997–2015).",OADS,/arxiv_data1/oa_pdf/ac/17/nihms748068.PMC4705856.pdf
"iihttp://www.scbt.com/datasheet-13032-nrf2-h-300-antibody.html  Page last accessed on June 11, 2015.Kemmerer et al.",OADS,/arxiv_data1/oa_pdf/ac/17/nihms748068.PMC4705856.pdf
"We found that  iiihttp://www.scbt.com/datasheet-722-nrf2-c-20-antibody.html  Page last accessed on June 11, 2015.Kemmerer et al.",OADS,/arxiv_data1/oa_pdf/ac/17/nihms748068.PMC4705856.pdf
"Initially the strong detection of a band in HepG2 lysates near the correct migration  ivhttp://www.cellsignal.com/product/productDetail.jsp?productId=12721  Page last accessed June 11, 2015.Kemmerer et al.",OADS,/arxiv_data1/oa_pdf/ac/17/nihms748068.PMC4705856.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/bf/ftv117.PMC4705866.pdf
Available from http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/ all-cancers-combined/#UK (accessed on 13 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/35/a5/bjc2015219a.PMC4705871.pdf
Available from http://www.cancerresearchuk.org/cancer-info/cancerstats/mortality/ all-cancers-combined (accessed on 13 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/35/a5/bjc2015219a.PMC4705871.pdf
"All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/LETTERS TO THE EDITOR British Journal of Cancer (2015) 113, 1632 | doi: 10.1038/bjc.2015.219 1632 www.bjcancer.com",Non-OADS,/arxiv_data1/oa_pdf/35/a5/bjc2015219a.PMC4705871.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ *Correspondence: Dr P Cazorla-Saravia; E-mail: patrickcazorla@hotmail.com Published online 11 August 2015 &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/a8/e7/bjc2015293a.PMC4705872.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ 1638 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/a8/e7/bjc2015293a.PMC4705872.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ www.bjcancer.com 1639,Non-OADS,/arxiv_data1/oa_pdf/a8/e7/bjc2015293a.PMC4705872.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ *Correspondence: Dr P Cazorla-Saravia; E-mail: patrickcazorla@hotmail.com Published online 11 August 2015 &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/71/64/bjc2015294a.PMC4705873.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ 1638 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/71/64/bjc2015294a.PMC4705873.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ 1634 www.bjcancer.comLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/10/8a/bjc2015316a.PMC4705874.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ *Correspondence: Dr A Rowland; E-mail: andrew.rowland@flinders.edu.au Published online 10 September 2015 &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/10/8a/bjc2015316a.PMC4705874.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ www.bjcancer.com 1635LETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/10/8a/bjc2015316a.PMC4705874.pdf
Available from http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/ all-cancers-combined/#UK (accessed on 13 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/f5/44/bjc2015317a.PMC4705875.pdf
Available from http://www.cancerresearchuk.org/cancer-info/cancerstats/mortality/ all-cancers-combined (accessed on 13 February 2015).,Non-OADS,/arxiv_data1/oa_pdf/f5/44/bjc2015317a.PMC4705875.pdf
"All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/LETTERS TO THE EDITOR British Journal of Cancer (2015) 113, 1632 | doi: 10.1038/bjc.2015.219 1632 www.bjcancer.com",Non-OADS,/arxiv_data1/oa_pdf/f5/44/bjc2015317a.PMC4705875.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ www.bjcancer.com 1633LETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/f5/44/bjc2015317a.PMC4705875.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ www.bjcancer.com 1633LETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/43/b6/bjc2015320a.PMC4705876.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ 1634 www.bjcancer.comLETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/43/b6/bjc2015320a.PMC4705876.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ *Correspondence: Dr A Rowland; E-mail: andrew.rowland@flinders.edu.au Published online 10 September 2015 &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/25/82/bjc2015325a.PMC4705877.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ www.bjcancer.com 1635LETTERS TO THE EDITOR,Non-OADS,/arxiv_data1/oa_pdf/25/82/bjc2015325a.PMC4705877.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ *Correspondence: Dr P Cazorla-Saravia; E-mail: patrickcazorla@hotmail.com Published online 11 August 2015 &2015 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/71/90/bjc2015330a.PMC4705878.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ 1638 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/71/90/bjc2015330a.PMC4705878.pdf
Because of the lack of evidence for effectiveness the PulMiCC trial (Pulmonary Metastasectomy in ColorectalCancer) seeks to answer that question (http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=9018).,Non-OADS,/arxiv_data1/oa_pdf/ac/d1/bjc2015331a.PMC4705879.pdf
All rights reserved 0007 – 0920/15 http://creativecommons.org/licenses/by-nc-sa/4.0/ 1636 www.bjcancer.com,Non-OADS,/arxiv_data1/oa_pdf/ac/d1/bjc2015331a.PMC4705879.pdf
"Toxicities were graded using the National Cancer Institute Common Toxicity Criteria for Adverse Events version 3.0 (DCTD, NCI, NIH, DHHS; http://ctep.cancer.gov).",Non-OADS,/arxiv_data1/oa_pdf/09/a4/bjc2015343a.PMC4705880.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Phase I eribulin and gemcitabine in solid tumours 1540 www.bjcancer.com | DOI:10.1038/bjc.2015.343,Non-OADS,/arxiv_data1/oa_pdf/09/a4/bjc2015343a.PMC4705880.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Type 2 diabetes, HbA1c, and pancreatic cancer 1614 www.bjcancer.com | DOI:10.1038/bjc.2015.353",Non-OADS,/arxiv_data1/oa_pdf/6f/e2/bjc2015353a.PMC4705881.pdf
"As potential biomarkers, relevant features selected by Progenesis were exported in .mgf files and the corresponding proteins were identified using the MASCOT software (http://www.matrixscience.com/) and SwissProt database (http://web.expasy.org/docs/swiss-prot_guideline.html).",OADS,/arxiv_data1/oa_pdf/e6/45/bjc2015370a.PMC4705884.pdf
Statistical analysis were done with FactoMineR package for R software (http://cran.r-project.org/ web/packages/FactoMineR/).,OADS,/arxiv_data1/oa_pdf/e6/45/bjc2015370a.PMC4705884.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Histopathology of post-Chernobyl PTC in a UkrAm cohort 1564 www.bjcancer.com | DOI:10.1038/bjc.2015.372,Non-OADS,/arxiv_data1/oa_pdf/a1/10/bjc2015372a.PMC4705885.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER A large retrospective nationwide study 1606 www.bjcancer.com | DOI:10.1038/bjc.2015.375,Non-OADS,/arxiv_data1/oa_pdf/a9/3f/bjc2015375a.PMC4705887.pdf
Available at http://www.R-project.org/ (accessed 12 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/30/d8/bjc2015377a.PMC4705888.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)39Department of Clinical Sciences, Obstetrics and Gy necology, Umeå University, SE-901 87 Umeå, Sweden;40Department of Public Health and Clinical Medicine, Nutritional R esearch, Umeå University, SE-901 87 Umeå, Sweden;41Department of Medical Biosciences and Pathology, Umeå University, Umeå SE-901 87, Sweden;42MRC Epidemiology Unit, University of Cambridge, Institute of Metabolic Science, Box 285, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 0QQ, UK;43School of Clinical Medicine, University of Cambridge, Addenbrooke’s Hospital, Hills Rd, Cambridge CB2 0SP, UK;44Cancer Epidemiology Unit, Nuffield Department of Population Health, University o f Oxford, Richard Doll Building, Oxford OX3 7LF, UK and45International Agency for Research on Cancer, 150 Cours Albert-Thomas, Lyon Cedex 08 69372, FranceReproductive factors and ovarian cancer-specific survival BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.377 1631",Non-OADS,/arxiv_data1/oa_pdf/30/d8/bjc2015377a.PMC4705888.pdf
"Statistical analyses were performed with SPSS, version 21.0 (IBM, Armonk, NY, USA), Stata SE, version 12.1 (Stata, College Station, TX, USA) and R software packages, version 3.1.2 (The RFoundation for Statistical Computing; http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/b9/ca/bjc2015379a.PMC4705889.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Conditional survival prognoses of IL-6 and IL-6R in ccRCC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.379 1589,Non-OADS,/arxiv_data1/oa_pdf/b9/ca/bjc2015379a.PMC4705889.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Phase I clinical trial with MOC31PE immunotoxin BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.380 1555,Non-OADS,/arxiv_data1/oa_pdf/a7/8d/bjc2015380a.PMC4705890.pdf
Available from: http://www.acr.org (cited in 2014).,OADS,/arxiv_data1/oa_pdf/cd/49/bjc2015381a.PMC4705891.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)HPV vaccination for men BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.403 1601,Non-OADS,/arxiv_data1/oa_pdf/6e/46/bjc2015403a.PMC4705902.pdf
Available at: http://www.irosrc.it/wp-content/uploads/Iros_Art.6.pdf; www.irosrc.it/research.,Non-OADS,/arxiv_data1/oa_pdf/75/91/cornea-35-145.PMC4705913.pdf
"4, 512–523, http://dx.doi.org/10.1080/10803548.2015.1095547 Kickback risk of portable chainsaws while cutting wood of diﬀerent properties: laboratory tests and deductions Andrzej D ˛ abrowski∗ Central Institute of Labour Protection – National Research Institute (CIOP-PIB), Poland Portable chainsaws are associated with substantial risk and can cause serious injury to operators, especially during kickback.",Non-OADS,/arxiv_data1/oa_pdf/31/e0/tose-21-512.PMC4706016.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/31/e0/tose-21-512.PMC4706016.pdf
Available from:http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri = OJ:L:2006:157:0024:0086:en:PDF [5] D ˛ abrowski A.,Non-OADS,/arxiv_data1/oa_pdf/31/e0/tose-21-512.PMC4706016.pdf
Available from: http://www.oregonproducts.com/pro/ service/faq.htm [16] Gendek A. Wpływ parametrów sprz˛ egła na wyda- jno´s´c skrawania drewna pilark ˛ a spalinow ˛ a [Inﬂuence of clutch parameters on combustion chain saw woodwork- ing eﬃciency] [doctoral dissertation].,Non-OADS,/arxiv_data1/oa_pdf/31/e0/tose-21-512.PMC4706016.pdf
Available from:http://annals-wuls.sggw.pl/ﬁles/ﬁles/agriculture/afe2012no60art11.pdf [18] Zychowicz W. Analysis of age and size structure of chain saws used in the selected regions of Poland.,Non-OADS,/arxiv_data1/oa_pdf/31/e0/tose-21-512.PMC4706016.pdf
Available from:http://annals-wuls.sggw.pl/ﬁles/ﬁles/afe2009no53art08pub.pdf,Non-OADS,/arxiv_data1/oa_pdf/31/e0/tose-21-512.PMC4706016.pdf
"S2, S177–S189, http://dx.doi.org/10.1080/13691058.2015.105341 2 © 2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/91/ba/tchs-17-177.PMC4706017.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDeriva- tives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/91/ba/tchs-17-177.PMC4706017.pdf
"“Systematic Review Draft Protocol, Version 6.2Feburary 2014. Review Title: Health System andCommunity-Based Interventions forImproving Maternal Health andforReducing Maternal Health Inequalities inLow-andMiddle-Income Countries: ATwo-Stage Mixed-Methods Research Synthesis.” http://www.mascotfp7.eu/wp-content/ uploads/2012/03/Mascot_systematic_review_protocol_Final_20130912.pdf MASCOT/WOTRO.",Non-OADS,/arxiv_data1/oa_pdf/91/ba/tchs-17-177.PMC4706017.pdf
"S2, S223–S237, http://dx.doi.org/10.1080/13691058.2015.103858 6 © 2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/1a/68/tchs-17-223.PMC4706018.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDeriva- tives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/1a/68/tchs-17-223.PMC4706018.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDeriva-tives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.Culture, Health & Sexuality , 2015 Vol.",Non-OADS,/arxiv_data1/oa_pdf/ad/86/tchs-17-096.PMC4706020.pdf
"S2, S96 –S111, http://dx.doi.org/10.1080/13691058.2015.1075253",Non-OADS,/arxiv_data1/oa_pdf/ad/86/tchs-17-096.PMC4706020.pdf
"*Email: mﬂood@uow.edu.auCulture, Health & Sexuality , 2015 http://dx.doi.org/10.1080/13691058.2015.1070435 Vol.",Non-OADS,/arxiv_data1/oa_pdf/69/56/tchs-17-159.PMC4706022.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDeriva- tives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/69/56/tchs-17-159.PMC4706022.pdf
(See http://www.walkamileinhershoes.org/ .),Non-OADS,/arxiv_data1/oa_pdf/69/56/tchs-17-159.PMC4706022.pdf
"Paper presented at the annual meeting of the American Sociological Association Annual Meeting, Hilton San Francisco Union Square and Parc 55 Wyndham San Francisco, San Francisco, CA, Aug 15, 2014. ,http://citation.allacademic.com/meta/p721846_index.html .",Non-OADS,/arxiv_data1/oa_pdf/69/56/tchs-17-159.PMC4706022.pdf
"MenEngage , URL; http://menengage.org/resources/menenga ge-accountability-st andards-guidelines/ .",Non-OADS,/arxiv_data1/oa_pdf/69/56/tchs-17-159.PMC4706022.pdf
"URL: http://feministcurrent.com/7868 /why-talking-about-healthy- masculinity , Accessed August 12 2013.",Non-OADS,/arxiv_data1/oa_pdf/69/56/tchs-17-159.PMC4706022.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDer- ivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or builtupon in any way.",Non-OADS,/arxiv_data1/oa_pdf/e6/46/rccm-9-056.PMC4706023.pdf
"1, 56 –70, http://dx.doi.org/10.1080/17542863.2015.1106569",Non-OADS,/arxiv_data1/oa_pdf/e6/46/rccm-9-056.PMC4706023.pdf
"Retrieved from http://ajp.psychiatryonline.org/doi/abs/10.1176/ajp.148.11.1548 Cheung, P .",Non-OADS,/arxiv_data1/oa_pdf/e6/46/rccm-9-056.PMC4706023.pdf
"Retrieved from https://us.sagepub.com/en-us/nam/evaluation/book224290 Saxena, S., Lora, A., van Ommeren, M., Barrett, T., Morris, J., & Saraceno, B.",Non-OADS,/arxiv_data1/oa_pdf/e6/46/rccm-9-056.PMC4706023.pdf
"Retrieved from http://www.un.org/ en/peacekeeping/missions/unmil/ Vinck, P ., Pham, P .",Non-OADS,/arxiv_data1/oa_pdf/e6/46/rccm-9-056.PMC4706023.pdf
"JOURNALOFOCCUPATIONALANDENVIRONMENTALHYGIENE ,VOL.,NO.,– http://dx.doi.org/./.. Immediate screening of lead exposure in the workplace using portable X-ray ﬂuorescence Jean-PhilippeGorceandMartinRoff HealthandSafetyLaboratory,Buxton,UnitedKingdom KEYWORDS Fieldinstrument;in-situ measurements;lead poisoning;metalsexposure;XRFspectroscopy;samplingmethodologyABSTRACT TheuseofaportableX-rayfluorescencespectrometer(PXRF)equippedwithaminiaturisedX-raytube producingasmall8mmdiameterX-raybeamrequiredthevalidationoftwonewsamplingprotocolsfortheimmediatescreeningofoccupationalleadexposure.",Non-OADS,/arxiv_data1/oa_pdf/60/87/uoeh-13-102.PMC4706026.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionLicense(http://creativecommons.org/licenses/by/ .),whichpermits unrestricteduse,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.Themoralrightsofthenamedauthor(s )havebeen asserted.and able to confirm that the workplace is the origin of exposure.Usually,leadexposureisquantifiedatanoff-sitelaboratory several days after sampling.",OADS,/arxiv_data1/oa_pdf/60/87/uoeh-13-102.PMC4706026.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDeriva-tives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.Culture, Health & Sexuality , 2015 Vol.",Non-OADS,/arxiv_data1/oa_pdf/fe/e0/tchs-17-085.PMC4706027.pdf
"S2, S85 –S95, http://dx.doi.org/10.1080/13691058.2015.1092260",Non-OADS,/arxiv_data1/oa_pdf/fe/e0/tchs-17-085.PMC4706027.pdf
"4, 558–567, http://dx.doi.org/10.1080/10803548.2015.1095010 The strategy of training staﬀ for a new type of helicopter as an element of raising the security level of ﬂight operations Robert Gał ˛ azkowskia,b, Władysław Wołkowskib, Marcin Mikosc, Sławomir Szajdad, Arkadiusz Wejnarskiband Stanisław Paweł ´Swie˙ zewskia,b∗ aMedical University of Warsaw, Poland;bPolish Medical Air Rescue, Poland;cJagiellonian University Medical College, Poland; dMedical University in Białystok, Poland In 2008, the Polish Medical Air Rescue started replacing its ﬂeet with modern EC135 machines.",Non-OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
Available from: http://czytelnia.cnbop.pl/czytelnia/7/188 [2] Smalko Z.,Non-OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
"Available from: http://www.journal.itwl.pl/ index.php/spis-rocznikow?id =85 [3] Durkee A, Padula S, Paquette J.",OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
Available from: http://www.wpi.edu/Pubs/E- project/Available/E-project-041813-124558/unrestricted/Master_Copy_[PDF].pdf [4] Zarz ˛ adzenie Nr 14 Prezesa Urz˛ edu Lotnictwa Cywilnego z dnia 14 grudnia 2006 r. w sprawie wprowadzenia klasy-ﬁkacji grup przyczynowych zdarze ´n lotniczych [Order No.,Non-OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
Available from:http://www.ulc.gov.pl/_download/prawo/dzienniki_urzedowe/2006/dzurz_10_06.pdf [5] JAA ATPL.,OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
Available from: http://www.problemyeksploatacji.itee.,Non-OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
"Available from:http://czytelnia.cnbop.pl/czytelnia/22/221 [12] Popiel A. Pragłowska E. Wypadek komunikacyjny – dra- mat, którego nie leczy czas.",Non-OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
"Availablefrom: http://kwartalnik.csp.edu.pl/kp/archiwum-1/2010/nr- 42010/1244,wypadek-komunikacyjny-dramat-ktorego-nie-leczy-czas-o-zespole-stresu-pourazowego.html [13] Dudek B. Stres traumatyczny zwi ˛ azany z prac ˛ a, czyn- niki ryzyka [Work-related traumatic stress, risk factors].Bezpiecze ´nstwo Pracy.",Non-OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
Available from:http://www.ulc.gov.pl/_download/prawo/prawo_krajowe/ustawa_prawo_lot_akty_wyk/dz.u.07.35.225.pdf [15] Pawłowska Z. Zarz ˛ adza ´c bezpiecze ´nstwem – to przewidy- wa´c zagro˙ zenia [Managing safety is to predict threats].,Non-OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
Available from: http://www.ulc.gov.pl/_download/ bezpieczenstow_lotow/konferencje/2010/info_bl_2009.pdf [20] D ˛ abrowska J. Czynnik ludzki w lotnictwie [The human fac- tor in aviation].,Non-OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
Available from: http://ilot.edu.pl/ prace_ilot/public/PDF/spis_zeszytow/221_2011/05.%20D%C4%85browska%20J..pdf [21] International Civil Aviation Organization (ICAO).,Non-OADS,/arxiv_data1/oa_pdf/56/5e/tose-21-558.PMC4706028.pdf
"S2, S190–S205, http://dx.doi.org/10.1080/13691058.2015.102787 8 © 2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/5c/fc/tchs-17-190.PMC4706030.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDeriva- tives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/5c/fc/tchs-17-190.PMC4706030.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDer- ivatives License ( http://creativecommons.org/Licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or builtupon in any way.",Non-OADS,/arxiv_data1/oa_pdf/f1/99/rccm-9-001.PMC4706033.pdf
"1, 1 –13, http://dx.doi.org/10.1080/17542863.2015.1074260",Non-OADS,/arxiv_data1/oa_pdf/f1/99/rccm-9-001.PMC4706033.pdf
"World Psychiatry ,1(1), 16 –20.http://onlinelibrary.wiley.com/journal/10.",Non-OADS,/arxiv_data1/oa_pdf/f1/99/rccm-9-001.PMC4706033.pdf
"International Psychiatry ,11(2), 3. http://www.rcpsych.ac.uk/pdf/ PUB_IPv11n2.pdf Kakuma, R., Minas, H., van Ginneken, N., Dal Poz, M. R., Desiraju, K., Morris, J. E., … Schef ﬂer, R. M. (2011).",Non-OADS,/arxiv_data1/oa_pdf/f1/99/rccm-9-001.PMC4706033.pdf
"Retrieved from http://www.open-the-doors.com/english/ media/Training_8.15.05.pdf Wrigley, S., Jackson, H., Judd, F., & Komiti, A.",Non-OADS,/arxiv_data1/oa_pdf/f1/99/rccm-9-001.PMC4706033.pdf
"S2, S144–S158, http://dx.doi.org/10.1080/13691058.2015.104852 7 © 2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/a3/43/tchs-17-144.PMC4706035.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDeriva- tives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/a3/43/tchs-17-144.PMC4706035.pdf
"Accessed February 92015.http://www.anc.org.za/list.php?t ¼Discussion%20Documents Barker, G.,andC.Ricardo.",Non-OADS,/arxiv_data1/oa_pdf/a3/43/tchs-17-144.PMC4706035.pdf
"“TheBoys whoLosttheirManhood.” Mail&Guardian ,16Aug.Accessed February 52015.http://mg.co.za/article/2013-08-16-00-the-boys-who-lost-their-manhood Mama, A.2006.",Non-OADS,/arxiv_data1/oa_pdf/a3/43/tchs-17-144.PMC4706035.pdf
"Accessed February 52015.http://www.news24.com/SouthAfrica/News/Race-is-dividing-SA- Rupert-20150204 Spall, J.2014.",Non-OADS,/arxiv_data1/oa_pdf/a3/43/tchs-17-144.PMC4706035.pdf
Accessed Feb52015.http://www.timeslive.co.za/businesstimes/2014/12/06/rich- list-leaderboard-shows-it-s-still-a-man-s-world World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/a3/43/tchs-17-144.PMC4706035.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivativesLicense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.Culture, Health & Sexuality , 2015 Vol.",Non-OADS,/arxiv_data1/oa_pdf/63/e9/tchs-17-112.PMC4706037.pdf
"S2, S112 –S127, http://dx.doi.org/10.1080/13691058.2015.1085094",Non-OADS,/arxiv_data1/oa_pdf/63/e9/tchs-17-112.PMC4706037.pdf
"S2, S206 –S222, http://dx.doi.org/10.1080/13691058.2015.1070434 © 2015 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/f1/3e/tchs-17-206.PMC4706040.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDeriva- tives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/f1/3e/tchs-17-206.PMC4706040.pdf
See http://www.promundo.org.br/en/activities/activities-posts/program-h/ .,Non-OADS,/arxiv_data1/oa_pdf/f1/3e/tchs-17-206.PMC4706040.pdf
"ORCID Jeffrey Edmeades http://orcid.org/0000-0003-4092-7700 References Barker, G., and P. Pawlak.",Non-OADS,/arxiv_data1/oa_pdf/f1/3e/tchs-17-206.PMC4706040.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/8f/ott-9-131.PMC4706119.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 131–138OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  131Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9499 7Detection of lung adenocarcinoma with ROS1   rearrangement by ihc , Fish, and r T -Pcr and  analysis of its clinicopathologic features Bing cao1–3,* Ping Wei1–3,* Zebing liu4 rui Bi1–3 Y ongming lu1–3 ling Zhang1–3 Jing Zhang1–3 Yusi Yang1–3 chen shen1–3 Xiang Du1–3 Xiaoyan Zhou1–3 1Department of Pathology, Fudan  University shanghai cancer center,   shanghai, People’s republic of  china; 2Department of Oncology,   shanghai Medical college, 3institute  of Pathology, Fudan University,   shanghai, People’s republic of china;   4Department of Pathology, renji  hospital, school of Medicine, shanghai  Jiaotong University, shanghai, People’s  republic of china *These authors contributed equally  to this workObjective:  To detect ROS1  rearrangement using three different assays, including  immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and reverse transcription  polymerase chain reaction (RT-PCR), and to analyze the clinicopathologic features of ROS1   rearrangement in patients with lung adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/f4/8f/ott-9-131.PMC4706119.pdf
"Keywords:  ROS1 , lung adenocarcinoma, rearrangement, IHC, FISH, RT-PCR Introduction Lung adenocarcinoma is the most common histological subtype of lung cancer, which  is the leading cause of cancer-related deaths worldwide.1,2 There is increasing evidence  that lung adenocarcinoma could be divided into different molecular subgroups based on  the identification of oncogenic drivers, such as EGFR , ALK , ROS1 , RET , and MET , with  unique clinicopathologic characteristics and the potential for targeted therapies.3 ROS1 is a receptor tyrosine kinase that encodes a transmembrane protein with  evolutionary relationships to ALK.4 ROS1  fusion was originally identified in the human  glioblastoma cell line U118MG in 1987.5 Recently, ROS1  fusions have been discovered  in several other tumors, including cholangiocarcinoma,6 non-small-cell lung cancer  (NSCLC),7–12 ovarian cancer,13 gastric carcinoma,14 and colorectal cancer.15 ROS1   fusion in NSCLC was initially identified by Rikova et al7 in 2007 using a phosphop - roteomic screen, and ROS1  fusion was shown to participate in the formation of lung correspondence: Xiaoyan Zhou Department of Pathology, Fudan  University shanghai cancer center,  270 Dongan road, shanghai 200032,  People’s republic of china Tel +86 21 6417 5590 ext 8330 Fax +86 21 6417 0067 email xyzhou100@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Cao et al Running head recto: Detection of lung adenocarcinoma with ROS1  rearrangement DOI: http://dx.doi.org/10.2147/OTT.S94997",Non-OADS,/arxiv_data1/oa_pdf/f4/8f/ott-9-131.PMC4706119.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f4/8f/ott-9-131.PMC4706119.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/8f/ott-9-131.PMC4706119.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/bc/opth-10-065.PMC4706120.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2016:10 65–69Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  65MethO dOlOgyopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S9084 4evaluation and validity of the danish version of  the Adult Strabismus Questionnaire AS-20 Nafisa Ali1 Mette S Sørensen2 torben l Sørensen1,3 Panteleimon Mortzos1 1department of Ophthalmology,   Copenhagen University hospital  Roskilde, Roskilde, 2Research Unit  for Women’s and Children’s health,   National University hospital, 3Faculty  of health Sciences, University of  Copenhagen, Copenhagen, denmarkPurpose:  Assessing health-related quality of life in patients with strabismus is important in  evaluating the clinical benefits of strabismus treatment.",Non-OADS,/arxiv_data1/oa_pdf/e1/bc/opth-10-065.PMC4706120.pdf
"The composite score Correspondence: Panteleimon Mortzos department of Ophthalmology,  Copenhagen University hospital Roskilde,  Køgevej 7-13, 4000 Roskilde, denmark tel +45 4732 3901 email pmz@regionsjaelland.d k Journal name: Clinical Ophthalmology Article Designation: Methodology Y ear: 2016 Volume: 10 Running head verso: Ali et al Running head recto: Danish version of the Adult Strabismus Quality of Life Questionnaire DOI: http://dx.doi.org/10.2147/OPTH.S90844",Non-OADS,/arxiv_data1/oa_pdf/e1/bc/opth-10-065.PMC4706120.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e1/bc/opth-10-065.PMC4706120.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/bc/opth-10-065.PMC4706120.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/67/ceor-8-015.PMC4706121.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2016:8 15–21ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  15ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S9364 1Budget impact analysis of sofosbuvir-based  regimens for the treatment of hiV/hCV- coinfected patients in northern italy: a multicenter  regional simulation giovanni Cenderello1 stefania artioli2 Claudio Viscoli3 ambra Pasa4 Mauro giacomini5 Barbara giannini5 Chiara Dentone6 laura ambra nicolini3 giovanni Cassola1 antonio Di Biagio3 1infectious Diseases Unit EO,   Ospedali galliera, genoa, 2infectious  Diseases Unit, asl-5 spezzina, la  spezia, 3infectious Diseases Unit, aOU  san Martino, isT, genoa University,   genoa, 4iT Unit, Ospedali galliera,   genoa, 5Department of informatics,   Bioengineering, Robotics and system  Engineering (D iBRis), University of  genoa, genova, 6infectious Diseases  Unit, asl-1 imperiese, sanremo,   imperia, italy Correspondence: giovanni Cenderello   infectious Diseases Unit EO, Ospedali  galliera, Mura delle Cappuccine 14,  16128 genoa, italy   Tel +39 010 5634 478   Fax +39 010 5744 480   Email giovanni.cenderello@galliera.i tObjectives:  Chronic hepatitis C virus (HCV) is a leading cause of hospitalization and death  in populations coinfected with human immunodeficiency virus (HIV).",Non-OADS,/arxiv_data1/oa_pdf/65/67/ceor-8-015.PMC4706121.pdf
Available from:  http://espresso.repubblica.it/visioni/scienze/2015/02/27/news/quel- farmaco-costa-troppo-1.201536.,Non-OADS,/arxiv_data1/oa_pdf/65/67/ceor-8-015.PMC4706121.pdf
Available from:  http://www.webaisf.org/ .,Non-OADS,/arxiv_data1/oa_pdf/65/67/ceor-8-015.PMC4706121.pdf
Available from: http://www.rainews.it/dl/rainews/articoli/ Luca-Pani-direttore-AIFA-Le-criticita-ci-sono-ma-solo-in-alcune- Regioni-7ad958b2-2174-4a4e-a339-7b0b959964da.html .,Non-OADS,/arxiv_data1/oa_pdf/65/67/ceor-8-015.PMC4706121.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/65/67/ceor-8-015.PMC4706121.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/67/ceor-8-015.PMC4706121.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/36/31/ott-9-123.PMC4706122.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 123–129OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  123Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9073 2alpha-fetoprotein- l3 and golgi protein 73 may  serve as candidate biomarkers for diagnosing alpha- fetoprotein-negative hepatocellular carcinoma Zhiguo Zhang1 Yanying Zhang2 Yeying Wang1 lingling Xu3 Wanju Xu3 1Department of clinical laboratory,   Zhangqiu Maternity and child care  hospital, Zhangqiu, 2Department  of clinical laboratory, Zaozhuang  city Wangkai infection hospital,   Zaozhuang, 3Department of clinical  laboratory, Qianfoshan hospital,   Jinan, People’s republic of chinaAbstract:  Currently, there is no reliable biomarker for use in diagnosing alpha-fetoprotein  (AFP)-negative hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/36/31/ott-9-123.PMC4706122.pdf
"One  specific type of AFP, AFP-L3, binds to lectin Lens culinaris  agglutinin and displays correspondence: Wanju Xu Department of clinical laboratory,  Qianfoshan hospital, Jingshi road,   no 16766, Jinan 250014, People’s  republic of china Tel +86 137 9107 7359 email tksxfd@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: AFP-L3 and GP73 as biomarkers for diagnosing hepatocellular carcinoma DOI: http://dx.doi.org/10.2147/OTT.S90732",Non-OADS,/arxiv_data1/oa_pdf/36/31/ott-9-123.PMC4706122.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/36/31/ott-9-123.PMC4706122.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/31/ott-9-123.PMC4706122.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a6/b2/ndt-12-049.PMC4706123.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 49–56Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  49OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9554 1affective network and default mode network in  depressive adolescents with disruptive behaviors sun Mi Kim1 sung Y ong Park1 Y oung in Kim1 Y oung Don son2 Un-sun chung3,4 Kyung Joon Min1 Doug hyun han1 1Department of Psychiatry, school  of Medicine, chung-ang University,   seoul, 2Department of Biomedical  engineering, gachon University  of Medicine and science, incheon,   3Department of Psychiatry,   school of Medicine, Kyungpook  National University, 4school Mental  health resources and research  center, Kyungpook National  University children’s hospital,   Daegu,  south KoreaAim:  Disruptive behaviors are thought to affect the progress of major depressive disorder  (MDD) in adolescents.",Non-OADS,/arxiv_data1/oa_pdf/a6/b2/ndt-12-049.PMC4706123.pdf
"Keywords:  resting-state functional connectivity, major depressive disorder, disruptive  behaviors, limbic network, default mode network Introduction Major depressive disorder and disruptive behavior in  adolescence Major depressive disorder (MDD) is a common psychiatric disorder in adolescence,  with a prevalence rate higher than 4%.1 Compared to classical depressive features,  including low self-esteem, excessive guilt, suicidal behaviors or thoughts, sleep and  appetite disturbance, and agitation in adults, adolescent depression tends to be more  complex, presenting with comorbidities (anxiety disorder, alcohol and substance use,  conduct disorder, or oppositional defiant disorder [ODD]).2 Among various comorbidi - ties, ODD might be one of the strongest comorbid conditions that affects the progress  of adolescent depressive symptoms.2 Moreover, it has been suggested that the irri - table sub-component of ODD shares a genetic association with major depression and  increases the risk of depression.3 The clinical symptoms of ODD or conduct disorder  have also been frequently observed in adolescents with attention-deficit hyperactivity correspondence: Doug hyun han Department of Psychiatry, school  of Medicine, chung-ang University,  heukseok-ro 102, Dongjack-gu,  seoul 156-755, south Korea Tel +82 2 6299 3132 email hduk@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Kim et al Running head recto: Brain network and disruptive behaviors DOI: http://dx.doi.org/10.2147/NDT.S95541",Non-OADS,/arxiv_data1/oa_pdf/a6/b2/ndt-12-049.PMC4706123.pdf
"Data process - ing was carried out using the Data Processing Assistant for  Resting-State fMRI (DPARSFA, http://www.restfmri.ne t) in  Statistical Parameter Mapping (SPM8, http://ww w.fil.ion.ucl.",OADS,/arxiv_data1/oa_pdf/a6/b2/ndt-12-049.PMC4706123.pdf
"ac.uk/spm/software/spm8 /) and the Resting-State fMRI Data Analysis toolkit (REST, http://resting-fmri.sourceforge.ne t).",OADS,/arxiv_data1/oa_pdf/a6/b2/ndt-12-049.PMC4706123.pdf
"The mean time series of an ROI was extracted  by Wake Forest University PickAtlas software, version 2.4   (http://fmri.wfubmc.edu/software/PickAtla s; Wake Forest  University School of Medicine Location, Winston-Salem, NC,  USA),25,26 and ROIs were predefined by automated anatomical  labeling equipped with PickAtlas.",OADS,/arxiv_data1/oa_pdf/a6/b2/ndt-12-049.PMC4706123.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a6/b2/ndt-12-049.PMC4706123.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/b2/ndt-12-049.PMC4706123.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1f/d0/ott-9-139.PMC4706124.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 139–148OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  139Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9556 5exosomal microRNA-141  is upregulated in the  serum of prostate cancer patients Zhuo li1,2,* Yue-Yun Ma1,* Juan Wang1 Xian-Fei Zeng1 rui li1 Wei Kang2 Xiao-Ke hao1 1Department of laboratory Medicine,   Xijing hospital, Fourth Military  Medical University, 2Department  of laboratory Medicine, The First  affiliated hospital of Xi’an Medical  University, Xi’an, shaanxi Province,   People’s republic of china *These authors contributed equally  to this workPurpose:  Novel biomarkers for the diagnosis of prostate cancer (PCa) are urgently required.",Non-OADS,/arxiv_data1/oa_pdf/1f/d0/ott-9-139.PMC4706124.pdf
"Exosomes are widely distributed in the correspondence: Xiao-Ke hao Department of laboratory Medicine,  Xijing hospital, Fourth Military Medical  University, 15 changle West road,  Xi’an 710032, shaanxi Province, People’s  republic of china Tel +86 29 8477 5572 email haoxkg@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li et al Running head recto: Serum exosomal miR-141  is upregulated in PCa DOI: http://dx.doi.org/10.2147/OTT.S95565",Non-OADS,/arxiv_data1/oa_pdf/1f/d0/ott-9-139.PMC4706124.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1f/d0/ott-9-139.PMC4706124.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/d0/ott-9-139.PMC4706124.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/59/46/rru-8-001.PMC4706125.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/59/46/rru-8-001.PMC4706125.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Research and Reports in Urology 2016:8 1–10Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  1ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RRU.S9719 4Efficacy and safety evaluation of pentoxifylline  associated with other antioxidants in medical  treatment of Peyronie’s disease: a case-control  study gianni Paulis1,2 Davide Barletta3 Paolo T urchi4 antonio Vitarelli5 giuseppe Dachille6 andrea Fabiani7 Romano gennaro8 1Regina apostolorum hospital,   andrology center, albano l,   2castelfidardo Medical T eam,   Peyronie’s Disease care center,   Rome, 3Department of Urology,   andrology center, san Matteo  hospital, Pavia, 4azienda asl 4  Prato – andrology service, Prato,   5Department of Urology, University  of Bari, 6Department of Urology, s  giacomo hospital, Monopoli, Bari,   7Department of surgery, section of  Urology and andrology, Macerata,   8Department of Urologic Oncology,   section of avellino, italian league  against cancer, avellino, italy correspondence: gianni Paulis   Castefidardo Medical Team (SMS),   Via Castefidardo  34, 00185 Rome, italy   Tel +39 06 4281 4211  email paulisg@libero.i tAbstract:  Peyronie’ s disease (PD) is a chronic disorder involving the tunica albuginea  surrounding the corpora cavernosa of the penis.",Non-OADS,/arxiv_data1/oa_pdf/59/46/rru-8-001.PMC4706125.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/59/46/rru-8-001.PMC4706125.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/59/46/rru-8-001.PMC4706125.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/46/rru-8-001.PMC4706125.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ed/80/dddt-10-107.PMC4706126.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 107–115Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  107ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9658 9Efficacy and safety of topical herbal medicine  treatment on recurrent aphthous stomatitis:  a systemic review Chun-Lei Li1,* He-Long Huang1,* Wan-Chun Wang2 Hong Hua1 1Department of Oral Medicine, Peking  University School and Hospital of  Stomatology, Beijing, 2Department  of Oral Medicine, Qingdao  Stomatological Hospital, Qingdao,   People’s Republic of China *These authors contributed equally  to this workAbstract:  This study aimed to evaluate the efficacy and safety of topical treatment with  natural herbal medicines on recurrent aphthous stomatitis (RAS).",Non-OADS,/arxiv_data1/oa_pdf/ed/80/dddt-10-107.PMC4706126.pdf
"Therefore, we conducted this analysis to evaluate the efficacy and safety of  topical treatment with natural herbal medicines on RAS.Correspondence: Hong Hua Department of Oral Medicine,  Peking University School and Hospital  of Stomatology, 22 Zhongguancun  Avenue South, Haidian District, Beijing  100081, People’s Republic of China Tel +86 10 8219 5218 Email honghua1968@aliyun.co m Wan-Chun Wang Qingdao Stomatological Hospital, No 17  Dexian Road Shinan, Qingdao 266001,  People’s Republic of China Tel +86 10 8279 2425 Email kqwwch@126.co mJournal name: Drug Design, Development and Therapy Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 10 Running head verso: Li et al Running head recto: Topical herbal medicine for recurrent aphthous stomatitis DOI: http://dx.doi.org/10.2147/DDDT.S96589",Non-OADS,/arxiv_data1/oa_pdf/ed/80/dddt-10-107.PMC4706126.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ed/80/dddt-10-107.PMC4706126.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/80/dddt-10-107.PMC4706126.pdf
Avail - able from: http://handbook.cochrane.org /.,OADS,/arxiv_data1/oa_pdf/ed/80/dddt-10-107.PMC4706126.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/57/ott-9-075.PMC4706127.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2016:9 75–86OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  75Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6855 8Profile of panitumumab as first-line treatment  in patients with wild-type KRAS metastatic  colorectal cancer Shiven B Patel* David Gill* Ignacio Garrido-Laguna Department of Internal Medicine,   Oncology Division and Center  for Investigational Therapeutics,   Huntsman Cancer Institute, University  of Utah, Salt Lake City, UT, USA *These authors contributed equally  to this workAbstract:  Targeted therapies against EGFR, vascular endothelial growth factor, and vascular  endothelial growth factor receptor have expanded treatment options for patients with metastatic  colorectal cancer (mCRC).",Non-OADS,/arxiv_data1/oa_pdf/0c/57/ott-9-075.PMC4706127.pdf
"Currently, treatment strategies for these patients are based on a  continuum care paradigm whereby patients are exposed throughout the course of their  disease to different active drugs, their treatment is personalized according to the need for  rapid response and the burden of disease and RAS status, drugs are often reintroduced if  they showed activity in a previous line of therapy, and finally, intervals of maintenance  chemotherapy are considered.7 This strategy has recently provided survival figures  above 30 months for patients with unresectable disease.8,9 Here, we review available  data for the use of panitumumab, a monoclonal antibody against EGFR, as the first-line  treatment in patients with KRAS  exon 2 wild-type mCRC.Correspondence: Ignacio Garrido-Laguna Department of Internal Medicine,  Oncology Division and Center for  Investigational Therapeutics, Huntsman  Cancer Institute, University of Utah  School of Medicine, 2000 Circle of  Hope, Suite 2100, Salt Lake City,  UT 84112, USA Tel +1 801 585 0255 Fax +1 801 585 0124 email ignacio.garrido-laguna@hci.utah.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Patel et al Running head recto: First-line panitumumab treatment in metastatic colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S68558",Non-OADS,/arxiv_data1/oa_pdf/0c/57/ott-9-075.PMC4706127.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/0c/57/ott-9-075.PMC4706127.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0c/57/ott-9-075.PMC4706127.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/57/ott-9-075.PMC4706127.pdf
Available from: https://www.clinicaltrials.gov/ ct2/show/NCT02164916.,Non-OADS,/arxiv_data1/oa_pdf/0c/57/ott-9-075.PMC4706127.pdf
Available from: https://www.clinicaltrials.gov/ct2/show/NCT01719380.,Non-OADS,/arxiv_data1/oa_pdf/0c/57/ott-9-075.PMC4706127.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b2/dc/ott-9-149.PMC4706128.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 149–158OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  149Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9474 7Clinical impacts of a micropapillary pattern in lung  adenocarcinoma: a review Ying Cao Li-Zhen Zhu Meng-Jie Jiang Ying Yuan Department of Medical Oncology,   The Second Affiliated Hospital,   Zhejiang University School of  Medicine, Hangzhou, People’s   Republic of ChinaAbstract:  Lung adenocarcinoma with a micropapillary pattern (MPPAC) has recently drawn  increased attention among researchers.",Non-OADS,/arxiv_data1/oa_pdf/b2/dc/ott-9-149.PMC4706128.pdf
"The term “pre - dominant” is applied to describe invasive ADC, which is defined by assessment of  histological patterns semiquantitatively in 5% increments on resection specimens.4  The new classification also recommends that pathologists list every present subtype Correspondence: Ying Yuan Department of Medical Oncology,  The Second Affiliated Hospital, Zhejiang  University School of Medicine, 88 Jiefang  Road, Hangzhou 310009, People’s  Republic of China Tel +86 571 8778 4795 Fax +86 571 8721 4404 email yuanying1999@zju.edu.cn  Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Cao et al Running head recto: Clinical impacts of a micropapillary pattern DOI: http://dx.doi.org/10.2147/OTT.S94747",Non-OADS,/arxiv_data1/oa_pdf/b2/dc/ott-9-149.PMC4706128.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b2/dc/ott-9-149.PMC4706128.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/dc/ott-9-149.PMC4706128.pdf
http://apps.who.int/iris/bitstream/10665/44165/1/9789241547833_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/98/medi-95-e1997.PMC4706243.pdf
"It is known that O174:H21 STEC strains are associated with cattle (http://www.microbionet.co- m.au/vtectable.htm) and have been isolated from food, mainlyfrom meat (beef and game), 14,15but also from raw milk and from semihard cow’s milk cheeses.16,17 Here, the STEC strain could not be isolated from the cow feces, an unsurprising result since fecal shedding of STEC istransient in cattle.18Accordingly, because feces from ‘‘healthy’’ cattle are undoubtedly a major source of milk contamination by STEC,19and milk from this animal was occasionally distributed locally, thereby posing a serious threatfor the whole village, this particular cow was destroyed.",Non-OADS,/arxiv_data1/oa_pdf/5b/e4/medi-95-e2050.PMC4706244.pdf
2003:CD003395http://onlinelibrary.wiley.com/doi/ 10.1002/14651858.CD003395/pdf/standard.,Non-OADS,/arxiv_data1/oa_pdf/02/d2/medi-95-e2204.PMC4706248.pdf
"5In lead-induced anemia, a person’s lead status could be underestimated by whole blood lead, and such underestimation can be avoided by the use of hematocrit- and hemoglobin-correction.5 Additional rationale for correcting blood lead for hematocritor hemoglobin is provided in eAppendix (Supplemental Digital Content, http://links.lww.com/MD/A583).",Non-OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
"Models A0, B0, and C0 are minimally adjusted with no adjustment for nonlead metal biomarkers.Results from interim models are included in eTable 2, http://links.lww.com/MD/A583 (Supplemental Digital Content, http:// links.lww.com/MD/A583).",Non-OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
"The log-transformed hematocrit-corrected blood lead and hemoglobin-corrected blood lead were highly correlated (cor- relation coefficient, 0.999, eTable 1, Supplemental Digital Content, http://links.lww.com/MD/A583).",OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
"Additional results from models with just 1 nonlead biomarker are shown ineTable 2, http://links.lww.com/MD/A583 (SupplementalDigital Content, http://links.lww.com/MD/A583).",Non-OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
"Examination of eTable 2, http://links.lww.com/MD/A583 (Supplemental Digital Content, http://links.lww.com/MD/A583)Medicine /C15Volume 95, Number 1, January 2016 Blood Lead and Other Metal Biomarkers as Risk Factors for CVD Copyright #2016 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
"Serum calcium had a U-shaped association with hematocrit-c orrected blood lead (eFigure 1, Supplemental Digital Conten t, http://links.lww.com/MD/ A583).DISCUSSION With adjustment for demographic factors and some important potential confounders, we observed a positive associ- ation between hematocrit- or hemoglobin-corrected blood leadand CVD mortality with estimated relative risks of 1.44 and1.46, respectively, per 10-fold increase in corrected blood lead.",Non-OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
"33On the other hand, most, if not all, recent studies have reported positive associati ons between serum calcium and CVD risk.34In the current study, extremely low and high serum calcium levels were asso ciated with slightly higher hematocrit-corre cted blood lead (eFigure 1, Supplemental Digital Content, http://links.lww.com/MD/A583) and withhigher CVD mortality (Fig.",Non-OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
http://www.atsdr.cdc.gov/ toxprofiles/tp13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
http://ofmpub.epa.gov/eims/eimscomm.getfile?p_downloa-d_id=518908.,OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
http://www.cdc.gov/nchs/ data_access/data_linkage/mortality.htm.,Non-OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
http://wwwn.cdc.gov/nchs/nhanes/2009-2010/BIOPRO_F.htm.,Non-OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
http://wwwn.cdc.gov/nchs/nhanes/ search/datapage.aspx?Component=Laboratory.,OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
"Fourth National Report on Human Exposure to Environmental Chemicals Updated Tables, August, 2014. http://www.cdc.gov/expo surereport/pdf/fourthreport_updatedtables_aug2014.pdf.",OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
http://www.cdc.gov/nutritionre- port/pdf/Nutrition_Book_complete508_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/da/medi-95-e2223.PMC4706249.pdf
"After controlling for potential confounders, underweight was significantly associated with a higher risk of all-cause mortalityduring treatment (AHR, 1.54; 95% CI, 1.18–2.01) (Table S1,http://links.lww.com/MD/A564).",Non-OADS,/arxiv_data1/oa_pdf/3b/9d/medi-95-e2300.PMC4706252.pdf
"Also, multinomial Cox regression analysis showed that underweight was significantly associated with higher risks of TB-specific mortality (AHR,1.82; 95% CI, 1.01–3.27) and non-TB-specific mortality (AHR, 1.48; 95% CI, 1.08–2.02) during treatment, while overweight was not (Table S2, http://links.lww.com/MD/A564).",Non-OADS,/arxiv_data1/oa_pdf/3b/9d/medi-95-e2300.PMC4706252.pdf
2. http://www.who.int/tb/publications/global_report/gtbr12_annex4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/9d/medi-95-e2300.PMC4706252.pdf
18. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5710a2.htm.,OADS,/arxiv_data1/oa_pdf/e5/f7/medi-95-e2327.PMC4706254.pdf
19. http://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescenttreat- ment-guidelines/0.AIDSinfo April 8th 2015.20.,Non-OADS,/arxiv_data1/oa_pdf/e5/f7/medi-95-e2327.PMC4706254.pdf
"Both the 2 scales were validly downloaded from the official website of EORTC (http://groups.eortc.be/qol/) and their Chinese versions had been tested for both credibility and validityin Chinese patients with cancers, promising its use for evaluationof HRQOL of Chinese patients.",Non-OADS,/arxiv_data1/oa_pdf/ff/dc/medi-95-e2363.PMC4706258.pdf
"Before it, we had assessed the correlationbetween global-QOL and domains in QLQ-H&N35 through Spearman correlation method, which usually pioneers or pro- vides some reference for GLM analysis (Supplemental Table,http://links.lww.com/MD/A580).",OADS,/arxiv_data1/oa_pdf/ff/dc/medi-95-e2363.PMC4706258.pdf
The statistical analyses were performed using R version 2.5.1 (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/e0/3a/medi-95-e2395.PMC4706260.pdf
"The respective data for the per-protocol analysis are provided in the Online Appendix,Table 3 (uploaded to ‘‘Supplemental Digital Content,’’ http://links.lww.com/MD/A589).",OADS,/arxiv_data1/oa_pdf/e0/3a/medi-95-e2395.PMC4706260.pdf
"A comparison of per-protocoland intention-to-treat analysis for the secondary outcomes can be found in the Online Appendix Table 5 (uploaded to ‘‘Supple- mental Digital Content,’’ http://links.lww.com/MD/A589).",Non-OADS,/arxiv_data1/oa_pdf/e0/3a/medi-95-e2395.PMC4706260.pdf
"RESULTS Results on Literature Search and Selection We identified 14 SRs through the literature search (Appendix 1, http://links.lww.com/MD/A593).",OADS,/arxiv_data1/oa_pdf/87/a1/medi-95-e2410.PMC4706264.pdf
"Hence, 61 RCTs were included in this overview (Appendix 2, http://links.lww.com/MD/A593).Details on the literature selection are presented in Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/87/a1/medi-95-e2410.PMC4706264.pdf
2015; http://www.who.int/med- iacentre/factsheets/fs297/en/.,Non-OADS,/arxiv_data1/oa_pdf/87/a1/medi-95-e2410.PMC4706264.pdf
http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/87/a1/medi-95-e2410.PMC4706264.pdf
"2015; http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-what-is-non-small-cell-lung-cancer.Accessed May 4, 2015.",Non-OADS,/arxiv_data1/oa_pdf/87/a1/medi-95-e2410.PMC4706264.pdf
2015; http://www.uptodate.com/contents/palliative-care-overview-of-fatigue-weakness-and-asthenia?source=machineLearning&search=fatigue&selectedTitle=2 /C24150&sectionRank =4&anchor=H29611194#H29611194.,Non-OADS,/arxiv_data1/oa_pdf/87/a1/medi-95-e2410.PMC4706264.pdf
https://ideas.repec.org/c/boc/bocode/s410501.html.,Non-OADS,/arxiv_data1/oa_pdf/87/a1/medi-95-e2410.PMC4706264.pdf
NCI Dictionary of Cancer Terms http://www.cancer.gov/dictionary?cdrid=44156.,Non-OADS,/arxiv_data1/oa_pdf/87/a1/medi-95-e2410.PMC4706264.pdf
This insurance system has covered approximately 99% of theentire 23 million population of Taiwan (http://www.nhi.gov.tw/english/index.aspx).,Non-OADS,/arxiv_data1/oa_pdf/93/db/medi-95-e2418.PMC4706265.pdf
"Statistical analyses were performed using a computerized statistics program (SAS ver- sion 9.2 for Windows; SAS Institute, Cary, NC) and R package,version 3.1.1 (http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/13/66/medi-95-e2435.PMC4706268.pdf
"There were 33 patients (8.8%, 33/375) who had one or more abnormal focal lesion(s) detected on postoperative sur-veillance US (Appendix, http://links.lww.com/MD/A599).",Non-OADS,/arxiv_data1/oa_pdf/13/66/medi-95-e2435.PMC4706268.pdf
Available at: http://www.nccn.org/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/13/66/medi-95-e2435.PMC4706268.pdf
"Method Study Population NHANES is an ongoing cross-sectional survey of the  U.S. civilian, noninstitutionalized population (available from http://www.cdc.gov/nchs/nhanes/nhanes_ques-tionnaires.htm).",OADS,/arxiv_data1/oa_pdf/45/ef/10.1177_2333721415607124.PMC4706363.pdf
Further vestibular testing procedure details are available at http://www.cdc.gov/nchs/data/nhanes/ba.pdf.,Non-OADS,/arxiv_data1/oa_pdf/45/ef/10.1177_2333721415607124.PMC4706363.pdf
"Retrieved from http://www.census.gov/prod/2012pubs/p70-131.pdf Cohen, H. S., & Kimball, K. T. (2000).",OADS,/arxiv_data1/oa_pdf/45/ef/10.1177_2333721415607124.PMC4706363.pdf
Available from: http://www.biomedcentral.com/1471-2393/14/36 2.,Non-OADS,/arxiv_data1/oa_pdf/55/7f/CCR3-4-101.PMC4706397.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/23/main.PMC4706555.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.11.009 2049-0801/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b0/23/main.PMC4706555.pdf
"On re-examination (Day 5) during his hospitalisa-tion, peripheral blood eosinophilia was noted (19%) with a totalContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.12.001 2211-7539/ &2015 International Society for Human and Animal Mycology.",Non-OADS,/arxiv_data1/oa_pdf/23/71/main.PMC4706556.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.11.010,Non-OADS,/arxiv_data1/oa_pdf/1d/db/main.PMC4706564.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1 1–12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/1d/db/main.PMC4706564.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/35/main.PMC4706565.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.11.011 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/88/35/main.PMC4706565.pdf
"Ref Type: Online Source, http://www.rcplondon.ac.uk/sites/default/ ﬁles/standards-for- the-clinical-structure-and-content-of-patient-records.pdf .",Non-OADS,/arxiv_data1/oa_pdf/88/35/main.PMC4706565.pdf
"Ref Type: Online Source, http://www.rcseng.ac.uk/surgeons/surgical- standards/professionalism-surgery/good-surgical-practice .",Non-OADS,/arxiv_data1/oa_pdf/88/35/main.PMC4706565.pdf
"Ref Type: Online Source, http://www.gmc-uk.org/Good_Medical_Practice_2012___ Draft_for_consultation.pdf_45081179.pdf .R.",Non-OADS,/arxiv_data1/oa_pdf/88/35/main.PMC4706565.pdf
Direct microscopy of smears from debrided tissues showedContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.12.003 2211-7539/ &2015 International Society for Human and Animal Mycology.,Non-OADS,/arxiv_data1/oa_pdf/2d/d9/main.PMC4706566.pdf
Obtained nucleotide sequences (bp 709; Genebank accession number KT149770) were tested on the BLAST electronic system (http://blast.ncbi.nlm.nih.gov/Blast.,OADS,/arxiv_data1/oa_pdf/2d/d9/main.PMC4706566.pdf
"School of Molecular & Biomedical Science, The University of Adelaide, Australia 5005, 2014. http://www.mycology.adelaide.edu.au Accessed March 2014.",Non-OADS,/arxiv_data1/oa_pdf/2d/d9/main.PMC4706566.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.11.008 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3099002/ .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://dx.doi.org/10.1002/bjs.1800830120 .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://dx.doi.org/10.1111/j.1463- 1318.2008.01681.x .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://journals.lww.com/annalsofsurgery/Fulltext/2012/01000/Topical_ Diltiazem_Cream_Versus_Botulinum_Toxin_A.4.aspx .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://dx.doi.org/10.1007/s10151-007-0373-7 .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://dx.doi.org/10.1007/s00423-012-0948-2 .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://dx.doi.org/10.1111/codi.12108 .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://dx.doi.org/10.1007/s00384-011-1234-4 .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://dx.doi.org/10.1111/j.1463-1318.2011.02840.x .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://dx.doi.org/10.1007/s00268-009- 9937-1 .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Avail- able from: http://dx.doi.org/10.1007/BF02238595 .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://www.sciencedirect.,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
Available from: http://dx.doi.org/10.1007/ BF02053862 .,Non-OADS,/arxiv_data1/oa_pdf/35/62/main.PMC4706569.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/27/main.PMC4706571.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.11.010 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/86/27/main.PMC4706571.pdf
"2011 (2011)357195, http://dx.doi.org/10.1155/2011/357195 .",Non-OADS,/arxiv_data1/oa_pdf/86/27/main.PMC4706571.pdf
"18 (1) (2011) 214 e218, http://dx.doi.org/10.1245/s10434-010-1334-3 .",Non-OADS,/arxiv_data1/oa_pdf/86/27/main.PMC4706571.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.11.003,Non-OADS,/arxiv_data1/oa_pdf/b1/81/main.PMC4706599.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1 3–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/b1/81/main.PMC4706599.pdf
New Microbe and New Infect 2016; 9:35–44 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.11.002,Non-OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
"The 16S rRNA nucleo- tide sequence was corrected using Chromas Pro 1.34 software (Technelysium, Tewantin, Australia), and the BLASTn searches were performed by the National Center for BiotechnologyInformation tool ( http://blast.ncbi.nlm.nih.gov.gate1.inist.fr/ Blast.cgi ).",OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
"Gram coloration was performed using a Color Gram 2 Kit36 New Microbes and New Infections , Volume 9 Number C, January 2016 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,9,3 5–44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
"Genome annotation and comparison Using Prodigal ( http://prodigal.ornl.gov/ ) with default parame- ters, we predicted open reading frames (ORFs).",OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
"nov. genome 37 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,9,3 5–44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
"MALDI-TOF, matrix-assisted laser desorption/ionization time-of- ﬂight mass spectrometry.38 New Microbes and New Infections , Volume 9 Number C, January 2016 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,9,3 5–44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
"nov. genome 39 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,9,3 5–44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
"From outside to center: contigs (red/grey), Clusters of Orthologous Groups (COGs) database category of genes on forward strand (three circles), genes on forward (blue circle) and reverse strands (red circle), COGs category on reverse strand (three circles), GC content.40 New Microbes and New Infections , Volume 9 Number C, January 2016 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,9,3 5–44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
"nov. genome 41 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,9,3 5–44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
"Numbers of orthologous protein-coding genes shared between genomes (upper right)a Alistipes ﬁnegoldiiAlistipes shahiiBacteroides doreiBacteroides fragilisBacteroides salanitronisBarnesiella viscericolaGabonia massiliensisHelicobacter pyloriOrnithobacterium rhinotracheale Alistipes ﬁnegoldii 3,231 1,091 1,060 1,072 931 916 953 269 633 Alistipes shahii 83.25 3,132 1,011 1,040 911 881 936 256 620 Bacteroides dorei 59.43 58.96 4,269 1,682 1,476 1,248 1,454 309 734 Bacteroides fragilis 61.02 61.06 71.11 4,373 1,448 1,258 1,454 307 754 Bacteroides salanitronis 62.34 62.53 71.23 69.52 3,686 1,166 1,277 287 687 Barnesiella viscericola 64.82 65.16 63.85 65.37 66.25 2,499 1,238 288 673 Gabonia massiliensis 56.41 55.84 65.64 65.48 63.62 64.46 3,349 302 699 Helicobacter pylori 52.40 52.06 56.20 56.07 55.61 53.74 56.77 1,579 262 Ornithobacterium rhinotracheale56.44 56.41 61.12 61.46 60.98 59.38 61.07 57.86 2,312 aAverage percentage similarity of nucleotides corresponding to orthologous protein shared between genomes (lower left) and numbers of proteins per genome (bold).42 New Microbes and New Infections , Volume 9 Number C, January 2016 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,9,3 5–44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
"nov. genome 43 © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,9,3 5–44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
"Int J Syst Bac- teriol 1994;44:637 –40.44 New Microbes and New Infections , Volume 9 Number C, January 2016 NMNI © 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,9,3 5–44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/45/cb/main.PMC4706602.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.11.004,Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,2 4–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"Data on den- sity of livestock and human population in different districts aswell as geographical data were assessed from the German Regional Database ( https://www.regionalstatistik.de/ ; codes 116-33-4, 173-21-4, 449-01-4).",OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,2 4–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,2 4–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,2 4–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,2 4–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,2 4–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"is interesting, as clinical isolates of these species are resistant in higher proportions according to German national surveillance data, where cefuroxime/cefotaxime were susceptible in 88.3/ 92.4% of E.coli, 81.3/90.8% of K. pneumoniae and 87.5/95.3% of K. oxytoca isolates ( https://ars.rki.de/ ; reference data for ambu- latory care, 2013).",Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,2 4–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,2 4–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
Environ Microbiol 2015. http://dx.doi.org/10.1111/1462-2920.12891 .,OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,2 4–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,2 4–34 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/59/8f/main.PMC4706603.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.11.005,Non-OADS,/arxiv_data1/oa_pdf/27/8e/main.PMC4706606.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,8–10 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/27/8e/main.PMC4706606.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,8–10 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/27/8e/main.PMC4706606.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.11.007,Non-OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1 5–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
"Genome annotation and comparison Prodigal software ( http://prodigal.ornl.gov/ ) adjusted with default parameters was used to predict open reading frames (ORFs), and the predicted ORFs were excluded if they spanned a sequencing gap region.",OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1 5–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
of Orthologous Groups (COGs) databases using BLASTP on the NCBI website ( http://blast.ncbi.nlm.nih.gov/Blast.cgi ).,OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1 5–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1 5–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1 5–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1 5–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1 5–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
Acknowledgements The authors thank the Xegen Company ( http://www.xegen.fr/ ) for automating the genomic annotation process and C. Andrieu for administrative assistance.,Non-OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,1 5–23 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/16/4f/main.PMC4706609.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2015.12.001 2211-3207/ ©2015 Published by Elsevier Ltd on behalf of Australian Society for Parasitology.,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1017/ S003118201300022X .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1371/journal.pone.0128707 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2007.04.026 .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1016/ j.imbio.2014.12.006 .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1016/ j.exppara.2008.09.007 .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1371/journal.pntd.0000419 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1128/AAC.49.4.1521-1528.2005 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1016/ j.cardiores.2004.06.029 .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1093/jac/dks027 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1016/j.ijpara.2010.12.002 .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
"Shock 34, 60e67.http://dx.doi.org/10.1097/SHK.0b013e3181cdc398 .",Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1371/journal.pone.0079445 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
"51, e69 e75.http://dx.doi.org/10.1086/656917 .",Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1017/S1462399410001560 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
"32, 9e15.http://dx.doi.org/10.1385/0-89603-268-X:9 .",Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1371/ journal.pone.0009252 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/ 10.1016/j.molimm.2010.06.002 .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1093/jac/dkn092 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/ 10.1016/j.cbpa.2006.03.004 .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1093/infdis/jis331 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1093/ cid/civ005 .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
"127, 6 e13.http://dx.doi.org/10.1016/j.actatropica.2013.03.006 .",OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1016/j.lfs.2004.09.013 .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1016/j.bbadis.2014.12.019 .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1093/jac/dkp357 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1128/AAC.01401-12 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/ 10.1016/S0140-6736(09)61117-X .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1136/hrt.2008.159624 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/ 10.1089/vbz.2009.0167 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1016/ j.actatropica.2014.01.002 .,OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/10.1097/01.qco.0000247592.21295.a5 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
http://dx.doi.org/ 10.1586/14787210.7.2.157 .,Non-OADS,/arxiv_data1/oa_pdf/25/68/main.PMC4706620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/09/main.PMC4706622.pdf
"PAS staining showed numerous ribbon-like,Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.12.004 2211-7539/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/9d/09/main.PMC4706622.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/09/main.PMC4706622.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/28/main.PMC4706624.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2015.11.003 2211-3207/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/28/main.PMC4706624.pdf
On abdominal ultrasonography there was circumferentialContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.12.002 2211-7539/ &2015 International Society for Human and Animal Mycology.,OADS,/arxiv_data1/oa_pdf/69/24/main.PMC4706628.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/b7/civ883.PMC4706634.pdf
Supportin ginformation andORCID(s )from theauthor(s) forthis article areavailable ontheWWW under http://dx.doi.org/ 10.1002/ anie.201509 616.,Non-OADS,/arxiv_data1/oa_pdf/78/72/anie0055-0693.PMC4706644.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/47/75/ircmj-17-12-20026.PMC4706710.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/36/36/ircmj-17-12-17298.PMC4706711.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ad/e9/ircmj-17-12-20017.PMC4706712.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a6/72/ircmj-17-12-29536.PMC4706727.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/2d/d9/ircmj-17-12-20302.PMC4706728.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/79/1e/ircmj-17-12-20082.PMC4706729.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/da/88/ircmj-17-12-20147.PMC4706730.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/4e/98/ircmj-17-12-19271.PMC4706732.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/83/71/ircmj-17-12-23145.PMC4706733.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/5f/89/ircmj-17-12-24723.PMC4706734.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/41/nihms747167.PMC4706740.pdf
http://dx.doi.org/10.1016/j.yrtph.2014.07.003 .,OADS,/arxiv_data1/oa_pdf/9c/41/nihms747167.PMC4706740.pdf
http://dx.doi.org/10.1016/j.yrtph.2014.05.012 .,OADS,/arxiv_data1/oa_pdf/9c/41/nihms747167.PMC4706740.pdf
http://dx.doi.org/10.1016/j.yrtpr.2014.05.014 .,OADS,/arxiv_data1/oa_pdf/9c/41/nihms747167.PMC4706740.pdf
http://dx.doi.org/10.1016/0003-2697(85)90442-7 .,OADS,/arxiv_data1/oa_pdf/9c/41/nihms747167.PMC4706740.pdf
http://dx.doi.org/10.1016/j.yrtph.2014.04.010 .,OADS,/arxiv_data1/oa_pdf/9c/41/nihms747167.PMC4706740.pdf
Acknowledgments This project was funded by the National Insti- tute for Health Research (NIHR) Health Technology Assessment (HTA) Program (project number 11/07/01) [see the HTA program website for further information— http://www.hta.ac.uk ].,Non-OADS,/arxiv_data1/oa_pdf/5a/03/40273_2015_Article_318.PMC4706836.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/5a/03/40273_2015_Article_318.PMC4706836.pdf
Available at: http://www.nice.org.uk/Media/Default/About/ what-we-do/NICE-guidance/NICE-technology-appraisals/Guide-to-the-single-technology-appraisal-process.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5a/03/40273_2015_Article_318.PMC4706836.pdf
Available at: http://guidance.nice.org.uk/TAG/291 .,Non-OADS,/arxiv_data1/oa_pdf/5a/03/40273_2015_Article_318.PMC4706836.pdf
Available at: http://www.hesonline.nhs.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/5a/03/40273_2015_Article_318.PMC4706836.pdf
Available at: http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Assessment_Report_-_ Variation/human/000717/WC500146340.pdf .,Non-OADS,/arxiv_data1/oa_pdf/5a/03/40273_2015_Article_318.PMC4706836.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/9e/32/40261_2015_Article_345.PMC4706838.pdf
http://www.ine.es .,Non-OADS,/arxiv_data1/oa_pdf/9e/32/40261_2015_Article_345.PMC4706838.pdf
Vacunacio ´n en adultos: recomendaciones an ˜o 2004. http://www.msssi.gob.es/ciudadanos/ proteccionSalud/vacunaciones/docs/recoVacunasAdultos.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9e/32/40261_2015_Article_345.PMC4706838.pdf
http://www.ema.europa.eu/docs/es_ES/ document_library/EPAR_-_Product_Information/human/001104/ WC500057247.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9e/32/40261_2015_Article_345.PMC4706838.pdf
http://www.msssi.,Non-OADS,/arxiv_data1/oa_pdf/9e/32/40261_2015_Article_345.PMC4706838.pdf
Hospital Morbidity Survey 2012. http://www.ine.es .,Non-OADS,/arxiv_data1/oa_pdf/9e/32/40261_2015_Article_345.PMC4706838.pdf
http://www.cdc.gov/nchs/?,Non-OADS,/arxiv_data1/oa_pdf/9e/32/40261_2015_Article_345.PMC4706838.pdf
http://www.msssi.gob.es/estadEstudios/estadis ticas/cmbd.htm .,Non-OADS,/arxiv_data1/oa_pdf/9e/32/40261_2015_Article_345.PMC4706838.pdf
BOE de 24 de Mayo 2010;126. http://www.boe.es/boe/dias/2010/ 05/24/pdfs/BOE-A-2010-8228.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9e/32/40261_2015_Article_345.PMC4706838.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which16 M. Huss et al.",Non-OADS,/arxiv_data1/oa_pdf/15/09/40261_2015_Article_336.PMC4706844.pdf
2013. http://www.nice.org.uk/guidance/cg72/ evidence/cg72-attention-deﬁcit-hyperactivity-disorder-adhd-full- guideline-2 .,Non-OADS,/arxiv_data1/oa_pdf/15/09/40261_2015_Article_336.PMC4706844.pdf
2015. http://www.shirecanada.com/en/documents/INTUNIV_XR_PM_ EN.pdf .,OADS,/arxiv_data1/oa_pdf/15/09/40261_2015_Article_336.PMC4706844.pdf
2015. http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Product_Information/human/003759/WC500195130.pdf .,Non-OADS,/arxiv_data1/oa_pdf/15/09/40261_2015_Article_336.PMC4706844.pdf
2014. http://www.kapvay.com/ pdf/kapvay-conc-v1-USPI.pdf .,Non-OADS,/arxiv_data1/oa_pdf/15/09/40261_2015_Article_336.PMC4706844.pdf
2014. http://pi.lilly.com/us/ strattera-pi.pdf .,Non-OADS,/arxiv_data1/oa_pdf/15/09/40261_2015_Article_336.PMC4706844.pdf
2014. http://clinicaltrials.gov/ ct2/show/study/NCT01081145?sect=X01256 .,Non-OADS,/arxiv_data1/oa_pdf/15/09/40261_2015_Article_336.PMC4706844.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/be/96/ircmj-17-12-23010.PMC4706847.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/87/d3/ircmj-17-12-33569.PMC4706848.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/77/76/ircmj-17-12-25536.PMC4706849.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3a/78/ircmj-17-12-22053.PMC4706980.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/78/56/ircmj-17-12-26095.PMC4706981.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f4/9d/ircmj-17-12-24438.PMC4706982.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/23/0c/ircmj-17-12-19406.PMC4706985.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1e/51/ircmj-17-12-28974.PMC4706990.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/57/0b/ircmj-17-12-16823.PMC4706991.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/17/0c/ircmj-17-12-31047.PMC4706992.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/71/34/ircmj-17-12-22467.PMC4707010.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/32/f5/ircmj-17-12-17211.PMC4707011.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/94/nihms749123.PMC4707049.pdf
"155 Lab Anim Res 2015: 31(4), 155-165 http://dx.doi.org/10.5625/lar.2015.31.4.155ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Modeling Parkinson’s disease in the common marmoset (Callithrix jacchus ): overview of models, methods, and animal care Jun-Won Yun1, Jae-Bum Ahn1,2, Byeong-Cheol Kang1,2,3,* 1Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea 2Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Korea 3Designed Animal Research Center, Institute of GreenBio Science Technology, Seoul National University, Pyeongchang-gun, Gangwon, Korea The common marmoset  (Callithrix jacchus ) is a small-bodied, popular New World monkey and is used widely in reproductive biology, neuroscience, and drug development, due to its comparative ease ofhandling, high reproductive efficiency, and its unique behavioral characters.",Non-OADS,/arxiv_data1/oa_pdf/69/32/lar-31-155.PMC4707143.pdf
"166 Lab Anim Res 2015: 31(4), 166-173 http://dx.doi.org/10.5625/lar.2015.31.4.166ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Comparative analysis of growth characteristics of Sprague Dawley rats obtained from different sources Marcia Brower1, Martha Grace2, Catherine M. Kotz2, Vijay Koya1,* 1Boston Scientific Corporation, St. Paul, MN, USA 2Veteran Affairs Medical Center, Minnesota Obesity Center, Minneapolis, MN, USA Genetic background in animal models is an intrinsic research variable in biomedical research.",Non-OADS,/arxiv_data1/oa_pdf/d4/fa/lar-31-166.PMC4707144.pdf
"174 Lab Anim Res 2015: 31(4), 174-179 http://dx.doi.org/10.5625/lar.2015.31.4.174ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Intraperitoneal co-administration of low dose urethane with xylazine and ketamine  for extended duration of surgical anesthesia in rats Arun H. S. Kumar1,*, Anthony J. P .",Non-OADS,/arxiv_data1/oa_pdf/54/93/lar-31-174.PMC4707145.pdf
"180 Lab Anim Res 2015: 31(4), 180-187 http://dx.doi.org/10.5625/lar.2015.31.4.180ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Supraphysiologic glucocorticoid  administration increased  biomechanical bone strength of rats' vertebral body Azam Najar1, Mohammadjavad Fridoni2, Fatemesadat Rezaei3, Saba Bayat4, Mohammad Bayat3,* 1Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences,  Tehran, Iran 2Department of Anatomy, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran 3Celluar and Molecular Biology Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran 4School of Medicine, Arak University of Medical Sciences, Arak, Iran The aim of this study is to assess the effects of different glucocorticoid administration protocols on biomechanical properties of the first lumbar vertebral body in rats.",Non-OADS,/arxiv_data1/oa_pdf/12/82/lar-31-180.PMC4707146.pdf
"188 Lab Anim Res 2015: 31(4), 188-197 http://dx.doi.org/10.5625/lar.2015.31.4.188ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Tissue transglutaminase-interleukin -6 axis facilitates peritoneal  tumor spreading and metastasis of human ovarian cancer cells Keunhee Oh1,4, Hyeong-Gon Moon3,5, Dong-Sup Lee2,3,4, Young-Bok Yoo6,* 1PharmAbcine, Inc., #402 DaejeonBioventure Town, Jeonmin-dong, Yusung-gu, Daejeon, Korea 2Laboratory of Immunology/Cancer Biology, Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehakro, Jongno-gu, Seoul 110-799, Korea 3Cancer Research Institute, Interdisciplinary Program of Tumor Biology, Seoul National University College of Medicine, 103 Daehakro, Jongno-gu, Seoul 110-799, Korea 4Transplantation Research Institute, Seoul National University College of Medicine, 103 Daehakro, Jongno-gu, Seoul 110-799, Korea 5Department of Surgery, Seoul National University College of Medicine, 103 Daehakro, Jongno-gu, Seoul 110-799, Korea  6Department of Anatomy, Dankook University College of Medicine, 119 Dandaero, Dongnam-gu, Cheonan, Chungnam 31116, Korea Inflammation has recently been implicated in cancer formation and progression.",OADS,/arxiv_data1/oa_pdf/3a/fd/lar-31-188.PMC4707147.pdf
"198 Lab Anim Res 2015: 31(4), 198-203 http://dx.doi.org/10.5625/lar.2015.31.4.198ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Curcumin attenuates the middle ce rebral artery occlusion-induced  reduction in γ-enolase expression in an animal model Sang-Ah Gim#, So-Ra Lee#, Fawad-Ali Shah, Phil-Ok Koh* Department of Anatomy, College of Veterinary Medicine, Institute of Agriculture and Life Science, Gyeongsang National University, Jinju, Korea Curcumin exerts a protective effect in cerebral ischemia through its anti-oxidant and anti-inflammatory activities.",Non-OADS,/arxiv_data1/oa_pdf/70/3f/lar-31-198.PMC4707148.pdf
"204 Lab Anim Res 2015: 31(4), 204-208 http://dx.doi.org/10.5625/lar.2015.31.4.204ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Radiation-induced eosinophilic, polymorphic, and pruritic eruption in a pig skin model Joong Sun Kim1,2,*, Won Seok Jang1, Min Ji Bae2, Sunhoo Park1, Seung Sook Lee1,* 1Lab.",OADS,/arxiv_data1/oa_pdf/b9/27/lar-31-204.PMC4707149.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Autism Optimal outcomes LanguagefMRI 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1016/j.nicl.2015.11.014 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1002/hbm.22242 (Epub 22013 Feb 22213).,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1111/jcpp.12178 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1111/ejn.12252 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1111/j.1460-9568.2010.,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1016/j.jaac.2012.08.018 .,OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1016/j.bandl.2012.1011.1001 (Epub 2013 Jan 1017).,OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1111/jcpp.12037 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.2009.02.021 .,OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/ 10.1093/cercor/bhp264 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.21371/journal.,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1371/journal.pone.0011571 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1007/s10803- 10009-10872-10807 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
"8 (1),60–72.http://dx.doi.org/10.1007/s11682-11013-19245-11680 .",Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1093/brain/awl164 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1016/j.bandl.2013.1006.1002 (Epub 2013 Nov 1011).,OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1017/S1355617708081216 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1016/j.bandl.2009.11.005 .,OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1523/jneurosci.1511-13.2013 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
"120 (1), 42 –51.http://dx.doi.org/10.1016/j.bandl.2011.1008.1005 (Epub 2011 Sep 1011).",OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1093/brain/awr151 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
"Autism 5 (1), 8. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
"11, 12 –17.http://dx.doi.org/10.1016/j.dcn.2014.06.001 .",OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
"Psychiatry 58 (1), 1 –9.http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
"104 (1), 51 –74.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
"Neuropsychologia 48 (1), 86 –95.http://dx.doi.org/ 10.1016/j.neuropsychologia.2009.1008.1013 (Epub).",Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1016/j.apmr.2011.1003.1036 .190 I.-M. Eigsti et al.,OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1177/ 1362361312473519 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
"NeuroImage 4, 374– 382. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
http://dx.doi.org/10.1162/jocn.2009.21309 .,Non-OADS,/arxiv_data1/oa_pdf/dd/68/main.PMC4707189.pdf
The results were interpreted according to the recommendations of theComité de l ’Antibiogramme de la Société Française de Micro- biologie ( http://www.sfm-microbiologie.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/93/main.PMC4707190.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.11.009,Non-OADS,/arxiv_data1/oa_pdf/ea/93/main.PMC4707190.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,4 5 –46 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/ea/93/main.PMC4707190.pdf
"Tel: +1-612-626-6852, Fax: +1-612-624-5445, E-mail: Songx001@ umn.edu CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(4):265-275 http://dx.doi.org/10.3857/roj.2015.33.4.265 pISSN 2234-1900 · eISSN 2234-3156  Review Article",Non-OADS,/arxiv_data1/oa_pdf/20/3f/roj-33-265.PMC4707209.pdf
"Mi-Sook Kim , et al 266 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.265Direct Tumor Cell Death Cannot Account  for the Efficacy of SBRT and SRS In treating intracranial or extracranial disorders with SRS,  the targets are irradiated with 15–25 Gy of radiation in 1–2  fractions, and treating extracranial tumors with SBRT, tumors  are treated with 30–60 Gy of irradiation in 2–5 fractions.",Non-OADS,/arxiv_data1/oa_pdf/20/3f/roj-33-265.PMC4707209.pdf
267Radiobiology of SBRT/SRS www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.265cell death through vascular damage occurs when tumors are  exposed to high dose hypo-fractionated irradiation [10-15].High Dose Hypo-fractionated Irradiation  Causes Vascular Damage in Tumors The increasing needs for vital nutrients including oxygen in  growing tumors stimulate formation of new tumor blood  0.01Intravascularvolume(mL/tumor) Weight oftumor (dried) (g)A 10 0.1 10.05 0.01 0.005 0.001 0.0050.1 0.5 5 0.01Intravascularvolume(mL/tumor) Weight oftumor (dried) (g)B 10 0.1 10.05 0.01 0.005 0.001 0.0050.1 0.5 52Gy 2Days 6Days 0.01 0.01Intravascularvolume(mL/tumor) Intravascularvolume(mL/tumor)Weight oftumor (dried) (g) Weight oftumor (dried) (g)C E10 100.1 0.11 10.05 0.050.01 0.010.005 0.0050.001 0.0010.005 0.0050.1 0.1 0.5 0.55 50.01 0.01Intravascularvolume(mL/tumor) Intravascularvolume(mL/tumor)Weight oftumor (dried) (g) Weight oftumor (dried) (g)D F10 100.1 0.11 10.05 0.050.01 0.010.005 0.0050.001 0.0010.005 0.0050.1 0.1 0.5 0.55 510Gy 2Days 6Days5Gy 2Days 6Days 30Gy 2Days 12Days60Gy 2Days 12Days Fig.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/roj-33-265.PMC4707209.pdf
"Mi-Sook Kim , et al 268 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.265vessels [20].",OADS,/arxiv_data1/oa_pdf/20/3f/roj-33-265.PMC4707209.pdf
269Radiobiology of SBRT/SRS www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.265are remarkably radioresistant.,OADS,/arxiv_data1/oa_pdf/20/3f/roj-33-265.PMC4707209.pdf
"Mi-Sook Kim , et al 270 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.265vascular damages caused by irradiation in Walker tumors  of rats or neuroblastoma of mice led to secondary tumor  cell death in 2 to 3 days.",OADS,/arxiv_data1/oa_pdf/20/3f/roj-33-265.PMC4707209.pdf
271Radiobiology of SBRT/SRS www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.265suppresses immune competency of the host.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/roj-33-265.PMC4707209.pdf
"Mi-Sook Kim , et al 272 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.2651.",OADS,/arxiv_data1/oa_pdf/20/3f/roj-33-265.PMC4707209.pdf
273Radiobiology of SBRT/SRS www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.265multi-fractionated radiotherapy.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/roj-33-265.PMC4707209.pdf
"Mi-Sook Kim , et al 274 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.26512.",OADS,/arxiv_data1/oa_pdf/20/3f/roj-33-265.PMC4707209.pdf
275Radiobiology of SBRT/SRS www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.26543.,Non-OADS,/arxiv_data1/oa_pdf/20/3f/roj-33-265.PMC4707209.pdf
"Tel: +82-2-3410-2605, Fax: +82-2-3410-2619,  E-mail: hee.ro.park@samsung.com CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(4):276-283 http://dx.doi.org/10.3857/roj.2015.33.4.276 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/09/e4/roj-33-276.PMC4707210.pdf
"277Hepatic re-irradiation for HCC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.276In the clinical reality, we face the situations that re-irradiation  is needed for the patients with recurrent HCC, mainly due  to the lack of available local salvage modalities for the very  patients [14].",Non-OADS,/arxiv_data1/oa_pdf/09/e4/roj-33-276.PMC4707210.pdf
"Seung Won Seol , et al 278 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.276the chi-square test.",OADS,/arxiv_data1/oa_pdf/09/e4/roj-33-276.PMC4707210.pdf
"279Hepatic re-irradiation for HCC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.276months, and it was significantly affected by the Child-Pugh  class and the modified UICC T stage.",Non-OADS,/arxiv_data1/oa_pdf/09/e4/roj-33-276.PMC4707210.pdf
"Seung Won Seol , et al 280 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.276p = 0.199) (Fig.",OADS,/arxiv_data1/oa_pdf/09/e4/roj-33-276.PMC4707210.pdf
281Hepatic re-irradiation for HCC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.276needed for successful treatment of individual patients [8].,Non-OADS,/arxiv_data1/oa_pdf/09/e4/roj-33-276.PMC4707210.pdf
"Seung Won Seol , et al 282 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.276Conflict of Interest No potential conflict of interest relevant to this article was  reported.",OADS,/arxiv_data1/oa_pdf/09/e4/roj-33-276.PMC4707210.pdf
283Hepatic re-irradiation for HCC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.276hypertension.,Non-OADS,/arxiv_data1/oa_pdf/09/e4/roj-33-276.PMC4707210.pdf
"Tel: +82-2-3010-4431, Fax: +82-2-3010-6950,  E-mail: coocoori@gmail.com CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(4):284-293 http://dx.doi.org/10.3857/roj.2015.33.4.284 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/83/06/roj-33-284.PMC4707211.pdf
"285Definitive radiotherapy for T4N0-1 NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.284[3,4].",Non-OADS,/arxiv_data1/oa_pdf/83/06/roj-33-284.PMC4707211.pdf
"Yeon Joo Kim , et al 286 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.284every week.",OADS,/arxiv_data1/oa_pdf/83/06/roj-33-284.PMC4707211.pdf
"287Definitive radiotherapy for T4N0-1 NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.284vertebral invasion but had a primary lung lesion widely abutted  to the thoracic spines, so he also received IMRT to adjust the  spinal cord dose.",Non-OADS,/arxiv_data1/oa_pdf/83/06/roj-33-284.PMC4707211.pdf
"Yeon Joo Kim , et al 288 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.284simultaneous integrated boost.",OADS,/arxiv_data1/oa_pdf/83/06/roj-33-284.PMC4707211.pdf
"289Definitive radiotherapy for T4N0-1 NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.284percent of patients (n = 24) received definitive RT alone due to  old age, poor ECOG-PS, and/or poor lung function.",Non-OADS,/arxiv_data1/oa_pdf/83/06/roj-33-284.PMC4707211.pdf
"Yeon Joo Kim , et al 290 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.284patients, and one patient had grade 3 esophagitis.",OADS,/arxiv_data1/oa_pdf/83/06/roj-33-284.PMC4707211.pdf
291Definitive radiotherapy for T4N0-1 NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.284compared standard-dose (60 Gy/30 fractions) and dose- escalated (74 Gy/37 fractions) radiation in stage III NSCLC.,Non-OADS,/arxiv_data1/oa_pdf/83/06/roj-33-284.PMC4707211.pdf
"Yeon Joo Kim , et al 292 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.284Another novel class of radio-sensitizers is nanoparticles (NP).",OADS,/arxiv_data1/oa_pdf/83/06/roj-33-284.PMC4707211.pdf
293Definitive radiotherapy for T4N0-1 NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.28411.,Non-OADS,/arxiv_data1/oa_pdf/83/06/roj-33-284.PMC4707211.pdf
"Tel: +82-53-250-7665, Fax: +82-53-250-7984, E-mail:  jhkim@dsmc.or.kr CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(4):294-300 http://dx.doi.org/10.3857/roj.2015.33.4.294 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/97/96/roj-33-294.PMC4707212.pdf
295Concurrent chemoradiotherapy in bladder www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.294selected patients has become widely used.,Non-OADS,/arxiv_data1/oa_pdf/97/96/roj-33-294.PMC4707212.pdf
"Sang Jun Byun , et al 296 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.294rest five patients were diagnosed incidentally.",OADS,/arxiv_data1/oa_pdf/97/96/roj-33-294.PMC4707212.pdf
"297Concurrent chemoradiotherapy in bladder www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.294vinblastine, doxorubicin, and cisplatin) for 2 to 10 cycles  (median, 8 cycles).",Non-OADS,/arxiv_data1/oa_pdf/97/96/roj-33-294.PMC4707212.pdf
"Sang Jun Byun , et al 298 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.294factors related to survival rates.",OADS,/arxiv_data1/oa_pdf/97/96/roj-33-294.PMC4707212.pdf
299Concurrent chemoradiotherapy in bladder www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.294the small number of patients.,Non-OADS,/arxiv_data1/oa_pdf/97/96/roj-33-294.PMC4707212.pdf
"Sang Jun Byun , et al 300 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.2944.",OADS,/arxiv_data1/oa_pdf/97/96/roj-33-294.PMC4707212.pdf
"Tel: +82-2-3410-2436, Fax: +82-2-3410-2619,  E-mail: doho.choi@samsung.com CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(4):301-309 http://dx.doi.org/10.3857/roj.2015.33.4.301 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/9b/89/roj-33-301.PMC4707213.pdf
"Gyu Sang Yoo , et al 302 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.301benefits in survival outcome by multidisciplinary therapies  including local modalities.",OADS,/arxiv_data1/oa_pdf/9b/89/roj-33-301.PMC4707213.pdf
303RT in extracranial oligometastatic breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.301interval from the beginning of treatment for primary breast  cancer to the first diagnosis of distant metastasis.,Non-OADS,/arxiv_data1/oa_pdf/9b/89/roj-33-301.PMC4707213.pdf
"Gyu Sang Yoo , et al 304 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.301favorable prognostic factor with marginal significance (p =  0.055) for the LC of lesions where RT was applied ( Table 3 ).",OADS,/arxiv_data1/oa_pdf/9b/89/roj-33-301.PMC4707213.pdf
"305RT in extracranial oligometastatic breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.301analysis, however, none of above was identified as independent  favorable prognostic factors for DPFS (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/9b/89/roj-33-301.PMC4707213.pdf
"Gyu Sang Yoo , et al 306 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.301comparable or superior to those of other studies.",Non-OADS,/arxiv_data1/oa_pdf/9b/89/roj-33-301.PMC4707213.pdf
"307RT in extracranial oligometastatic breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.301genes that lead to organ-specific metastasis [23,24].",Non-OADS,/arxiv_data1/oa_pdf/9b/89/roj-33-301.PMC4707213.pdf
"Gyu Sang Yoo , et al 308 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.301In conclusion, high-dose RT that is performed early, i.e.,  while WLRT is still an option, has the potential to improve PFS  and OS of patients with EOMBC.",Non-OADS,/arxiv_data1/oa_pdf/9b/89/roj-33-301.PMC4707213.pdf
309RT in extracranial oligometastatic breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.30119:2012-9.,Non-OADS,/arxiv_data1/oa_pdf/9b/89/roj-33-301.PMC4707213.pdf
"Tel: +82-2-2228-8117, Fax: +82-2-2227-7823, E-mail: cosuh317@yuhs.ac CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(4):310-319 http://dx.doi.org/10.3857/roj.2015.33.4.310 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/f1/19/roj-33-310.PMC4707214.pdf
"311Radiotherapy for follicular lymphoma www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.310treatment is required in symptomatic or bulky tumors, and  chemotherapy including rituximab is usually recommended.",Non-OADS,/arxiv_data1/oa_pdf/f1/19/roj-33-310.PMC4707214.pdf
"Seo Hee Choi , et al 312 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.3101–2 chemotherapy cycles and one received RT for suspected  residual disease after 6 chemotherapy cycles.",OADS,/arxiv_data1/oa_pdf/f1/19/roj-33-310.PMC4707214.pdf
313Radiotherapy for follicular lymphoma www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.310up date for patients who did not experience these events.,Non-OADS,/arxiv_data1/oa_pdf/f1/19/roj-33-310.PMC4707214.pdf
"Seo Hee Choi , et al 314 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.31084 months).",OADS,/arxiv_data1/oa_pdf/f1/19/roj-33-310.PMC4707214.pdf
315Radiotherapy for follicular lymphoma www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.310alive without evidence of disease at 75 and 118 months after  RT.,Non-OADS,/arxiv_data1/oa_pdf/f1/19/roj-33-310.PMC4707214.pdf
"Seo Hee Choi , et al 316 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.310Table 2.",OADS,/arxiv_data1/oa_pdf/f1/19/roj-33-310.PMC4707214.pdf
317Radiotherapy for follicular lymphoma www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.310demonstrated an outstanding survival advantage.,Non-OADS,/arxiv_data1/oa_pdf/f1/19/roj-33-310.PMC4707214.pdf
"Seo Hee Choi , et al 318 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.310chemotherapy.",OADS,/arxiv_data1/oa_pdf/f1/19/roj-33-310.PMC4707214.pdf
319Radiotherapy for follicular lymphoma www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.310analysis of 987 cases.,Non-OADS,/arxiv_data1/oa_pdf/f1/19/roj-33-310.PMC4707214.pdf
"Tel: +82-32-621-5887, Fax: +82-32-621-5018, E-mail:  drmoonrt@schmc.ac.kr CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(4):320-327 http://dx.doi.org/10.3857/roj.2015.33.4.320 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/5e/d8/roj-33-320.PMC4707215.pdf
"321Tomotherapy to metastatic CRC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.320overall survival (OS) times in selected patients and now an  intermediate state of metastases termed “oligometastases”  offers the opportunity for cure [3,4].",Non-OADS,/arxiv_data1/oa_pdf/5e/d8/roj-33-320.PMC4707215.pdf
"Sun Hyun Bae , et al 322 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.320defined as disease progression.",OADS,/arxiv_data1/oa_pdf/5e/d8/roj-33-320.PMC4707215.pdf
323Tomotherapy to metastatic CRC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.320overlapped with previous preoperative CCRT; 2 liver lesions  were overlapped with previous HT to liver metastases; 1  pelvic LN was consulted duo to PD after previous palliative  RT with 2-dimensional (2D) technique.,Non-OADS,/arxiv_data1/oa_pdf/5e/d8/roj-33-320.PMC4707215.pdf
"Sun Hyun Bae , et al 324 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.320LPFS rates according to PTV and BED.",OADS,/arxiv_data1/oa_pdf/5e/d8/roj-33-320.PMC4707215.pdf
"325Tomotherapy to metastatic CRC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.320to conventional linear accelerators-based IMRT, enabling  treatment implementation for a wide spectrum of clinical  cases, ranging from very small tumor to vast target volumes  [15].",Non-OADS,/arxiv_data1/oa_pdf/5e/d8/roj-33-320.PMC4707215.pdf
"Sun Hyun Bae , et al 326 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.320Conflict of Interest No potential conflict of interest relevant to this article was  reported.",Non-OADS,/arxiv_data1/oa_pdf/5e/d8/roj-33-320.PMC4707215.pdf
327Tomotherapy to metastatic CRC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.320colorectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/5e/d8/roj-33-320.PMC4707215.pdf
"CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(4):328-336 http://dx.doi.org/10.3857/roj.2015.33.4.328 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/54/7c/roj-33-328.PMC4707216.pdf
"329Met inactivation by S-allylcysteine www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.328concurrent chemoradiotherapy (CCRT), where the 5-year  overall survival (OS) was 72.3% in a major clinical study [1].",Non-OADS,/arxiv_data1/oa_pdf/54/7c/roj-33-328.PMC4707216.pdf
"Oyeon Cho , et al 330 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.328was added to each well of a 24-well plate on an underlayer  of 0.8% noble agar in DMEM with 20% FBS at 37oC.",OADS,/arxiv_data1/oa_pdf/54/7c/roj-33-328.PMC4707216.pdf
331Met inactivation by S-allylcysteine www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.328 A SAC (mM) HGF +01 02 04 0HNE1 01 02 04 0HONE1 Control100 90 80 70 6050 40 30 20 10 WoundclosureofHNE1(%) SAC (mM)0 10 20 40 10 20 40 HGF HGF 10ng/mL +SAC (mM)*************** Control100 9080 70 6050 40 30 20 10 WoundclosureofHONE1(%) SAC (mM)0 10 20 40 10 20 40 HGF HGF 10ng/mL +SAC (mM)NS********* * Control200 180160 140 120 100 80 60 40 20 SAC (mM)0 10 20 40 10 20 40 HGF HGF 10ng/mL +SAC (mM)*** *** ***B SAC (mM) HGF +01 02 04 0HNE1 01 02 04 0HONE1 Control160 80 60 40 20InvasioncellsofHNE1(number) SAC (mM)0 10 20 40 10 20 40 HGF HGF 10ng/mL +SAC (mM)*** ********* 140 120 100 NS InvasioncellsofHONE1(number) ****** Fig.,Non-OADS,/arxiv_data1/oa_pdf/54/7c/roj-33-328.PMC4707216.pdf
"Oyeon Cho , et al 332 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.328treatment with SAC and HGF in HNE1 significantly decreased  colony size and number.",OADS,/arxiv_data1/oa_pdf/54/7c/roj-33-328.PMC4707216.pdf
333Met inactivation by S-allylcysteine www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.328signal transduction in HNE1 and HONE1 cells.,Non-OADS,/arxiv_data1/oa_pdf/54/7c/roj-33-328.PMC4707216.pdf
"Oyeon Cho , et al 334 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.328Discussion and Conclusion Met is one of the prognostic factors for advanced NPC [14].",OADS,/arxiv_data1/oa_pdf/54/7c/roj-33-328.PMC4707216.pdf
"335Met inactivation by S-allylcysteine www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.328decrease in Slug started after 6 hours in HNE1 and 12 hours in  HONE1, and this supports the idea of delayed effects of SAC in  HONE cells [23].",Non-OADS,/arxiv_data1/oa_pdf/54/7c/roj-33-328.PMC4707216.pdf
"Oyeon Cho , et al 336 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.328Conflict of Interest No potential conflict of interest relevant to this article was  reported.",Non-OADS,/arxiv_data1/oa_pdf/54/7c/roj-33-328.PMC4707216.pdf
"Tel: +82-2-3410-2604, Fax: +82-2-3410-2619,  E-mail: youngyih@skku.edu CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(4):337-343 http://dx.doi.org/10.3857/roj.2015.33.4.337 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/5c/1b/roj-33-337.PMC4707217.pdf
"Kwangzoo Chung , et al 338 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.337Introduction The Samsung Medical Center (SMC) was founded on November  9, 1994 under the philosophy of “contributing to improving  the nation’s health through the best medical service, advanced  medical research, and development of outstanding medical  personnel.” SMC consists of a hospital and a cancer center; the  hospital is located in an intelligent building with 20 floors above  ground and 5 floors underground, housing 40 departments,  10 specialist centers, and 120 special clinics.",Non-OADS,/arxiv_data1/oa_pdf/5c/1b/roj-33-337.PMC4707217.pdf
339Status of the proton therapy system at SMC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.337cyclotron.,OADS,/arxiv_data1/oa_pdf/5c/1b/roj-33-337.PMC4707217.pdf
"Kwangzoo Chung , et al 340 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.337of a robotic couch (Forte Automation Systems Inc., Machesney  Park, IL, USA) and laser markers.",OADS,/arxiv_data1/oa_pdf/5c/1b/roj-33-337.PMC4707217.pdf
341Status of the proton therapy system at SMC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.337the nozzles using TOPAS is available elsewhere [4].,Non-OADS,/arxiv_data1/oa_pdf/5c/1b/roj-33-337.PMC4707217.pdf
"Kwangzoo Chung , et al 342 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.337sum of these uncertainties yields a total uncertainty of 1.4 mm  and this is a conservative estimation as the correlation among  the items has been ignored.",OADS,/arxiv_data1/oa_pdf/5c/1b/roj-33-337.PMC4707217.pdf
343Status of the proton therapy system at SMC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.337References 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/1b/roj-33-337.PMC4707217.pdf
Available from:  http://www.ptcog.ch/index.php/facilities-under-construction.,Non-OADS,/arxiv_data1/oa_pdf/5c/1b/roj-33-337.PMC4707217.pdf
"Tel: +82-64-717-1330, Fax: +82-64-717-1169, E-mail: yskim@ jejunuh.co.kr CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(4):344-349 http://dx.doi.org/10.3857/roj.2015.33.4.344 pISSN 2234-1900 · eISSN 2234-3156  Case Report",Non-OADS,/arxiv_data1/oa_pdf/bf/73/roj-33-344.PMC4707218.pdf
"345Neck muscle atrophy and fibrosis www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.344approach, left marginal mandibulectomy, left MRND type I,  and reconstruction with a radial forearm free flap.",Non-OADS,/arxiv_data1/oa_pdf/bf/73/roj-33-344.PMC4707218.pdf
"Jinu Kim , et al 346 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.344showed no evidence of disease.",OADS,/arxiv_data1/oa_pdf/bf/73/roj-33-344.PMC4707218.pdf
347Neck muscle atrophy and fibrosis www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.344them to move as a single unit) was observed in the left neck  nodal levels I through IV [5].,Non-OADS,/arxiv_data1/oa_pdf/bf/73/roj-33-344.PMC4707218.pdf
"Jinu Kim , et al 348 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.344contain two, three, or more nuclei; 3) in some areas, bundles  of nearly normal striated muscle fibers merge into groups of  bizarre multinucleated giant cells, which are often considered  regenerating but also possibly degenerating skeletal muscle  cells; 4) foci of inflammatory cell infiltrates are seen; 5) broad  areas of dense fibrosis are also prominent; 6) fibroblasts with a  large, hyperchromatic nucleus are seen in the areas of fibrosis;  7) small blood vessels, probably arterioles or small arteries, with  greatly thickened walls are found; and 8) a few dilated, thin- walled vessels suggesting telangiectasia are noted [16].",Non-OADS,/arxiv_data1/oa_pdf/bf/73/roj-33-344.PMC4707218.pdf
349Neck muscle atrophy and fibrosis www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.4.344Neuroradiol 2005;26:1174-7.,Non-OADS,/arxiv_data1/oa_pdf/bf/73/roj-33-344.PMC4707218.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cb/84/ircmj-17-12-29513.PMC4707237.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Isolated gonadotropin-releasing hormone de ﬁ- ciencyKallmann syndromeKAL1 mutations Clinical phenotype 1.,Non-OADS,/arxiv_data1/oa_pdf/36/e5/main.PMC4707242.pdf
http://dx.doi.org/10.1016/j.mgene.2015.12.001 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/36/e5/main.PMC4707242.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/e5/main.PMC4707242.pdf
The primers were designed using the UCSC ExonPrimer online software(http://genome.ucsc.edu/index.html ).,OADS,/arxiv_data1/oa_pdf/36/e5/main.PMC4707242.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Genetic polymorphismUlcerative colitisSusceptibilityMethylenetetrahydrofolate reductaseGlutathione S-transferasesMoldavian population 1.,Non-OADS,/arxiv_data1/oa_pdf/4b/13/main.PMC4707243.pdf
http://dx.doi.org/10.1016/j.mgene.2015.12.0022214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/13/main.PMC4707243.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/13/main.PMC4707243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: HCC MiRNA 1.,Non-OADS,/arxiv_data1/oa_pdf/05/f7/main.PMC4707244.pdf
http://dx.doi.org/10.1016/j.mgene.2015.11.0022214-5400/© 2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/05/f7/main.PMC4707244.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/f7/main.PMC4707244.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/37/main.PMC4707245.pdf
http://dx.doi.org/10.1016/j.mgene.2015.11.0032214-5400/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/37/main.PMC4707245.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/37/main.PMC4707245.pdf
"The primers were designed for the four selected SNPs using the Primer3 online tool, (http://bioinfo.ut.ee/primer3-0.4.0/ ).",OADS,/arxiv_data1/oa_pdf/ff/37/main.PMC4707245.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Naga King Chili PhylogeneticSequence analysisNucleotide diversityHaplotype 1.,Non-OADS,/arxiv_data1/oa_pdf/e2/d2/main.PMC4707246.pdf
http://dx.doi.org/10.1016/j.mgene.2015.11.006 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/d2/main.PMC4707246.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/d2/main.PMC4707246.pdf
"Guinness Book of World Records, 2006. http://en.wikipedia.org/wiki/Bhut_Jolokia Hall, T.A., 1999.",Non-OADS,/arxiv_data1/oa_pdf/e2/d2/main.PMC4707246.pdf
http://dx.doi.org/10.1371/journal.pone.0017863 .,Non-OADS,/arxiv_data1/oa_pdf/e2/d2/main.PMC4707246.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: EpendymomaIsoseqPacBioAnnotation 1.,Non-OADS,/arxiv_data1/oa_pdf/ea/d2/main.PMC4707247.pdf
http://dx.doi.org/10.1016/j.mgene.2015.11.004 2214-5400/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/d2/main.PMC4707247.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/d2/main.PMC4707247.pdf
"Gene ontology (GO) annotation analysis was performed in Blast2GO ( http://www.blast2go.org /) version 2.5.0 (Conesa et al., 2005 ) for the assignment of gene ontology terms.",OADS,/arxiv_data1/oa_pdf/ea/d2/main.PMC4707247.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ea/d2/main.PMC4707247.pdf
http://dx.doi.org/10.1172/JCI67228 (Epub 2013 Sep 3).,Non-OADS,/arxiv_data1/oa_pdf/ea/d2/main.PMC4707247.pdf
Oncogene.http://dx.doi.org/10.1038/onc.2015.172 ([Epub ahead of print]).,Non-OADS,/arxiv_data1/oa_pdf/ea/d2/main.PMC4707247.pdf
6044. http://dx.doi.org/10.1038/ncomms7044 .,Non-OADS,/arxiv_data1/oa_pdf/ea/d2/main.PMC4707247.pdf
"Rep. 4, 6566. http://dx.doi.org/10.1038/srep06566 .",Non-OADS,/arxiv_data1/oa_pdf/ea/d2/main.PMC4707247.pdf
http://dx.doi.org/10.1007/s00401-013-1218-2 (Epub 2013 Dec 3).75 N. Singh et al.,OADS,/arxiv_data1/oa_pdf/ea/d2/main.PMC4707247.pdf
OnFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Although walking with his walker, mild intermittent myoclonus of the left leg, mainly generatedfrom the proximal region, was present; however, he was able to ambulate.Termsarasab P, Frucht SJ Alcohol-responsive Action Myoclonus of the Leg in Prostate Cancer Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Immunopathological identification of antigenic targets in a human brain or spinal cord mayAlcohol-responsive Action Myoclonus of the Leg in Prostate Cancer Termsarasab P, Frucht SJ Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"20Ataxia—trunk andgaitCerebellar syndrome— subacute, cerebellar atrophy onneuroimaging LEMS68 5 Bony metastasis of the pelvis 2 years after the original tumor diagnosis, andlater to L2 and L3 vertebral bodiesOriginally adeno; small-cell ca on repeat biopsy 5 yrs laterAnti-VGCC (serum)Recurrent cancer was treated with bil orchiectomy; corticosteroids,PLEx and guanidine HCl (all no)Stable neurologic sx R rapid deterioration after hepatic metastasis 6 mo after the recurrenceTermsarasab P, Frucht SJ Alcohol-responsive Action Myoclonus of the Leg in Prostate Cancer Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"2This case was staged according to Union for International Cancer Control classification in 1978.Alcohol-responsive Action Myoclonus of the Leg in Prostate Cancer Termsarasab P, Frucht SJ Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Nat Rev Urol 2010;7:681–692, doi: http://dx.doi.org/10.1038/ nrurol.2010.186.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"J Neurol 2015;262:1548–1556, doi:http://dx.doi.org/ 10.1007/s00415-015-7751-2.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"A single- blind, open-label trial of sodium oxybate for myoclonus and essential tremor.Neurology 2005;65:1967–1969, doi: http://dx.doi.org/10.1212/01.wnl.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Mov Disord 2005;20:1330–1337, doi: http://dx.doi.org/10.1002/mds.20605.",OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"J Brachial Plex Peripher Nerve Inj 2010;5:9, doi: http://dx.doi.org/ 10.1186/1749-7221-5-9.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"J Urol 2006;175:541–546; discussion 546, doi: http://dx.doi.org/10.1016/S0022-5347(05)00156-4.",OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"JU r o l 2002;167:51–56, doi: http://dx.doi.org/10.1016/S0022- 5347(05)65381-5.",OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"J Neurol Neurosurg Psychiatry 1987;50: 628–631, doi: http://dx.doi.org/10.1136/jnnp.50.5.628.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"J Neurol Neurosurg Psychiatry 1999;67:126–127, doi: http://dx.doi.org/10.1136/jnnp.67.1.126.Termsarasab P, Frucht SJ Alcohol-responsive Action Myoclonus of the Leg in Prostate Cancer Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"J Neurol Neurosurg Psychiatry 2010;81:42– 45, doi: http://dx.doi.org/10.1136/jnnp.2008.159483.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Seizure 2013;22: 136–140, doi: http://dx.doi.org/10.1016/j.seizure.2012.12.013.",OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Lancet Neurol 2011;10:63–74, doi: http://dx.doi.org/ 10.1016/S1474-4422(10)70253-2.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Lancet Neurol 2008;7:327–340, doi: http://dx.doi.org/10.1016/S1474-4422(08)70060-7.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Neurology 1993;43:2591–2596, doi: http://dx.doi.org/10.1212/WNL.43.12.2591.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Acta Neurol Scand 2002;105:351–353, doi: http://dx.doi.org/10.1034/j.",OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Postgrad Med J 1992;68:584–586, doi: http://dx.doi.org/10.1136/pgmj.68.801.584.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"J Neurol Neurosurg Psychiatry 2007;78:775– 777, doi: http://dx.doi.org/10.1136/jnnp.2006.112961.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Neurol Sci 2015;36:1501–1503, doi: http://dx.doi.org/10.1007/s10072-015- 2113-5.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"J Neurol Neurosurg Psychiatry 2009; 80:934–935, doi: http://dx.doi.org/10.1136/jnnp.2008.153015.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Handb Clin Neurol 2011;100:315–321, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"Semin Oncol 2007;34:22–29, doi: http://dx.doi.org/10.1053/j.seminoncol.2006.10.026.Alcohol-responsive Action Myoclonus of the Leg in Prostate Cancer Termsarasab P, Frucht SJ Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/c0/44/tre-05-357-7436-1.PMC4707263.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d2/52/ircmj-17-12-20419.PMC4707290.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/75/0e/ircmj-17-12-32076.PMC4707291.pdf
"Of these deaths,  an estimated 7.4 million were attributable to coronary artery pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.195 REVIEW J Cardiovasc Ultrasound  2015;23(4):195-203 disease (CAD) and approximately 6.7 million due to stroke.1)  Notably, prior epidemiologic evidence indicates that these mor - bidity and mortality rates attributable to CVD tend to vary de - pending on race, ethnicity, or geographic regions, even within  a particular country.2-6) In an effort to prevent adverse cardiovas - cular events, accurate assessment of absolute CVD risk is para - •	Received: October 1, 2015  •	Revised: November 24, 2015  •	Accepted: November 25, 2015 •		Address for Correspondence: Hyuk-Jae Chang, Division of Cardiology, Yonsei Cardiovascular Center, Yonsei University Health System, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea   Tel: +82-2-2228-8460, Fax: +82-2-393-2041, E-mail: hjchang@yuhs.ac •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Reassessing the Usefulness of Coronary  Artery Calcium Score among Varying  Racial and Ethnic Groups by Geographic  Locations: Relevance of the Korea  Initiatives on Coronary Artery  Calcification Registry Ji Hyun Lee, MD1,2, Bríain Ó Hartaigh, PhD2, Donghee Han, MD1,2, Hyo Eun Park, MD3,   Su-Yeon Choi, MD, PhD3, Jidong Sung, MD4, and Hyuk-Jae Chang, MD, PhD1 1Division of Cardiology, Yonsei Cardiovascular Center, Yonsei University Health System, Seoul, Korea   2Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and the Weill Cornell Medical College,  New York, NY, USA   3Division of Cardiology, Department of Internal Medicine, Healthcare System Gangnam Center,   Seoul National University Hospital, Seoul, Korea   4Division of Cardiology, Heart Stroke & Vascular Institute, Samsung Medical Center, Seoul, Korea There is some disparity in the morbidity and mortality rates of cardiovascular disease (CVD) according to race, ethnicity, and geo - graphic regions.",Non-OADS,/arxiv_data1/oa_pdf/3d/9a/jcu-23-195.PMC4707303.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs317/en/.,Non-OADS,/arxiv_data1/oa_pdf/3d/9a/jcu-23-195.PMC4707303.pdf
Available from: http://www.who.int/cardiovascular_ diseases/publications/atlas_cvd/en/.,Non-OADS,/arxiv_data1/oa_pdf/3d/9a/jcu-23-195.PMC4707303.pdf
Available from: http://www.arizonahealthmatters.,Non-OADS,/arxiv_data1/oa_pdf/3d/9a/jcu-23-195.PMC4707303.pdf
Avail - able from: http://www.worldpopulationstatistics.com/asia-population-2013/.,Non-OADS,/arxiv_data1/oa_pdf/3d/9a/jcu-23-195.PMC4707303.pdf
Avail - able from: http://www.worldpopulationstatistics.com/asia-population-2013/.,Non-OADS,/arxiv_data1/oa_pdf/3d/9a/jcu-23-195.PMC4707303.pdf
Coronary computed tomography pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.204 REVIEW J Cardiovasc Ultrasound  2015;23(4):204-208 angiography (CCTA) can be considered as a non-invasive meth - od that may substitute CAG and IVUS.7)8) CCTA is still limited  by spatial and temporal resolution but enables non-invasive  patient-friendly assessment of the extent of coronary athero - sclerosis.9) Therefore it is expected that CCTA will be useful in  overcoming limitations of the current diagnosis and treatment  of coronary heart disease as shown below.,Non-OADS,/arxiv_data1/oa_pdf/0e/0c/jcu-23-204.PMC4707304.pdf
"CCTA can visualize the extent of severity  of coronary artery disease with good sensitivity and excellent  specificity.12)13) The performance of CCTA for plaque detection  •	Received: October 12, 2015  •	Revised: December 6, 2015  •	Accepted: December 7, 2015 •		Address for Correspondence: Jin-Ho Choi, Departments of Internal Medicine, Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School  of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea   Tel: +82-2-3410-3419, Fax: +82-2-3410-3849, E-mail: jhchoimd@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.How to Utilize Coronary Computed  Tomography Angiography in the Treatment  of Coronary Artery Disease Hyung-Yoon Kim, MD1 and Jin-Ho Choi, MD, PhD1,2 Departments of 1Internal Medicine, 2Emergency Medicine, Heart Vascular Stroke Institute,   Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Coronary computed tomography angiography (CCTA) has high negative predictive power for detecting coronary artery disease.",Non-OADS,/arxiv_data1/oa_pdf/0e/0c/jcu-23-204.PMC4707304.pdf
"This final results of the PROTECT AF trial followed  up for an accumulated exposure of 1588 patient-years revealed pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.209 LAA closure with the Watchman device to be non-inferior to  systemic anticoagulation with warfarin regarding prevention  of stroke, systemic embolism, and cardiovascular death.9) On  the basis of these data, LAA closure has been decided a class  IIb recommendation in the 2014 ACC/ASA guideline as an  alternative strategy to prevent stroke.",Non-OADS,/arxiv_data1/oa_pdf/b3/d0/jcu-23-209.PMC4707305.pdf
"•	Received: December 7, 2015  •	Revised: December 7, 2015  •	Accepted: December 7, 2015 •		Address for Correspondence: Ji Hyun Yoon, Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea   Tel: +82-2-2228-8460, Fax: +82-2-393-2041, E-mail: peacy83@yuhs.ac •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.How Could Pre-Procedural Imaging   Guide Successful Left Atrial   Appendage Closure?",Non-OADS,/arxiv_data1/oa_pdf/b3/d0/jcu-23-209.PMC4707305.pdf
"The 2014 American Heart  Association/American Stroke Association guidelines suggest  the role of LAA device closure as an alternative strategy for  stroke prevention in atrial fibrillation (AF) patients at high pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.211 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2015;23(4):211-218 risk of stroke who are poor candidates for oral anticoagula - tion.1) In some patients, peri-device leakage of the LAA per - sists due to incomplete occlusion, although the procedure’s  success rate is generally high.2-4) However, information regard - ing the presence of and factors contributing to peri-device  leakage is scarce, and further study to evaluate the anatomical  and procedure-related factors of this leakage has not been per - •	*	Hyemoon Chung and Byunghwan Jeon contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/3e/ac/jcu-23-211.PMC4707306.pdf
"•	Received: October 25, 2015  •	Revised: November 30, 2015  •	Accepted: November 30, 2015 •		Address for Correspondence: Hyuk-Jae Chang, Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine,   50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea   Tel: +82-2-2228-8461, Fax: +82-2-2227-7732, E-mail: hjchang@yuhs.ac •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Predicting Peri-Device Leakage of Left  Atrial Appendage Device Closure Using  Novel Three-Dimensional Geometric CT  Analysis Hyemoon Chung, MD1,2*, Byunghwan Jeon, BS2*, Hyuk-Jae Chang, MD, PhD1,2,   Dongjin Han, PhD2, Hackjoon Shim, PhD2, In Jeong Cho, MD1,2,   Chi Young Shim, MD, PhD1, Geu-Ru Hong, MD, PhD1, Jung-Sun Kim, MD, PhD1,   Yangsoo Jang, MD, PhD1,3, and Namsik Chung, MD, PhD1,2 1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea   2Yonsei-Cedar Sinai Integrative Cardiovascular Imaging Research Center, Seoul, Korea   3Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea Background:  After left atrial appendage (LAA) device closure, peri-device leakage into the LAA persists due to incomplete  occlusion.",Non-OADS,/arxiv_data1/oa_pdf/3e/ac/jcu-23-211.PMC4707306.pdf
Supplementary Materials The online-only Data Supplement is available with this ar - ticle at http://dx.doi.org/10.4250/jcu.2015.23.4.211.,OADS,/arxiv_data1/oa_pdf/3e/ac/jcu-23-211.PMC4707306.pdf
"LV systolic performance involves not only contraction  across its minor axis but both longitudinal and circumferential  shortening.3)4) In patients with hypertensive heart disease, heart  failure with preserved EF, and aortic stenosis, reduced longitu - dinal and mid-wall circumferential shortening occur despite  normal radial endocardial fiber shortening.5-8) We hypothesized that in chronic AR, there will be a reduc -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.219 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2015;23(4):219-227 tion in longitudinal shortening despite a preserved EF due to  normal endocardial minor axis shortening.",Non-OADS,/arxiv_data1/oa_pdf/d7/80/jcu-23-219.PMC4707307.pdf
"Patients deemed  •	Received: June 9, 2015  •	Revised: August 10, 2015  •	Accepted: November 18, 2015 •		Address for Correspondence: Steven J. Lavine, Division of Cardiology, Department of Internal Medicine, Quillen College of Medicine, East Tennessee State  University, 329 North State of Franklin Road, Johnson City, TN 37604, USA   Tel: +1-423-979-4130, Fax: +1-423-979-4137, E-mail: lavine@etsu.edu •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Reduced Longitudinal Function in Chronic  Aortic Regurgitation Steven J. Lavine, MD and Kais A. Al Balbissi, MD Division of Cardiology, Department of Internal Medicine, Quillen College of Medicine,   East Tennessee State University, Johnson City, TN, USA  Background: Chronic aortic regurgitation (AR) patients demonstrate left ventricular (LV) remodeling with increased LV mass  and volume but may have a preserved LV ejection fraction (EF).",Non-OADS,/arxiv_data1/oa_pdf/d7/80/jcu-23-219.PMC4707307.pdf
Echocardiographic assessment of pulmo - nary blood flow for measurement of pulsatility will provide a pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.228 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2015;23(4):228-232 noninvasive parameter for comparison and follow-up.,Non-OADS,/arxiv_data1/oa_pdf/9c/ad/jcu-23-228.PMC4707308.pdf
"Patients were excluded if they were not in  •	Received: June 13, 2015  •	Revised: August 21, 2015  •	Accepted: November 18, 2015 •		Address for Correspondence: Mohammad Reza Mirzaaghayan, Department of Pediatric Cardiac Surgery, Children’s Medical Center, Tehran University of Medical  Sciences, 62 Gharib Street, Tehran 14194, Iran   Tel: +98-91-2182-3090, Fax: +98-21-6693-0024, E-mail: mirzaaghayanm@yahoo.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Echocardiographic Assessment   of Pulmonary Arteries Pulsatility Index   in Fontan Circulation Reza Shabanian, MD1, Mohammad Reza Mirzaaghayan, MD2,   Minoo Dadkhah, MD1, Mehdi Hosseini, MD1, Mitra Rahimzadeh, PhD3,   Parvin Akbari Asbagh, MD4, and Mohammad Ali Navabi, MD2 Departments of 1Pediatric Cardiology, 2Pediatric Cardiac Surgery, Children’s Medical Center,   Tehran University of Medical Sciences, Tehran, Iran   3Department of Public Health, Alborz University of Medical Sciences, Karaj, Iran   4Department of Pediatric Cardiology, Imam Khomeni Hospital, Tehran University of Medical Sciences, Tehran, Iran Background:  Late complications after Fontan procedure may be due to the absence of pump and pulsatile pulmonary blood flow  in this type of palliation.",Non-OADS,/arxiv_data1/oa_pdf/9c/ad/jcu-23-228.PMC4707308.pdf
"It increases bioavail - ability and activates receptor signaling of incretin hormones in  response to oral food intake,1) and thus lowers blood glucose pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.233 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2015;23(4):233-243 level without risk of hypoglycemia.",Non-OADS,/arxiv_data1/oa_pdf/43/39/jcu-23-233.PMC4707309.pdf
"A few meta-analyses suggested that DPP-4  inhibitors are safe from a cardiovascular standpoint and decrease  •	Received: August 4, 2015  •	Revised: November 3, 2015  •	Accepted: November 18, 2015 •		Address for Correspondence: Yong-Jin Kim, Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro,  Jongno-gu, Seoul 03080, Korea   Tel: +82-2-2072-1963, Fax: +82-2-2072-2577, E-mail: kimdamas@snu.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effect of Dipeptidyl Peptidase-4 Inhibitor  on All-Cause Mortality and Coronary  Revascularization in Diabetic Patients Hyo Eun Park, MD1, Jooyeong Jeon, MS2, In-Chang Hwang, MD3, Jidong Sung, MD, MPH4,   Seung-Pyo Lee, MD, PhD3, Hyung-Kwan Kim, MD, PhD3, Goo-Yeong Cho, MD, PhD5,   Dae-Won Sohn, MD, PhD3, and Yong-Jin Kim, MD, PhD3 1Division of Cardiology, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea   2Master in Statistics, Department of Statistics, Sungkyunkwan University, Seoul, Korea   3Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea   4Division of Cardiology, Department of Internal Medicine, Sungkyunkwan University College of Medicine,   Samsung Medical Center, Seoul, Korea   5Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital,   Seongnam, Korea Background: Anti-atherosclerotic effect of dipeptidyl peptidase-4 (DPP-4) inhibitors has been suggested from previous stud - ies, and yet, its association with cardiovascular outcome has not been demonstrated.",Non-OADS,/arxiv_data1/oa_pdf/43/39/jcu-23-233.PMC4707309.pdf
"244Introduction Coronary artery disease (CAD) is one of the leading causes  of morbidity and mortality in developed countries.1) Moreover, pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.244 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2015;23(4):244-252 major CAD events such as sudden cardiac death, myocardial  infarction (MI), or unstable angina, are often the first manifes - tation of CAD in patients who did not experience symptoms Differential Prognostic Value   of Coronary Computed Tomography   Angiography in Relation to Exercise   Electrocardiography in Asymptomatic   Subjects Sang-Eun Lee, MD1, Iksung Cho, MD1, Geu-Ru Hong, MD, PhD1,   Hyuk-Jae Chang, MD, PhD1,2, Ji Min Sung, PhD3, In-Jeong Cho, MD1,   Chi Young Shim, MD, PhD1, Byoung Wook Choi, MD, PhD4, and Namsik Chung, MD, PhD1 1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine,   Yonsei University Health System, Seoul, Korea   2Severance Biomedical Science Institute, Yonsei University Health System, Seoul, Korea   3Department of Research Affairs, Yonsei University College of Medicine,   Yonsei University Health System, Seoul, Korea   4Division of Radiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Background:  To explore the prognostic performance of coronary computed tomography angiography (CCTA) and exercise  electrocardiography (XECG) in asymptomatic subjects.",Non-OADS,/arxiv_data1/oa_pdf/06/a9/jcu-23-244.PMC4707310.pdf
"•	Received: October 12, 2015  •	Revised: December 5, 2015  •	Accepted: December 7, 2015 •		Address for Correspondence: Hyuk-Jae Chang, Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University  Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea   Tel: +82-2-2228-8460, Fax: +82-2-393-2041, E-mail: hjchang@yuhs.ac •		This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/a9/jcu-23-244.PMC4707310.pdf
"Case A 68-year-old female visited the emergency department  for complaint of shortness of breath, general weakness and  abdominal distension which had progressed over the preced -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.253 CASE REPORT J Cardiovasc Ultrasound  2015;23(4):253-256 ing several weeks.",Non-OADS,/arxiv_data1/oa_pdf/69/ef/jcu-23-253.PMC4707311.pdf
"•	Received: January 23, 2015  •	Revised: October 19, 2015  •	Accepted: November 18, 2015 •		Address for Correspondence: Sang-Hyun Kim, Division of Cardiology, Department of Internal Medicine, SMG-SNU Seoul Boramae Hospital, Seoul National  University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea   Tel: +82-2-870-2216 , Fax: +82-2-870-3866 , E-mail: shkimmd@snu.ac.kr •		This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/ef/jcu-23-253.PMC4707311.pdf
"She had under -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.257 CASE REPORT J Cardiovasc Ultrasound  2015;23(4):257-261 gone AV replacement (AVR) with a Sorin 19 mm bileaflet  mechanical valve two years prior to presentation, for severe  aortic regurgitation (AR) of a bicuspid AV .",Non-OADS,/arxiv_data1/oa_pdf/ff/89/jcu-23-257.PMC4707312.pdf
"•	Received: May 14, 2015  •	Revised: September 3, 2015  •	Accepted: November 18, 2015 •		Address for Correspondence: Eva D Papadimitraki, Department of Cardiology, Laiko General Hospital, 17 Agiou Thoma Street, Athens 11527, Greece     Tel: +30-210-7456258, Fax: +30-213-20161761, E-mail: evapapadimitraki@hotmail.com •		This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/89/jcu-23-257.PMC4707312.pdf
Peripheral oxygen saturation was 96% with oxygen flow of 6 L/ pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.262 CASE REPORT J Cardiovasc Ultrasound  2015;23(4):262-265 min via facial mask.,Non-OADS,/arxiv_data1/oa_pdf/b5/8a/jcu-23-262.PMC4707313.pdf
"•	Received: June 2, 2015  •	Revised: August 17, 2015  •	Accepted: November 18, 2015 •		Address for Correspondence: Ji Yeon Hong, Division of Cardiology, KEPCO Medical Center, 308 Uicheon-ro, Dobong-gu, Seoul 01450, Korea   Tel: +82-2-901-3011, Fax: +82-2-901-3014, E-mail: gladyshong@gmail.com •		This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/8a/jcu-23-262.PMC4707313.pdf
"266Introduction The Klippel-Trenaunay syndrome is a rare mesodermal ab - normality characterized by a triad of vascular nevus, varicose  veins, and soft tissue and bony hypertrophy of limb.1) Klippel- Trenaunay syndrome can be diagnosed on the basis of any  two of these three features.2) Clinical presentation of Klippel- Trenaunay syndrome has wide spectrum from asymptomatic  state to potentially life-threatening complications, such as  hypercoagulability, deep vein thrombosis and pulmonary  thromboembolism (PTE).1) The hypercoagulability may be  attributed to stagnation of blood within the disordered, en - larged venous blood vessels, which can lead to the continuous  formation of thrombi, resulting in recurrent PTE.1) Venous  thromboembolism has been reported to occur in 8 –22% of  Klippel-Trenaunay syndrome patient population.3) Over 30  cases on Klippel-Trenaunay syndrome-associated PTE have  been reported.3-8) Also, compromised vascular integrity in -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.266 CASE REPORT J Cardiovasc Ultrasound  2015;23(4):266-270 creases risk of thrombus formation of the cerebral aneurysm  and stroke in patients with Klippel-Trenaunay syndrome.9) Here, we report a rare case of Klippel-Trenaunay syndrome  with unruptured basilar tip aneurysm, complicated by acute  submassive PTE treated successfully with intravenous throm - bolytic therapy.",Non-OADS,/arxiv_data1/oa_pdf/03/90/jcu-23-266.PMC4707314.pdf
"•	Received: June 8, 2015  •	Revised: August 31, 2015  •	Accepted: November 18, 2015 •		Address for Correspondence: Jung Ju Sir, Department of Internal Medicine, Cardiovascular Center, National Medical Center, 245 Eulji-ro, Jung-gu, Seoul 04564,  Korea   Tel: +82-2-2260-7430, Fax: +82-2-2262-4749, E-mail: seo0515@medimail.co.kr •		This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/90/jcu-23-266.PMC4707314.pdf
"pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.271 http://dx.doi.org/10.4250/jcu.2015.23.4.241 CASE REPORT J Cardiovasc Ultrasound  2015;23(4):271-273 Cerebrovascular angiography and thrombectomy were per - formed, and red thrombi with whitish amorphous materials  were acquired from the procedure.",Non-OADS,/arxiv_data1/oa_pdf/20/9b/jcu-23-271.PMC4707315.pdf
"However, the medial por - •	Received: October 22, 2015  •	Revised: November 23, 2015  •	Accepted: November 24, 2015 •		Address for Correspondence: Seong-Mi Park, Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College  of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea   Tel: +82-2-920-5448, Fax: +82-2-927-1478, E-mail: smparkmd@korea.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Unexpected Pathologic Diagnosis   of the Mitral Valvular Mass Su-A Kim, MD1, Seong-Mi Park, MD, PhD2, Seong-Ho Hwang, MD3, Mi-Na Kim, MD2,   Ho-Sung Son, MD, PhD4, and Wan-Joo Shim, MD, PhD2 1Division of Cardiology, Department of Internal Medicine, Cheil General Hospital, Dankook University   College of Medicine, Seoul, Korea   2Division of Cardiology, Departments of Internal Medicine, 3Radiology, 4Thoracic Surgery, Korea University Anam  Hospital, Korea University College of Medicine, Seoul, Korea A 59-year-old man with multifocal cerebral infarction was found to have the large obstructive mitral valvular mass.",Non-OADS,/arxiv_data1/oa_pdf/20/9b/jcu-23-271.PMC4707315.pdf
"Surgical management should be considered very  rare, in patients with intractable severe rhythm disorders, he - modynamic instability, symptoms of superior vena cava syn - drome or right atrium obstruction.1-3) Despite the fact that to  date more than 200 cases have been published, LHIS remains pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.274 under recognized and frequently misdiagnosed as a malignant  tumor.",Non-OADS,/arxiv_data1/oa_pdf/e4/b4/jcu-23-274.PMC4707316.pdf
"•	Received: April 21, 2015  •	Revised: May 16, 2015  •	Accepted: November 18, 2015 •		Address for Correspondence: Damir Fabijanic, Department of Cardiology, University Hospital Centre Split, 1 Spinciceva, Split 21000, Croatia    Tel: +385-21-556-766, Fax: +385-21-556-031, E-mail: damir.fabijanic@st.t-com.hr •		This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/b4/jcu-23-274.PMC4707316.pdf
Invasive coronary angiography showed extrinsic compres - sion (60% diameter stenosis) of the proximal left anterior de -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2015 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2015.23.4.276 scending coronary artery (Fig.,Non-OADS,/arxiv_data1/oa_pdf/b4/48/jcu-23-276.PMC4707317.pdf
"The presence of right bundle branch  block along with left axis deviation in the baseline electrocar - diogram suggest erosion into the septal area by the LVOT pseu -IMAGES IN CARDIOVASCULAR ULTRASOUND J Cardiovasc Ultrasound  2015;23(4):276-279 •	Received: July 7, 2015  •	Revised: September 15, 2015  •	Accepted: December 7, 2015 •		Address for Correspondence: Rajiv Bharat Kharwar, Department of Cardiology, U N Mehta Institute of Cardiology and Research Centre, Civil Hospital Campus,  Asarwa, Ahmedabad, Gujarat 380016, India   Tel: +91-990-480-5283, Fax: +91-79-2268-5349, E-mail: dr.rajivkharwar@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Huge Multilobulated Left Ventricular  Outflow Tract Pseudoaneurysm  Presenting with Ventricular Tachycardia Rajiv Bharat Kharwar, MD, DM and Anand Shukla, MD, DM Department of Cardiology, U N Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India KEY WORDS:  Ventricular tachycardia  · Pseudoaneurysm  · Left ventricular outflow tract.",Non-OADS,/arxiv_data1/oa_pdf/b4/48/jcu-23-276.PMC4707317.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/de/rjv168.PMC4707387.pdf
"The recommended daily quantity of vitamin C is 75 mg for women and 90 mg for man [ 4] (http://www.who.int/ en/), but up to 40% more can be necessary in smokers and duringinfection [ 1].",Non-OADS,/arxiv_data1/oa_pdf/20/de/rjv168.PMC4707387.pdf
"Recently, in Wales (UK) in 2011, a young patient died of scurvy (http://www.bbc.com/news/uk-wales-31039895).",Non-OADS,/arxiv_data1/oa_pdf/20/de/rjv168.PMC4707387.pdf
Available from URL: http://www.who.int/tb/publications/global_report/ en/   3.,OADS,/arxiv_data1/oa_pdf/0a/da/SaudiMedJ-36-1400.PMC4707395.pdf
Available from: https://www.idf.org/ diabetesatlas   2.,Non-OADS,/arxiv_data1/oa_pdf/58/d3/SaudiMedJ-36-1420.PMC4707397.pdf
Available from: http://www.idf.org/diabetesatlas   2.,Non-OADS,/arxiv_data1/oa_pdf/0a/81/SaudiMedJ-36-1425.PMC4707398.pdf
Available from: http://www.popline.org/node/197567 10.,Non-OADS,/arxiv_data1/oa_pdf/0a/81/SaudiMedJ-36-1425.PMC4707398.pdf
Available from URL: http://verathon.com 12.,Non-OADS,/arxiv_data1/oa_pdf/46/f1/SaudiMedJ-36-1446.PMC4707401.pdf
Available from URL: http://www.parkermedical.com/parker-intubating- stylets 17.,Non-OADS,/arxiv_data1/oa_pdf/46/f1/SaudiMedJ-36-1446.PMC4707401.pdf
Available from: http://www.who.int/mediacentre/news/statements/2015/climate-change/en/# ------------------------------------------------------------------------------------------------------- measles Vaccinati On Has sa Ved an estimated 17.1 milli On  liVes since 2000 12 nOVemBer 2015 ¦ gene Va - The number of measles-related deaths has decreased 79% from 546 800 at  the beginning of the century to 114 900 in 2014.,Non-OADS,/arxiv_data1/oa_pdf/04/08/SaudiMedJ-36-1506.PMC4707414.pdf
Available from: http://www.who.int/mediacentre/news/statements/2015/climate-change/en/# ------------------------------------------------------------------------------------------------------- Measles vaccination has saved an esti Mated 17.1 Million  lives since 2000 12 noveMBeR 2015 ¦ Geneva - The number of measles-related deaths has decreased 79% from 546 800 at  the beginning of the century to 114 900 in 2014.,Non-OADS,/arxiv_data1/oa_pdf/13/1b/SaudiMedJ-36-1507.PMC4707415.pdf
“A coordinated approach that puts stronger routine immunization at its core will be central to getting measles under control and securing further reductions in mortality from this vaccine-preventable disease.” Available from: http://www.who.int/mediacentre/news/releases/2015/measles-vaccination/en/WHO News Release,Non-OADS,/arxiv_data1/oa_pdf/13/1b/SaudiMedJ-36-1507.PMC4707415.pdf
Available from: http://www.nice.org.uk/article/pmg9/chapter/foreword.,Non-OADS,/arxiv_data1/oa_pdf/83/a7/eye2015170a.PMC4707499.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Eye website (http://www.nature.com/eye)Comparing ophthalmologists ’vsoptometrists ’retreatment decisions for wet AMD J Taylor et al 78 Eye",Non-OADS,/arxiv_data1/oa_pdf/83/a7/eye2015170a.PMC4707499.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/3e/1d/nihms733488.PMC4707679.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.php Correspondence: Carrie J McAdams, University of Texas at Southwestern, Medical Center, 5323 Harry Hines, BL 6.110, Dallas, TX  75390-8828, USA, Tel +1 214 648 4145, Fax +1 214 648 5321, carrie.mcadams@utsouthwestern.edu.",Non-OADS,/arxiv_data1/oa_pdf/3e/1d/nihms733488.PMC4707679.pdf
Each map  can be examined at http://www.neurosynth.org/analyses/terms/reward ; http:// www.neurosynth.org/analyses/terms/decision ; and http://www.neurosynth.org/analyses/ terms/social .McAdams and Smith Page 22 Neurosci Neuroecon .,Non-OADS,/arxiv_data1/oa_pdf/3e/1d/nihms733488.PMC4707679.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/e9/nihms725687.PMC4707685.pdf
"In contrast,  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,   provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/a5/glu222.PMC4707686.pdf
"170 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/09/glu223.PMC4707687.pdf
The  remaining classical strains were chosen because they were rec - ommended by the Mouse Phenome Project based on genetic diver - sity and common use ( http://phenome.jax.org/db/q?rtn=strains/ searchstep2&reqpanel=mpd_priority&nosearch=1 ).,Non-OADS,/arxiv_data1/oa_pdf/db/09/glu223.PMC4707687.pdf
Details of JAX NSC procedures for each  project can be found on the MPD website ( http://phenome.jax.,Non-OADS,/arxiv_data1/oa_pdf/db/09/glu223.PMC4707687.pdf
"Elevated  plasma homocysteine is a risk factor for brain atrophy and  cognitive decline, and treatment with B vitamins reduces brain  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/16/glv109.PMC4707688.pdf
"Recommendations for Testing, Managing, and Treating  Hepatitis C. Available from: http://www.hcvguidelines.org.",Non-OADS,/arxiv_data1/oa_pdf/35/79/SJG-21-345.PMC4707801.pdf
Available from: http://www.gilead.ca/pdf/ca/harvoni_pm_english.,Non-OADS,/arxiv_data1/oa_pdf/35/79/SJG-21-345.PMC4707801.pdf
Available from: http://www.gilead.com/ news/press‑releases/2014/11/european‑commission‑grants‑marketing‑ authorization‑for‑gileads‑harvoni‑ledipasvirsofosbuvir‑the‑first‑single‑ tablet‑regimen‑to ‑treat‑the‑majority ‑of‑chronic‑hepatitis‑c‑patients‑ with‑genotype‑1‑and‑4.,Non-OADS,/arxiv_data1/oa_pdf/35/79/SJG-21-345.PMC4707801.pdf
Trial registration: clinicaltrials.gov Identifier: NCT01755286  (http://clinicaltrials.gov/ct2/show/NCT01755286?term=otonomy %2C+pediatric&rank=3).,Non-OADS,/arxiv_data1/oa_pdf/dc/dd/10.1177_0003489415599001.PMC4707869.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/8a/main.PMC4707971.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.09.001,OADS,/arxiv_data1/oa_pdf/92/8a/main.PMC4707971.pdf
(Cell Mol Gastroenterol Hepatol 2016;2:77 –91;http://dx.doi.org/ 10.1016/j.jcmgh.2015.08.007 )Keywords: Enteric Nervous System; Hemichannels; Oxidative Stress; Purines.,Non-OADS,/arxiv_data1/oa_pdf/ae/88/main.PMC4707972.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/88/main.PMC4707972.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.08.007,OADS,/arxiv_data1/oa_pdf/ae/88/main.PMC4707972.pdf
Images were obtained by epi ﬂuorescence microscopy as described above and the ratio of 546-maleimide/680-maleimide (SS/SH) calculated with ImageJ software(http://imagej.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/ae/88/main.PMC4707972.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3b/41/cardiovascmed-04-04-29614.PMC4707979.pdf
http://www.youtube.com/watch?v=HUv13Xy0GwE.,Non-OADS,/arxiv_data1/oa_pdf/0b/c1/10.1177_0884533615592954.PMC4708005.pdf
"Both schools of public health and liberal arts colleges have introduced public  health education at the undergraduate level, where it has become one of the fastest-growing  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/20/d3/nihms-737887.PMC4708056.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/f4/main.PMC4708064.pdf
A  point  mutation  in  the  P-glycoprotein  gene  homologue (pfmdr1)  at  codon  86  (Asn  to  Tyr)  was  reported  to  effect http://dx.doi.org/10.1016/j.ijms.2015.09.009 1387-3806/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/f4/main.PMC4708064.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/a4/f4/main.PMC4708064.pdf
"Supplementary  data Supplementary  data associated with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.ijms.2015.09.009 .",OADS,/arxiv_data1/oa_pdf/a4/f4/main.PMC4708064.pdf
Available at:  http://www.jointcommission.org/assets/1/6/PBM_Implementation_ Guide_20110624.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/31/ane-122-565.PMC4708068.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.11.011,Non-OADS,/arxiv_data1/oa_pdf/c9/39/main.PMC4708069.pdf
"BLAST analysis ( http://blast.ncbi.nlm.nih.gov ) showed 100% identity with C. hongkongensis (strain HKU16, accession no.",Non-OADS,/arxiv_data1/oa_pdf/c9/39/main.PMC4708069.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,5 4 –55 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c9/39/main.PMC4708069.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.11.008,Non-OADS,/arxiv_data1/oa_pdf/1b/36/main.PMC4708070.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,5 6 –57 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/1b/36/main.PMC4708070.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/b1/main.PMC4708071.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.12.048 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/b1/main.PMC4708071.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.11.006,Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC4708072.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,4 7 –49 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC4708072.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,4 7 –49 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC4708072.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/42/main.PMC4708073.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.12.045 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/42/main.PMC4708073.pdf
"3 (2012, Mar 14) CD005391, http://dx.doi.org/10.1002/ 14651858.CD005391.pub .",Non-OADS,/arxiv_data1/oa_pdf/8d/42/main.PMC4708073.pdf
"59 (2009) 2 e4,http://dx.doi.org/10.3322/ caac.20012 .",Non-OADS,/arxiv_data1/oa_pdf/8d/42/main.PMC4708073.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.10.013,Non-OADS,/arxiv_data1/oa_pdf/f0/31/main.PMC4708074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,5 0–53 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f0/31/main.PMC4708074.pdf
The culture isolates were analysed with pulsed- ﬁeld gel electrophoresis using a protocol based on PulseNet for E. coli (http://www.cdc.gov/pulsenet/pathogens/ ecoli.html ).,OADS,/arxiv_data1/oa_pdf/f0/31/main.PMC4708074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,5 0–53 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f0/31/main.PMC4708074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,9,5 0–53 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f0/31/main.PMC4708074.pdf
"During the subsequent year, her wound improved with  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1f/8c/nihms748715.PMC4708077.pdf
20 http://repository.edm-forum.org/egems/vol3/iss1/20 DOI: 10.13063/2327-9214.1196,Non-OADS,/arxiv_data1/oa_pdf/38/e3/egems1196.PMC4708091.pdf
20 http://repository.edm-forum.org/egems/vol3/iss1/20 DOI: 10.13063/2327-9214.1196,Non-OADS,/arxiv_data1/oa_pdf/38/e3/egems1196.PMC4708091.pdf
20 http://repository.edm-forum.org/egems/vol3/iss1/20 DOI: 10.13063/2327-9214.1196,Non-OADS,/arxiv_data1/oa_pdf/38/e3/egems1196.PMC4708091.pdf
20 http://repository.edm-forum.org/egems/vol3/iss1/20 DOI: 10.13063/2327-9214.1196,Non-OADS,/arxiv_data1/oa_pdf/38/e3/egems1196.PMC4708091.pdf
19 http://repository.edm-forum.org/egems/vol3/iss1/19 DOI: 10.13063/2327-9214.1200,Non-OADS,/arxiv_data1/oa_pdf/0c/22/egems1200.PMC4708092.pdf
19 http://repository.edm-forum.org/egems/vol3/iss1/19 DOI: 10.13063/2327-9214.1200,Non-OADS,/arxiv_data1/oa_pdf/0c/22/egems1200.PMC4708092.pdf
19 http://repository.edm-forum.org/egems/vol3/iss1/19 DOI: 10.13063/2327-9214.1200,Non-OADS,/arxiv_data1/oa_pdf/0c/22/egems1200.PMC4708092.pdf
19 http://repository.edm-forum.org/egems/vol3/iss1/19 DOI: 10.13063/2327-9214.1200,Non-OADS,/arxiv_data1/oa_pdf/0c/22/egems1200.PMC4708092.pdf
19 http://repository.edm-forum.org/egems/vol3/iss1/19 DOI: 10.13063/2327-9214.1200,Non-OADS,/arxiv_data1/oa_pdf/0c/22/egems1200.PMC4708092.pdf
19 http://repository.edm-forum.org/egems/vol3/iss1/19 DOI: 10.13063/2327-9214.1200,Non-OADS,/arxiv_data1/oa_pdf/0c/22/egems1200.PMC4708092.pdf
21 http://repository.edm-forum.org/egems/vol3/iss1/21 DOI: 10.13063/2327-9214.1195,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/egems1195.PMC4708093.pdf
21 http://repository.edm-forum.org/egems/vol3/iss1/21 DOI: 10.13063/2327-9214.1195,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/egems1195.PMC4708093.pdf
21 http://repository.edm-forum.org/egems/vol3/iss1/21 DOI: 10.13063/2327-9214.1195,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/egems1195.PMC4708093.pdf
21 http://repository.edm-forum.org/egems/vol3/iss1/21 DOI: 10.13063/2327-9214.1195,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/egems1195.PMC4708093.pdf
21 http://repository.edm-forum.org/egems/vol3/iss1/21 DOI: 10.13063/2327-9214.1195,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/egems1195.PMC4708093.pdf
21 http://repository.edm-forum.org/egems/vol3/iss1/21 DOI: 10.13063/2327-9214.1195,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/egems1195.PMC4708093.pdf
21 http://repository.edm-forum.org/egems/vol3/iss1/21 DOI: 10.13063/2327-9214.1195,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/egems1195.PMC4708093.pdf
21 http://repository.edm-forum.org/egems/vol3/iss1/21 DOI: 10.13063/2327-9214.1195,Non-OADS,/arxiv_data1/oa_pdf/a4/6b/egems1195.PMC4708093.pdf
"We successfully replicated these subphenotypes and epistatic modules in an independent dataset from Mexico genotyped with a different platform.Availability and implementation: JBASE is implemented in C þþ, supported on Linux and is avail- able at http://www.cs.toronto.edu/ /C24goldenberg/JBASE/jbase.tar.gz.",OADS,/arxiv_data1/oa_pdf/97/2c/btv504.PMC4708100.pdf
"203 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/2c/btv504.PMC4708100.pdf
"Availability and implementation: Software, annotation database and examples are available at http://dleelab.github.io/jepegmix/.",OADS,/arxiv_data1/oa_pdf/df/02/btv567.PMC4708106.pdf
"295 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/02/btv567.PMC4708106.pdf
"However, the conservativeness is expected tobecome negligible with the advent of extremely large reference panels(http://www.haplotype-reference-consortium.org).",Non-OADS,/arxiv_data1/oa_pdf/df/02/btv567.PMC4708106.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/79/copd-11-073.PMC4708173.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2016:11 73–79International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  73RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S7800 0Specific role of combination aclidinium: formoterol  in the treatment of chronic obstructive pulmonary  disease Maria Gabriella Matera1 Alessandro Sanduzzi2 Mario Cazzola3 1Department of experimental  Medicine, Second University of  Naples, 2Department of Respiratory  Diseases, Monaldi Hospital, University  Federico II, Naples, 3Department of  Systems Medicine, University of Rome  T or Vergata, Rome, ItalyAbstract:  Co-administration of a long-acting β2-agonist and a long acting muscarinic antagonist  produces superior bronchodilation compared with their individual effects.",Non-OADS,/arxiv_data1/oa_pdf/2e/79/copd-11-073.PMC4708173.pdf
"Keywords:  aclidinium, formoterol, fixed-dose combination, COPD, symptoms Background A solid body of evidence indicates that simultaneous administration of a long-acting  β2-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) produces superior  bronchodilation compared with their individual effects.1–7 In addition, the examination of  the literature reveals that the majority of the patients reported outcomes such as dyspnea,  other symptoms, rescue medication use, and quality of life, improve more with free LABA/ LAMA combinations than with the individual components administered alone.8 Simultaneous stimulation of β2-adrenoceptors and inhibition of the action of  acetylcholine at muscarinic receptors with antimuscarinic agent may elicit a larger  bronchodilation by relaxing the airway smooth muscle (ASM) in a more complete  manner.9 Furthermore, the intracellular crosstalk makes the β2-adrenoceptors and the  muscarinic pathways so linked to explain the favorable ASM relaxation induced by  LABA/LAMA combinations.10,11 The disparity in the duration of action of the twice-daily LABAs and a once-daily  LAMA, and the differences in the devices used to deliver the single medications, render  these free combinations inconvenient and unpredictable, especially if focused on the  adherence to prescribed treatment.12,13 Therefore, several fixed-dose combinations  (FDCs) of once- or twice-daily LABAs and LAMAs in a single delivery device have  been developed.14 In this review, we will focus on the clinical and functional benefits that can be  achieved in many COPD patients through the use of the twice-daily aclidinium bromide/ formoterol fumarate (ACLI/FORM) FDC.Correspondence: Maria Gabriella Matera Department of experimental Medicine,  Second University of Naples, via Santa  Maria di Costantinopoli, 16, 80138  Naples, Italy email mariagabriella.matera@unina2.i t Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Matera et al Running head recto: Aclidinium: formoterol FDC in COPD DOI: http://dx.doi.org/10.2147/COPD.S78000",Non-OADS,/arxiv_data1/oa_pdf/2e/79/copd-11-073.PMC4708173.pdf
"Available from:  http://www.astrazeneca.com/Media/Press-releases/Article/20141124--   duaklir-genuair-approved-in-the-european-unio n. Accessed July 10,  2015.",Non-OADS,/arxiv_data1/oa_pdf/2e/79/copd-11-073.PMC4708173.pdf
"Available from:  https://markets.jpmorgan.com/research/email/eevpt8pp/GPS- 1190044-0.pd f. Accessed July 9, 2015.",OADS,/arxiv_data1/oa_pdf/2e/79/copd-11-073.PMC4708173.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2e/79/copd-11-073.PMC4708173.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/79/copd-11-073.PMC4708173.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/45/ott-9-203.PMC4708174.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2016:9 203–210OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  203Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8996 7Pi3K inhibitors as new cancer therapeutics:  implications for clinical trial design Cristian Massacesi1 emmanuelle Di T omaso2 Patrick Urban3 Caroline Germa4 Cornelia Quadt5 Lucia Trandafir1 Paola Aimone3 Nathalie Fretault1 Bharani Dharan4 Ranjana Tavorath4 Samit Hirawat4 1Novartis Oncology, Paris, France;   2Novartis institutes for BioMedical  Research inc, Cambridge, MA,   USA; 3Novartis Pharma AG,   Basel, Switzerland; 4Novartis  Pharmaceuticals Corporation,   east Hanover, NJ, USA; 5Novartis  Pharmaceuticals KK, T okyo, JapanAbstract:  The PI3K–AKT–mTOR pathway is frequently activated in cancer.",Non-OADS,/arxiv_data1/oa_pdf/a0/45/ott-9-203.PMC4708174.pdf
"Indeed, the Novartis mTOR complex 1 inhibitor everolimus is now  approved for several indications, demonstrating the potential for PI3K–AKT–mTOR Correspondence: Cristian Massacesi Novartis Oncology, 10 Rue Lionel  Terray, Rueil-Malmaison,   Paris 92500, France Tel +33 1 5547 8343 Fax +33 1 5547 6049 email cristian.massacesi@novartis.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Massacesi et al Running head recto: PI3K inhibition in cancer therapy DOI: http://dx.doi.org/10.2147/OTT.S89967",Non-OADS,/arxiv_data1/oa_pdf/a0/45/ott-9-203.PMC4708174.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a0/45/ott-9-203.PMC4708174.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/45/ott-9-203.PMC4708174.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/cd/amep-7-001.PMC4708175.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2016:7 1–6Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  1OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S9648 1lecturing skills as predictors of tutoring skills   in a problem-based medical curriculum salah Eldin Kassab1 nahla hassan1 Marwan F Abu-hijleh2 reginald P sequeira3 1Department of Medical Education,   Faculty of Medicine, suez canal  University, ismailia, Egypt; 2college  of Medicine, Qatar University,   Doha, Qatar; 3college of Medicine  and Medical sciences, Arabian gulf  University, Manama, Kingdom of  Bahrain correspondence: salah Eldin Kassab   Department of Medical Education, Faculty  of Medicine, suez canal University, ring  road, ismailia, PO Box 41111, Egypt   Fax +20 64 3208543   Email kassabse@gmail.co mPurpose:  Recruitment of tutors to work in problem-based learning (PBL) programs is  challenging, especially in that most of them are graduated from discipline-based programs.",Non-OADS,/arxiv_data1/oa_pdf/67/cd/amep-7-001.PMC4708175.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/67/cd/amep-7-001.PMC4708175.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/cd/amep-7-001.PMC4708175.pdf
Available from http://dx.doi.org/10.3402/meo.,OADS,/arxiv_data1/oa_pdf/67/cd/amep-7-001.PMC4708175.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/7f/ccide-8-001.PMC4708190.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical, Cosmetic and Investigational Dentistry 2016:8 1–14Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  1OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCIDE.S9566 0arginine-containing desensitizing toothpaste for  the treatment of dentin hypersensitivity: a   meta-analysis Zheng-yan Yang1,2 Fei Wang1,2 Keke lu1,2 Yue-heng li1,2 Zhi Zhou1,2 1Department of Preventive Dentistry,   The College of stomatology,   2Department of Preventive Dentistry,   The affiliated hospital of stomatology,   Chongqing Medical University,   Chongqing, People’s republic of China Correspondence: Zhi Zhou   The Affiliated Hospital of Stomatology,  Chongqing Medical University, no 426,   songshibei road, Yubei District,  Chongqing 401147, People’s republic   of China   Tel +86 130 6238 1906   Fax +86 23 8886 0222   email zhouzhi_050918@hotmail.co mObjective:  To estimate the effect of arginine-containing desensitizing toothpaste on dentin  hypersensitivity (DH).",Non-OADS,/arxiv_data1/oa_pdf/7a/7f/ccide-8-001.PMC4708190.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/7a/7f/ccide-8-001.PMC4708190.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7a/7f/ccide-8-001.PMC4708190.pdf
"Available from: http://www.cochrane-handbook.or g. Accessed  November 25, 2015.",OADS,/arxiv_data1/oa_pdf/7a/7f/ccide-8-001.PMC4708190.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/c4/copd-11-061.PMC4708191.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2016:11 61–71International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  61OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9332 2Impact of individualized care on readmissions after  a hospitalization for acute exacerbation of COPD simon l adamson1 Jane Burns1,2 Pat g Camp1,2 Don D sin1,3 stephan F van eeden1,3 1The Centre for heart lung  Innovation, st Paul’s hospital,   University of British Columbia,   2Department of Physical Therapy,   3Division of respirology, Department  of Medicine, University of British  Columbia, Vancouver, BC, CanadaBackground:  Acute exacerbations of chronic obstructive pulmonary disease (AECOPD)  increase COPD morbidity and mortality and impose a great burden on health care systems.",Non-OADS,/arxiv_data1/oa_pdf/69/c4/copd-11-061.PMC4708191.pdf
"Keywords:  readmissions, care package, substance abuse, female, mortality Introduction Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are  characterized by a sudden worsening of patients’ respiratory symptoms such as shortness  of breath, cough, and sputum production1 and are defining events, which are associated  with increased COPD morbidity and mortality.2,3 These events also decrease quality of  life,4 accelerate the lung function decline,5 and are associated with significant health care  costs.6 Patients with COPD experience the greatest number of readmissions to acute  hospital care and the emergency room (ER) visits of any patient group, with more than  half of these readmissions due to COPD.7 Because of this, decreasing acute exacerba - tions and reducing readmissions remain the primary goals of COPD management.Correspondence: stephan F van eeden The Centre for heart lung Innovation,  st Paul’s hospital, University of British  Columbia, 1081 Burrard street,  Vancouver, BC V6Z1Y6, Canada Tel +1 604 806 8346 Fax +1 604 806 8351 email stephan.vaneeden@hli.ubc.c a Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Adamson et al Running head recto: Impact of individualized care on readmissions DOI: http://dx.doi.org/10.2147/COPD.S93322",Non-OADS,/arxiv_data1/oa_pdf/69/c4/copd-11-061.PMC4708191.pdf
Available from: https://www.thoracic.org/copd-guidelines/resources/ copddoc.pdf.,Non-OADS,/arxiv_data1/oa_pdf/69/c4/copd-11-061.PMC4708191.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/69/c4/copd-11-061.PMC4708191.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/c4/copd-11-061.PMC4708191.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/ef/copd-11-081.PMC4708192.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2016:11 81–90International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  81RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S8984 9Roflumilast: a review of its use in the treatment  of COPD Jadwiga A Wedzicha1 Peter MA Calverley2 Klaus F Rabe3,4 1Airways Disease Section, National  Heart and Lung Institute, Imperial  College London, London, 2Institute  of Ageing and Chronic Disease,   University of Liverpool, Liverpool, UK;   3Department of Internal Medicine,   Christian-Albrechts University, Kiel,   4Department of Pulmonary Medicine  and Medical Director, LungenClinic  Grosshansdorf, Airway Research  Centre North, German Centre  for Lung Research, Grosshansdorf,   GermanyAbstract:  COPD is a progressive condition involving chronic inflammation and parenchymal  destruction with resulting airflow limitation.",Non-OADS,/arxiv_data1/oa_pdf/03/ef/copd-11-081.PMC4708192.pdf
"Overall, the combined pathological defects of COPD translate to symptoms  of breathlessness, coughing, and variable sputum production that greatly impact a  patient’s quality of life.2 COPD is associated with an approximate 3.5-fold increase in the risk of death and  is linked to multiple comorbidities, including hypertension, heart failure, ischemic  heart disease, diabetes mellitus, myocardial infarction, osteoporosis, depression, Correspondence: Jadwiga A Wedzicha Respiratory Medicine, Airways Disease  Section, National Heart and Lung  Institute, Imperial College London, Guy  Scadding Building, Dovehouse Street,  London Sw3 6LY, UK Tel +44 20 7594 7947 email j.wedzicha@imperial.ac.u k Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Wedzicha et al Running head recto: Roflumilast in COPD DOI: http://dx.doi.org/10.2147/COPD.S89849",Non-OADS,/arxiv_data1/oa_pdf/03/ef/copd-11-081.PMC4708192.pdf
Avail - able from: http://www.thoracic.org/copd-guidelines/resources/copddoc.,Non-OADS,/arxiv_data1/oa_pdf/03/ef/copd-11-081.PMC4708192.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/03/ef/copd-11-081.PMC4708192.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/ef/copd-11-081.PMC4708192.pdf
"Available from: http://www.nhlbi.nih.gov/files/docs/ research/2012_ChartBook.pd f. Accessed January 23, 3015.",OADS,/arxiv_data1/oa_pdf/03/ef/copd-11-081.PMC4708192.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/44/ijn-11-147.PMC4708193.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2016:11 147–161International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  147OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8682 8size- and shape-dependent clinical and mycological  efficacy of silver nanoparticles on dandruff Mohammad F anwar1 Deepak Yadav2 swati Jain3 sumeet Kapoor4 shweta rastogi5 Indu arora6 Mohammed samim1 1Department of chemistry, Faculty of  science, 2Faculty of Medicine, Jamia  hamdard University, New Delhi,   3amity Institute of Nanotechnology,   amity University, Noida, Uttar  Pradesh, 4centre for Biomedical  engineering, Indian Institute of  T echnology, Delhi, 5Department  of chemistry, hans raj college,   6Department of Biomedical sciences,   rajguru college of applied sciences  for Women, University of Delhi, Delhi,   IndiaAbstract:  Dandruff is a prominent scalp problem caused by the growth of fungus Malassezia  furfur , potentially cascading into dermal inflammation, itching, and tissue damage.",Non-OADS,/arxiv_data1/oa_pdf/25/44/ijn-11-147.PMC4708193.pdf
"These antimicrobial agents  demonstrate antifungi and antiproliferative effects via disruption of either cellular correspondence: Mohammed samim Department of chemistry, Jamia  hamdard University, hamdard Nagar,  New Delhi 110062, India Tel +91 11 2605 9688 ext 5557 Fax +91 11 2605 9663 email shamim_chem@yahoo.co.i n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Anwar et al Running head recto: Clinical and mycological efficacy of silver nanoparticles on dandruff DOI: http://dx.doi.org/10.2147/IJN.S86828",Non-OADS,/arxiv_data1/oa_pdf/25/44/ijn-11-147.PMC4708193.pdf
Available from:  http://www.mycology.adelaide.edu.au/Mycoses/Superficial/ Malassezia_infections /.,Non-OADS,/arxiv_data1/oa_pdf/25/44/ijn-11-147.PMC4708193.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/25/44/ijn-11-147.PMC4708193.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/44/ijn-11-147.PMC4708193.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/0a/dddt-10-183.PMC4708194.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2016:10 183–203Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  183Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9722 1Baicalein attenuates the quorum sensing-controlled  virulence factors of Pseudomonas aeruginosa  and  relieves the inflammatory response in P. aeruginosa - infected macrophages by downregulating the  MaPK and nF κB signal-transduction pathways Jing luo* Jin-liang Kong* Bi-ying Dong  hong huang Ke Wang li-hong Wu chang-chun hou Yue liang Bing li Yi-qiang chen Department of respiratory Disease,   First affiliated hospital of guangxi  Medical University, nanning, People’s  republic of china *These authors contributed equally  to this workAbstract:  Burgeoning antibiotic resistance and unfavorable outcomes of inflammatory injury  after Pseudomonas aeruginosa  infection have necessitated the development of novel agents  that not only target quorum sensing (QS) but also combat inflammatory injury with the least  risk of resistance.",Non-OADS,/arxiv_data1/oa_pdf/c9/0a/dddt-10-183.PMC4708194.pdf
"Keywords:  baicalein, Pseudomonas aeruginosa , quorum sensing, virulence, inflammatory  cytokines, signal transduction Introduction Pseudomonas aeruginosa , an opportunistic Gram-negative bacillus, is a frequent  cause of hospital-acquired infections, including ventilator-associated pneumonia1 and  catheter infections in immunocompromised patients.2 The progressive deterioration of  the lungs due to chronic P. aeruginosa  infection and the resulting persistent inflam - mation are currently the main causes of morbidity and mortality in patients with cystic  fibrosis.3,4 P. aeruginosa  produces factors associated with intracellular communication  and extracellular virulence that are globally regulated by well-defined quorum-sensing  (QS) systems that determine bacterial pathogenesis.5 This regulatory system relies correspondence: Yi-qiang chen Department of respiratory Disease, First  Affiliated Hospital of Guangxi Medical  University, 6 shuangyong road, Qingxiu,  nanning, guangxi 530021, People’s  republic of china Tel/fax +86 771 535 0993 email chenyq2013@sohu.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Luo et al Running head recto: Effects of baicalein on P. aeruginosa  infection DOI: http://dx.doi.org/10.2147/DDDT.S97221",Non-OADS,/arxiv_data1/oa_pdf/c9/0a/dddt-10-183.PMC4708194.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c9/0a/dddt-10-183.PMC4708194.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/0a/dddt-10-183.PMC4708194.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3a/c1/ott-9-183.PMC4708195.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 183–190OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  183Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9699 9Expression and clinical significance of Nectin-4 in  hepatocellular carcinoma Jie Ma1,2,* ZhiY ong sheng3,* Yang lv4,* WenBin liu1,2 QiYang Yao1 TingTing Pan1 ZhiJun Xu1 chuanhai Zhang1,2 geliang Xu1,2 1anhui Province Key laboratory  of Hepatopancreatobiliary Surgery,   2Department of Hepatic Surgery,   Affiliated Provincial Hospital of Anhui  Medical University, Hefei, Anhui,   3Medical Center, University of Science  and T echnology of China; 4Department  of Plastic Surgery, The Second  Hospital of Anhui Medical University,   Hefei, Anhui, People’s Republic of  china *These authors contributed equally  to this workObjective:  Nectin-4 is a member of the Nectin family of four Ca+-independent  immunoglobulin-like cell adhesion molecules and implicated in cell adhesion, movement,  proliferation, differentiation, polarization, and survival.",Non-OADS,/arxiv_data1/oa_pdf/3a/c1/ott-9-183.PMC4708195.pdf
"Nectin is a family of four Ca+-independent immunoglobulin-like cell adhesion  molecules (Nectin-1 to 4), which contribute to cell–cell adhesion in a homotypic or  heterotypic manner and mediate several cellular behaviors, such as movement, prolif - eration, differentiation, polarization, survival, and the entry of viruses.5–10 All Nectins  share similar domain structure: an extracellular region with three immunoglobulin-like correspondence: geliang Xu anhui Province Key laboratory  of Hepatopancreatobiliary Surgery,  17 Lujiang Road, Hefei 230001,  People’s Republic of China Tel +86 551 6228 3740 Fax +86 551 6228 3740 Email xugeliang2014@126.comJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ma et al Running head recto: Expression and clinical significance of Nectin-4 DOI: http://dx.doi.org/10.2147/OTT.S96999",Non-OADS,/arxiv_data1/oa_pdf/3a/c1/ott-9-183.PMC4708195.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3a/c1/ott-9-183.PMC4708195.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/c1/ott-9-183.PMC4708195.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dd/3f/ijn-11-131.PMC4708196.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 131–145International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  131OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9477 7Injectable, degradable, electroactive nanocomposite  hydrogels containing conductive polymer  nanoparticles for biomedical applications Qinmei Wang1 Qiong Wang2 Wei T eng2 1laboratory of Biomaterials, Key  laboratory on assisted circulation,   Ministry of health, cardiovascular  Division, First affiliated hospital,   sun Yat-sen University, guangzhou,   People’s republic of china;   2Department of Prosthodontics,   hospital of stomatology, Institute of  stomatological research, guanghua  school of stomatology, sun Yat-sen  University, guangzhou, People’s  republic of chinaAbstract:  Injectable electroactive hydrogels (eGels) are promising in regenerative medicine and  drug delivery, however, it is still a challenge to obtain such hydrogels simultaneously possessing  other properties including uniform structure, degradability, robustness, and biocompatibility.",Non-OADS,/arxiv_data1/oa_pdf/dd/3f/ijn-11-131.PMC4708196.pdf
"Secondly, the injectability endows  hydrogels with many virtues such as improved patient compliance, facile adminis - tration via a minimally invasive mode, wide suitability for complex shapes of target correspondence: Wei Teng Department of Prosthodontics,  hospital of stomatology, Institute of  stomatological research, guanghua  school of stomatology, sun Yat-sen  University, 56 linyuanxi road,  guangzhou, guangdong 510600,  People’s republic of china Tel +86 20 8386 4039 email tengwei@mail.sysu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wang et al Running head recto: Injectable eGels for biomedical applications DOI: http://dx.doi.org/10.2147/IJN.S94777",Non-OADS,/arxiv_data1/oa_pdf/dd/3f/ijn-11-131.PMC4708196.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/dd/3f/ijn-11-131.PMC4708196.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/3f/ijn-11-131.PMC4708196.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/71/13/ott-9-171.PMC4708197.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 171–181OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  171Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9184 8The clinical pathological characteristics and  prognosis of FGFR1  gene amplification in non- small-cell lung cancer: a meta-analysis Fa-Jun Xie1,2 Hong-Yang Lu1,3 Qiu-Qing Zheng3 Jing Qin1,3 Yun Gao3 Yi-Ping Zhang1,3 Xun Hu2 Wei-Min Mao3,4 1Department of Medical Oncology,   Zhejiang Cancer Hospital, 2cancer  institute (Key laboratory for cancer  Intervention and Prevention, China  National Ministry of Education,   Zhejiang Provincial Key Laboratory  of Molecular Biology in Medical  sciences), second affiliated hospital,   Zhejiang University School of  Medicine,3Zhejiang Key Laboratory of  Diagnosis and Treatment T echnology  on Thoracic Oncology ( lung and  esophagus), hangzhou, 4Department  of Thoracic Surgery, Zhejiang Cancer  Hospital, Hangzhou, People’s Republic  of chinaAbstract:  FGFR1  amplification is recognized as a novel therapy target for non-small-cell  lung cancer (NSCLC), especially in squamous cell carcinoma (SCC).",Non-OADS,/arxiv_data1/oa_pdf/71/13/ott-9-171.PMC4708197.pdf
"FGFR1 has been recognized as one of the promising molecular targets for the  treatment of smoking-related lung cancer (SCC) providing a novel therapeutic target  for these tumors.5,6 FGFR1 is overexpressed by 10%–20% of lung cancer patients, and  is correlated with cigarette-smoking dosage and poor clinical outcomes in resected  SCC.7 FGFR1  gene amplification is often associated with FGFR overexpression, which  leads to ligand-independent signaling.6Correspondence: Wei-Min Mao Department of Thoracic surgery,  Zhejiang Cancer Hospital, 38 Guangji  Road, Banshanqiao, Hangzhou, Zhejiang  310022, People’s Republic of China Tel +86 571 8812 2182 Fax +86 571 8812 2181 email maowm1318@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xie et al Running head recto: FGFR1  gene amplification and NSCLC DOI: http://dx.doi.org/10.2147/OTT.S91848",Non-OADS,/arxiv_data1/oa_pdf/71/13/ott-9-171.PMC4708197.pdf
"If only Kaplan–Meier graphs were  published, the Kaplan–Meier curves were read by Engauge  Digitizer version 4.1 ( http://digitizer.sourceforge.ne t).",Non-OADS,/arxiv_data1/oa_pdf/71/13/ott-9-171.PMC4708197.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/71/13/ott-9-171.PMC4708197.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/13/ott-9-171.PMC4708197.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/47/clep-8-001.PMC4708198.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2016:8 1–5Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  1ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S9584 7Pilot study of participant-collected nasal swabs  for acute respiratory infections in a low-income,  urban population Celibell Y Vargas1 Liqun Wang1 Yaritza Castellanos de  Belliard1 Maria Morban 1 Hilbania Diaz1 Elaine L Larson2,3 Philip LaRussa1 Lisa Saiman1,4 Melissa S Stockwell1,5,6 1Department of Pediatrics, 2School  of Nursing, 3Department of  Epidemiology, Mailman School of  Public Health, Columbia University,   4Department of Infection Prevention  and Control, NewY ork-Presbyterian  Hospital, 5Department of Population  and Family Health, Mailman School of  Public Health, Columbia University,   6NewY ork-Presbyterian Hospital,    New Y ork, NY, USA Correspondence: Melissa S Stockwell   Department of Pediatrics, Division of  Child and Adolescent Health,   Columbia University, 622 W   168th Street, VC 417, New York,   NY 10032, USA   Tel +1 212 342 5732   Fax +1 212 305 8819   Email mss2112@columbia.ed uObjective:  To assess the feasibility and validity of unsupervised participant-collected nasal  swabs to detect respiratory pathogens in a low-income, urban minority population.",Non-OADS,/arxiv_data1/oa_pdf/af/47/clep-8-001.PMC4708198.pdf
Available from: http://www.huduser.,Non-OADS,/arxiv_data1/oa_pdf/af/47/clep-8-001.PMC4708198.pdf
"Available from: http://www.cdc.gov/nchs/data/series/ sr_10/sr10_260.pd f. Accessed May 2, 2015.",OADS,/arxiv_data1/oa_pdf/af/47/clep-8-001.PMC4708198.pdf
"Available  from: http://www.nyc.gov/html/dcp/html/neigh_info/mn12_info.shtm l.  Accessed May 2, 2015.",OADS,/arxiv_data1/oa_pdf/af/47/clep-8-001.PMC4708198.pdf
Available  from: http://pe.usps.com/widgets/hyperlinking/highlighted-viewserver.,Non-OADS,/arxiv_data1/oa_pdf/af/47/clep-8-001.PMC4708198.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/af/47/clep-8-001.PMC4708198.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4f/57/tcrm-12-041.PMC4708199.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 41–46Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  41ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9292 7Particulate matter is associated with sputum  culture conversion in patients with culture-positive  tuberculosis Kuan-Yuan Chen1,* Kai-Jen Chuang2,3,* hui-Chiao liu4,5 Kang-Yun lee1,6 Po-hao Feng1,6 Chien-ling su1,4 Chii-lan lin1,4 Chun-n in lee1,4 hsiao-Chi Chuang1,4 1Division of Pulmonary Medicine,   Department of internal Medicine,   shuang ho hospital, 2Department of  Public health, school of Medicine,   College of Medicine, 3school of Public  health, College of Public health and  nutrition, 4school of Respiratory  Therapy, College of Medicine, Taipei  Medical University, 5Division of  Pulmonary Medicine, Department  of internal Medicine, sijhih Cathay  general hospital, 6Department of  internal Medicine, school of Medicine,   College of Medicine, Taipei Medical  University, Taipei, Taiwan *These authors contributed equally  to the studyAbstract:  Emerging risk factors for tuberculosis (TB) infection, such as air pollution, play a  significant role at both the individual and population levels.",Non-OADS,/arxiv_data1/oa_pdf/4f/57/tcrm-12-041.PMC4708199.pdf
"A Taiwan cohort study further showed that expo - sure to outdoor fine particulate matter was associated with an increased risk of active  TB (adjusted hazard ratio =1.39 per 10 μg/m3).5 Jassal et al9 suggested that outdoor  fine particulate matter was associated with TB lung pathology and the prevalence of Correspondence: hsiao-Chi Chuang Taiwan CardioPulmonary Research  (T-CPR) group, school of Respiratory  Therapy, College of Medicine, Taipei  Medical University, no 250, Wuxing st,  Xinyi District, Taipei, Taiwan Tel +886 2 2736 1661 ext 3515 Fax +886 2 2739 1143 email r92841005@ntu.edu.t w Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Chen et al Running head recto: Delayed sputum culture conversion by PM10 DOI: http://dx.doi.org/10.2147/TCRM.S92927",Non-OADS,/arxiv_data1/oa_pdf/4f/57/tcrm-12-041.PMC4708199.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/4f/57/tcrm-12-041.PMC4708199.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/57/tcrm-12-041.PMC4708199.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/prbm-9-001.PMC4708200.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2016:9 1–6Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  1ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PRBM.S9417 7impact of stress and levels of corticosterone   on the development of breast cancer in rats José María De la Roca- chiapas1 gloria Barbosa-sabanero2 Jorge antonio Martínez- garcía3 Joel Martínez-soto1 Víctor Manuel Ramos- Frausto1 leivy Patricia gonzález- Ramírez1 Ken nowack4 1Department of Psychology,   2Department of Medical sciences,   Division of health sciences, campus  leon-University of guanajuato,   guanajuato,  3general Regional  hospital of leon, guanajuato, Mexico;   4envisia learning, inc., santa Monica,   ca, Usa correspondence: José María De la Roca- chiapas   Department of Psychology, Division  of health sciences, campus león- Universidad de guanajuato, Blvd.",Non-OADS,/arxiv_data1/oa_pdf/a7/7e/prbm-9-001.PMC4708200.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/a7/7e/prbm-9-001.PMC4708200.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/prbm-9-001.PMC4708200.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/36/ijn-11-121.PMC4708214.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2016:11 121–130International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  121RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S8403 5Recent insights into the biological activities  and drug delivery systems of tanshinones Yuee Cai1,* wenji Zhang2,* Zirong Chen3 Zhi Shi1,2 Chengwei He1 Meiwan Chen1 1State Key Laboratory of Quality  Research in Chinese Medicine,  Institute of Chinese Medical Sciences,  University of Macau, Macau, People’s  Republic of China; 2Department of Cell  Biology & Institute of Biomedicine,  National engineering Research Center  of Genetic Medicine, Guangdong  Provincial Key Laboratory of  Bioengineering Medicine, College of Life  Science and T echnology, Jinan University,  Guangzhou, Guangdong, People’s  Republic of China; 3Department of  Molecular Genetics and Microbiology,  Shands Cancer Center, University of  Florida, Gainesville, FL, USA *These authors contributed equally  to this workAbstract:  Tanshinones, the major lipid-soluble pharmacological constituents of the Chinese  medicinal herb Tanshen ( Salvia miltiorrhiza ), have attracted growing scientific attention because  of the prospective biomedical applications of these compounds.",Non-OADS,/arxiv_data1/oa_pdf/cf/36/ijn-11-121.PMC4708214.pdf
"Finally, we make a conclusion of our  personal perspectives on the directions for developing tanshinone.Correspondence: Meiwan Chen State Key Laboratory of Quality Research  in Chinese Medicine, Institute of Chinese  Medical Sciences, University of Macau,  Avenida da Universidade, Taipa, Macau,  People’s Republic of China Tel +853 8822 4675 Fax +853 2884 1358 email mwchen@umac.m o Zhi Shi Department of Cell Biology & Institute  of Biomedicine, National engineering  Research Center of Genetic Medicine,  Guangdong Provincial Key Laboratory of  Bioengineering Medicine, College of Life  Science and Technology, Jinan University,  601 Huangpu Avenue west, Guangzhou  510632, People’s Republic of China Tel +86 20 8522 4525 Fax +86 20 8522 5977 email tshizhi@jnu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Cai et al Running head recto: Biological activities and drug delivery systems of tanshinones DOI: http://dx.doi.org/10.2147/IJN.S84035",Non-OADS,/arxiv_data1/oa_pdf/cf/36/ijn-11-121.PMC4708214.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cf/36/ijn-11-121.PMC4708214.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/36/ijn-11-121.PMC4708214.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8a/8f/dddt-10-163.PMC4708225.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 163–182Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  163Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9145 5Design and evaluation of novel interferon lambda  analogs with enhanced antiviral activity and  improved drug attributes Debin Yu1 Mingzhi Zhao2 liwei Dong1 lu Zhao1 Mingwei Zou3 hetong sun4 Mengying Zhang4 hongyu liu4 Zhihua Zou1 1national engineering laboratory  for aiDs Vaccine, Key laboratory  for Molecular enzymology and  engineering of the Ministry of  education, school of life sciences,   Jilin University, changchun, 2state Key  laboratory of Proteomics, national  engineering research center for  Protein Drugs, Beijing Proteome  research center, Beijing institute of  radiation Medicine, Beijing, People’s  republic of china; 3Department  of Psychology, college of liberal  arts and social sciences, University  of houston, houston, TX, Usa; 4Prosit  sole Biotechnology, co., ltd., Beijing,   People’s republic of chinaAbstract:  Type III interferons (IFNs) (also called IFN- λ: IFN-λ1, IFN-λ2, IFN-λ3, and IFN- λ4)  are critical players in the defense against viral infection of mucosal epithelial cells, where the  activity of type I IFNs is weak, and unlike type I IFNs that are associated with severe and diverse  side effects, type III IFNs cause minimal side effects due to the highly restricted expression  of their receptors, and thus appear to be promising agents for the treatment and prevention of  respiratory and gastrointestinal viral infection.",Non-OADS,/arxiv_data1/oa_pdf/8a/8f/dddt-10-163.PMC4708225.pdf
"All class II  cytokines are characterized by an α-helical fold consisting of six helices labeled A to F.  The structural core is a compact four-helix bundle composed of helices A, C, D, and F.  Class II cytokines initiate their activities by binding to heterodimeric class II cytokine correspondence: Zhihua Zou national engineering laboratory for  aiDs Vaccine, Key laboratory for  Molecular enzymology and engineering of  the Ministry of education, school of life  sciences, Jilin University, 2699 Qianjin  street, changchun, Jilin Province 130012,  People’s republic of china Tel +86 431 8515 5349 email zouzh@jlu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Yu et al Running head recto: Novel interferon lambda analogs with enhanced antiviral activity DOI: http://dx.doi.org/10.2147/DDDT.S91455",Non-OADS,/arxiv_data1/oa_pdf/8a/8f/dddt-10-163.PMC4708225.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8a/8f/dddt-10-163.PMC4708225.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/8f/dddt-10-163.PMC4708225.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/17/3f/ott-9-159.PMC4708240.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 159–170OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  159Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9698 3The role of induction and adjuvant chemotherapy in  combination with concurrent chemoradiotherapy  for nasopharyngeal cancer: a Bayesian network  meta-analysis of published randomized  controlled trials hongliang Yu1,* Dayong gu1,* Xia he1 Xianshu gao2 Xiuhua Bian1 1Department of radiation Oncology,   Jiangsu cancer hospital affiliated  with n anjing Medical University,   nanjing, 2Department of radiation  Oncology, Peking University First  hospital, Peking University, Beijing,   People’s  republic of china *These authors contributed equally  to this workAbstract:  Whether the addition of induction chemotherapy (IC) or adjuvant chemotherapy  (AC) to concurrent chemoradiotherapy (CCRT) is superior to CCRT alone for locally advanced  nasopharyngeal cancer is unknown.",Non-OADS,/arxiv_data1/oa_pdf/17/3f/ott-9-159.PMC4708240.pdf
"With the purpose of further improving the treatment efficacy correspondence: Xiuhua Bian Department of radiation Oncology,  Jiangsu Cancer Hospital affiliated with  nanjing Medical University, 42 Baiziting,  Xuanwu District, nanjing, Jiangsu 210009,  People’s republic of china email yhllove1@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Yu et al Running head recto: Role of chemotherapy in treatment for NPC DOI: http://dx.doi.org/10.2147/OTT.S96983",Non-OADS,/arxiv_data1/oa_pdf/17/3f/ott-9-159.PMC4708240.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/17/3f/ott-9-159.PMC4708240.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/3f/ott-9-159.PMC4708240.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/24/dddt-10-155.PMC4708241.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2016:10 155–162Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  155Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9527 5Isolation and evaluation of biological efficacy of  quercetol in human hepatic carcinoma cells huma ali1 savita Dixit1 Daoud ali2 abdullah a alkahtane2 saud alarifi2 Bahy a ali2,3 saad alkahtani2 1Department of chemistry, Maulana  azad national institute of T echnology,   Bhopal, Madhya Pradesh, india;   2Department of Zoology, college of  science, King saud University, riyadh,   saudi arabia; 3Department of nucleic  acids research, genetic engineering  and Biotechnology research institute,   city science research and Technology  application, alexandria, egyptAbstract:  Quercetol is a polyphenolic molecule present in vegetables and fruits, and is beneficial  to human and animal health.",Non-OADS,/arxiv_data1/oa_pdf/a1/24/dddt-10-155.PMC4708241.pdf
"Scambia et al15 reported anti-proliferative  effects of quercetol in cancer cells.correspondence: huma ali Department of chemistry, Maulana  azad national institute of Technology,  link road number 3, Bhopal,  Madhya Pradesh 462003, india email humali.manit@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Ali et al Running head recto: Quercetol-induced DNA damage to HepG2 cells DOI: http://dx.doi.org/10.2147/DDDT.S95275",Non-OADS,/arxiv_data1/oa_pdf/a1/24/dddt-10-155.PMC4708241.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a1/24/dddt-10-155.PMC4708241.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/24/dddt-10-155.PMC4708241.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/d4/ijn-11-163.PMC4708242.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2016:11 163–177International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  163OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9159 6Effect of ultrafine poly( ε-caprolactone) fibers on  calcium phosphate cement: in vitro degradation  and in vivo  regeneration Boyuan Yang1 Yi Zuo1 Qin Zou1 limei li1 Jidong li1 Yi Man2 Yubao Li1 1research center for Nano  Biomaterials, Analytical and Testing  Center, Sichuan University, Chengdu,   People’s Republic of China; 2state  Key Laboratory of Oral Disease,   West China Hospital of Stomatology,   Sichuan University, Chengdu, People’s  Republic of ChinaAbstract:  We incorporated ultrafine polymer fibers into calcium phosphate cement (CPC)  to improve the resorption rate of CPC with fiber degradation.",Non-OADS,/arxiv_data1/oa_pdf/a1/d4/ijn-11-163.PMC4708242.pdf
"Fiber reinforcement of CPC is the most successful  approach to toughen this brittle material.1 Various fibers have already been used for  such a purpose, such as ceramic fibers (eg, carbon or glass fibers), nonresorbable poly - mer fibers, and resorbable polymer fibers (eg, polylactide, polyglycolide/polylactide  copolymers, poly- ε-caprolactone [PCL], etc).7 When bioresorbable or biodegradable  fibers are used, this will not only contribute to the initial mechanical strength, but also Correspondence: Yi Zuo; Yubao Li research center for Nano Biomaterials,  Sichuan University, 29 Jiuyanqiao  Wangjiang road, chengdu 610064,  People’s Republic of China Tel +86 28 8541 8178 Fax +86 28 8541 7273 email zoae@scu.edu.c n;   nic7504@scu.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y ang et al Running head recto: Effect of ultrafine PCL fibers on CPC cement: degradation and regeneration DOI: http://dx.doi.org/10.2147/IJN.S91596",Non-OADS,/arxiv_data1/oa_pdf/a1/d4/ijn-11-163.PMC4708242.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a1/d4/ijn-11-163.PMC4708242.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/d4/ijn-11-163.PMC4708242.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .,Non-OADS,/arxiv_data1/oa_pdf/87/3b/nihms749020.PMC4708267.pdf
Please see the supplementary material for more details (available online at http://cms.sagepub.com).,Non-OADS,/arxiv_data1/oa_pdf/c4/20/10.1177_1203475415597094.PMC4708614.pdf
Supplementary material for this article is available on the Journal of  Biomolecular Screening Web site at http://jbx.sagepub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/07/79/10.1177_1087057115613270.PMC4708616.pdf
"Assay Guidance Manual; Eli Lilly & Company and the National Center for Advancing Translational Sciences: Bethesda, MD, 2004. http://www.ncbi.nlm.nih.gov/books/NBK53196/  28.",Non-OADS,/arxiv_data1/oa_pdf/07/79/10.1177_1087057115613270.PMC4708616.pdf
"Definition palliative care, http://www.who.int/cancer/palliative/definition/en/ (accessed 21 August 2014).",Non-OADS,/arxiv_data1/oa_pdf/16/36/10.1177_0269216315601930.PMC4708617.pdf
"Global atlas of palliative care at the end of life, http://www.who.int/nmh/Global_Atlas_of_Palliative_Care.pdf (2014, accessed August 2014).",Non-OADS,/arxiv_data1/oa_pdf/16/36/10.1177_0269216315601930.PMC4708617.pdf
"Lyon: International Agency for Research on Cancer, http://globocan.iarc.fr (2013, accessed August 2014).",Non-OADS,/arxiv_data1/oa_pdf/16/36/10.1177_0269216315601930.PMC4708617.pdf
"Carers UK, London, May 2011, http://circle.leeds.ac.uk/files/2012/08/110512-circle-carers-uk-valuing-carers.pdf    9.",Non-OADS,/arxiv_data1/oa_pdf/16/36/10.1177_0269216315601930.PMC4708617.pdf
"London: NCPC, 2012. http://www.ncpc.org.uk/sites/default/files/Who_Cares_Conference_Report.pdf   10.",Non-OADS,/arxiv_data1/oa_pdf/16/36/10.1177_0269216315601930.PMC4708617.pdf
Supplementary material for this article is available on the Journal of  Biomolecular Screening Web site at http://jbx.sagepub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/45/09/10.1177_1087057115609564.PMC4708621.pdf
Available at: http://www.ohri.ca/programs/clinical_   epidemiology/nosgen.pdf 2012 January 18 (accessed 18 January 2012).,Non-OADS,/arxiv_data1/oa_pdf/38/b9/10.1177_0269215515575334.PMC4708622.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/82/jaa-9-001.PMC4708874.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Asthma and Allergy 2016:9 1–12Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  1OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S9797 3Predicting frequent asthma exacerbations using  blood eosinophil count and other patient data  routinely available in clinical practice David Price1,2 Andrew M Wilson3 Alison chisholm4 Anna rigazio2 Anne Burden2 Michael Thomas5 christine King2 1centre for Academic Primary care,   The institute of Applied health  sciences, University of Aberdeen,   Aberdeen, 2research in real-life,   cambridge, 3norwich Medical school,   University of east Anglia, norwich,    4respiratory effectiveness group,   cambridge, 5Primary Medical  care, University of southampton,   southampton, UK correspondence: David Price   centre for Academic Primary care, The  institute of Applied health sciences,  University of Aberdeen, Polwarth Building,  Foresterhill, Aberdeen AB25 2ZD, UK   T el +44 1224 55 4588   Fax +44 1224 55 0683   email david@respiratoryresearch.or gPurpose:  Acute, severe asthma exacerbations can be difficult to predict and thus prevent.",Non-OADS,/arxiv_data1/oa_pdf/a3/82/jaa-9-001.PMC4708874.pdf
http://dx.doi.org/10.1016/S2213- 2600(15)00367- 7.,OADS,/arxiv_data1/oa_pdf/a3/82/jaa-9-001.PMC4708874.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/a3/82/jaa-9-001.PMC4708874.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/82/jaa-9-001.PMC4708874.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/65/nss-8-009.PMC4708875.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNature and Science of Sleep 2016:8 9–20Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  9Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S6236 5Metabolic signals in sleep regulation: recent  insights Charu Shukla Radhika Basheer Department of Psychiatry, vA Boston  Healthcare System, Harvard Medical  School, west Roxbury, MA, USA Correspondence: Radhika Basheer   Department of Psychiatry, vA Boston  Healthcare System, Harvard Medical  School,  1400 vFw Parkway, west  Roxbury, MA  02132, USA   Tel +1 857 203 6181  Fax +1 857 203 5592  email r adhika_ basheer@hms.harvard.ed uAbstract:  Sleep and energy balance are essential for health.",Non-OADS,/arxiv_data1/oa_pdf/f3/65/nss-8-009.PMC4708875.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/f3/65/nss-8-009.PMC4708875.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/65/nss-8-009.PMC4708875.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7e/d6/oajsm-7-005.PMC4708876.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2016:7 5–10Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  5OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S9304 7What is the most effective posture to conduct  vibration from the lower to the upper extremities  during whole-body vibration exercise?,Non-OADS,/arxiv_data1/oa_pdf/7e/d6/oajsm-7-005.PMC4708876.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/7e/d6/oajsm-7-005.PMC4708876.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/d6/oajsm-7-005.PMC4708876.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/1e/mder-9-011.PMC4708877.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2016:9 11–18Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  11REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S5922 9NovoPen Echo® insulin delivery device Jacob Hyllested-winge1 Thomas Sparre2 Line Kynemund Pedersen2 1Novo Nordisk Pharma Ltd, T okyo,   Japan; 2Novo Nordisk A/S, Søborg,   Denmark Correspondence: Jacob Hyllested-winge   Novo Nordisk Pharma Ltd, Meiji Yasuda  Seimei Building, 2-1-1, Marunouchi,  Chiyoda-ku, Tokyo 100-0005, Japan   Tel +81 3 6266 1000   Email jhyw @novonordisk.co mAbstract:  The introduction of insulin pen devices has provided easier, well-tolerated, and more  convenient treatment regimens for patients with diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/5a/1e/mder-9-011.PMC4708877.pdf
Available from: http://www.novonordisk.,OADS,/arxiv_data1/oa_pdf/5a/1e/mder-9-011.PMC4708877.pdf
"Available from:  http://www.novonordisk.com/patients/diabetes-care/insulin-pens-and- needles/novotwist/news/news-new-needle-designed-for-simplicity- april2009.htm l. Accessed September 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5a/1e/mder-9-011.PMC4708877.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/5a/1e/mder-9-011.PMC4708877.pdf
"Available from: http://www.novonordisk.com/ patients/diabetes-care/insulin-pens-and-needles/innolet.htm l. Accessed  July 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5a/1e/mder-9-011.PMC4708877.pdf
Available from: http://www.novonordisk.,OADS,/arxiv_data1/oa_pdf/5a/1e/mder-9-011.PMC4708877.pdf
Available from: http://press.novonordisk-us.,Non-OADS,/arxiv_data1/oa_pdf/5a/1e/mder-9-011.PMC4708877.pdf
Available from: http://online.liebertpub.com/ doi/pdf/10.1089/dia.2015.152 5.,Non-OADS,/arxiv_data1/oa_pdf/5a/1e/mder-9-011.PMC4708877.pdf
"Available from: http://starsystem.sanofi.ca/ collections/insulinpen s. Accessed October 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5a/1e/mder-9-011.PMC4708877.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in a ny medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/d3/rrv041.PMC4708909.pdf
"METHODS A Geographic Information System (GIS) mapping program (ArcMap 9.1, ESRI Inc., 380 New York Street, Redlands, CA 92373-8100,1-909-793-2853, http://www.esri.com ) was used to map several data- sets relating to uranium deposits and radon concentrations in SouthDakota.",OADS,/arxiv_data1/oa_pdf/40/d3/rrv041.PMC4708909.pdf
"Mineral Resources Data System: U.S. Geological Survey, Reston, Virginia .http://mrdata.usgs.",OADS,/arxiv_data1/oa_pdf/40/d3/rrv041.PMC4708909.pdf
"Reformatted data from the National Uranium Resource Evaluation (NURE)Hydrogeochemical and Stream Sediment Reconnaissance (HSSR)Program, Version 1.30: U.S. Geological Survey Open-File Report97–492, WWW release only, URL: http://greenwood.cr.usgs.",OADS,/arxiv_data1/oa_pdf/40/d3/rrv041.PMC4708909.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/ec/rrv051.PMC4708911.pdf
"http://www.c-technol.co.jp/eng (5 June 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e6/ec/rrv051.PMC4708911.pdf
"Results of the (i) ﬁfth airborne monitoring survey and (ii) airborne monitoring survey outside 80 km from the Fukushima Dai-ichi NPPTokyo .http://radioactivity.nsr.go.jp/en/contents/6000/5790/24/ 203_0928_14e.pdf (5 June 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/e6/ec/rrv051.PMC4708911.pdf
"monitoring out of the 80 km from the Fukushima Dai-ichi NPP Tokyo .http://radioactivity.nsr.go.jp/en/contents/7000/6099/24/ 203_e_0301_18.pdf (5 June 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e6/ec/rrv051.PMC4708911.pdf
"Japan Pro ﬁle for Geographic Information Standards Tokyo .http://www.gsi.go.jp/ ENGLISH/page_e30210.html (5 June 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e6/ec/rrv051.PMC4708911.pdf
"Measurement results of radiationmonitoring action plan for supporting restoration of the formerevacuation-prepared area in case of emergency (Minamisoma city, Tamura city, Kawauchi village) .http://radioactivity.nsr.go.jp/ja/ contents/6000/5677/24/348_0706.pdf (5 June 2015, date last accessed) (in Japanese).",OADS,/arxiv_data1/oa_pdf/e6/ec/rrv051.PMC4708911.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/b0/rrv059.PMC4708915.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/aa/rrv071.PMC4708922.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/77/dddt-10-117.PMC4708959.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 117–128Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  117Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9590 5self-emulsifying drug delivery systems as a tool to  improve solubility and bioavailability of resveratrol gehan F Balata1 ebtessam a essa1,2 hanan a shamardl3,5 samira h Zaidan4 Mohammed as abourehab1,6 1Department of Pharmaceutics,   Faculty of Pharmacy, Umm al-Qura  University, Makkah, saudi arabia;   2Department of Pharmaceutics,   Faculty of Pharmacy, Tanta University,   Tanta, egypt; 3Department of  Pharmacology, 4Department of  Pharmacognosy, Faculty of Pharmacy,   Umm al-Qura University, Makkah,   saudi arabia; 5Department of  Pharmacology, Faculty of Medicine,   el Fayoom University, 6Department of  Pharmaceutics, Faculty of Pharmacy,   el-Minia University, egyptAbstract:  Resveratrol is a nonflavonoid polyphenolic compound which has a broad range  of desirable biological actions which include antioxidant, anti-inflammatory, antidiabetic,  cardioprotective, and antitumor activities.",Non-OADS,/arxiv_data1/oa_pdf/5e/77/dddt-10-117.PMC4708959.pdf
"In this context, a compound reducing blood glucose correspondence: gehan F Balata Faculty of Pharmacy, Umm al-Qura  University, el-abdia, Makkah, saudi  arabia Tel +966 5 4184 1800 Fax +966 2 550 7042 4225 email jfsyed@uqu.edu.s a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Balata et al Running head recto: Self emulsifying system of resveratrol DOI: http://dx.doi.org/10.2147/DDDT.S95905",Non-OADS,/arxiv_data1/oa_pdf/5e/77/dddt-10-117.PMC4708959.pdf
Available from:  http://www.toxicology.org/AI/FA/guidingprinciples.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5e/77/dddt-10-117.PMC4708959.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5e/77/dddt-10-117.PMC4708959.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/77/dddt-10-117.PMC4708959.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/23/ndt-12-057.PMC4708960.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 57–67Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  57Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S9639 2Long-term outcomes of antipsychotic treatment  in patients with first-episode schizophrenia: a  systematic review Correspondence: Craig Karson CNK Consultants, 220 Macfarlane Drive  #405, Delray Beach, FL 33483, USA Tel +1 617 388 4231 Fax +1 561 278 8288 email brainiacle520@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Karson et al Running head recto: Early schizophrenia treatment – systematic review DOI: http://dx.doi.org/10.2147/NDT.S9639 2 Craig Karson1 Ruth A Duffy2 Anna eramo3 Anna-Greta Nylander4 Steve J Offord5 1CNK Consultants, Delray Beach,   FL, 2Medical Affairs – Neuroscience,   Otsuka America Pharmaceutical,   inc., Princeton, NJ, 3Medical Affairs &  Phase iv Clinical Affairs, Lundbeck  LLC, Deerfield, iL, USA; 4Medical  Affairs Aripiprazole, H Lundbeck  A/S, valby, Denmark; 5Medical Affairs,   Otsuka America Pharmaceutical, inc.,   Princeton, NJ, USABackground:  Treatment during first-episode psychosis (FEP) or early schizophrenia may  affect the rates of relapse and remission, as well as cognitive functioning, over time.",Non-OADS,/arxiv_data1/oa_pdf/84/23/ndt-12-057.PMC4708960.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/84/23/ndt-12-057.PMC4708960.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/23/ndt-12-057.PMC4708960.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/29/dddt-10-129.PMC4708961.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2016:10 129–139Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  129Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9631 5Design, synthesis, and antihypertensive activity of  curcumin-inspired compounds via ace inhibition  and vasodilation, along with a bioavailability study  for possible benefit in cardiovascular diseases Xiao-dong Zhuang1,* li-zhen liao2,* Xiao-bian Dong1 Xun hu1 Yue guo1 Zhi-min Du1 Xin-xue liao1 li-chun Wang1 1Department of cardiology, First  affiliated hospital, sun Yat-sen  University, guangzhou, People’s  republic of china; 2Department of  health, guangdong Pharmaceutical  University, guangzhou higher  education Mega center, guangzhou,   People’s republic of china *These authors contributed equally  to this workAbstract:  This study describes the synthesis of a novel series of curcumin-inspired compounds  via a facile synthetic route.",Non-OADS,/arxiv_data1/oa_pdf/e7/29/dddt-10-129.PMC4708961.pdf
"Thus, its inhibition lowers blood pressure  and the amount of energy required for the heart to maintain normal blood circulation.5correspondence: li-chun Wang;   Xin-xue liao Department of Cardiology, First Affiliated  hospital, sun Yat-sen University, no 58,  2nd Zhongshan road, guangzhou  510080, People’s republic of china Tel +86 20 8733 2200 Fax +86 20 8733 2200 email wlc-lichun@hotmail.co m;  liaoxinxue6371@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zhuang et al Running head recto: Curcumin like derivatives as antihypertensive agents DOI: http://dx.doi.org/10.2147/DDDT.S96315",Non-OADS,/arxiv_data1/oa_pdf/e7/29/dddt-10-129.PMC4708961.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e7/29/dddt-10-129.PMC4708961.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/29/dddt-10-129.PMC4708961.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/60/dddt-10-141.PMC4708962.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2016:10 141–153Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  141Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9359 9Discovery of a novel anticancer agent with  both anti-topoisomerase i and ii activities in  hepatocellular carcinoma sK-hep-1 cells in vitro  and in vivo: Cinnamomum verum  component  2-methoxycinnamaldehyde Daw-shyong Perng1 Yu-hsin Tsai2 Jonathan cherng3 Jeng-shing Wang4 Kuo-shen chou5 chia-Wen shih6 Jaw-Ming cherng7 1Department of gastroenterology,   e-Da hospital, i-shou University,   Kaohsiung, Taiwan, republic of  china; 2sierra college, rocklin, ca,   Usa; 3Faculty of Medicine, Medical  University of lublin, lublin, Poland;   4Department of internal Medicine,   antai Tian-sheng Memorial hospital,   Pingtung, 5Department of Family  Medicine, saint Mary’s hospital  luodong, 6Department of Pathology,   lotung Poh-ai hospital, 7Department  of internal Medicine, saint Mary’s  hospital luodong, Yilan, Taiwan,   republic of chinaAbstract:  Cinnamomum verum  is used to make the spice cinnamon and has been used as  a traditional Chinese herbal medicine for various applications.",Non-OADS,/arxiv_data1/oa_pdf/9d/60/dddt-10-141.PMC4708962.pdf
"The bark of this plant is used  to make the spice cinnamon and has long been used as a traditional Chinese herbal correspondence: Jaw-Ming cherng Department of internal Medicine,  saint Mary’s hospital, luodong,  Yilan, Taiwan, rOc Tel +886 3 938 8652 Fax +886 3 957 5653 email happy.professor@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Perng et al Running head recto: Tumor suppression effect of 2-MCA in SK-Hep-1 cells DOI: http://dx.doi.org/10.2147/DDDT.S93599",Non-OADS,/arxiv_data1/oa_pdf/9d/60/dddt-10-141.PMC4708962.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9d/60/dddt-10-141.PMC4708962.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/60/dddt-10-141.PMC4708962.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/ee/nihms748990.PMC4709126.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, three figures, and one table and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2015.08.079 .",OADS,/arxiv_data1/oa_pdf/1d/ee/nihms748990.PMC4709126.pdf
"Krajowy Rejestr Nowotworów (National Cancer Register), http://onkologia.org.pl/nowotwory-zlosliwe-ogolem-2/, 10.08.2014, 11:01.",Non-OADS,/arxiv_data1/oa_pdf/38/87/WO-19-25988.PMC4709399.pdf
15. http://seer.cancer.gov/statfacts/html/colorect.html.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/WO-19-26228.PMC4709405.pdf
16. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/ bowel/survival/bowel-cancer-survival-statistics#one.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/WO-19-26228.PMC4709405.pdf
17.http://www.kreftregisteret.no/Global/Cancer%20in%20Nor - way/2012/CIN_2012-web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e2/dd/WO-19-26228.PMC4709405.pdf
Available at: http://clinicaltrials.gov/ct2/show/NCT01751451  10.,Non-OADS,/arxiv_data1/oa_pdf/5f/2d/WO-19-26455.PMC4709406.pdf
available at: http://www.accessdata.fda.gov/drug-satfda_docs/label/2011/202379lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/2d/WO-19-26455.PMC4709406.pdf
"In the future, various combination drugs will emerge for treating cross-risk fac-tors, reducing pill burden and price, and eventually pre-venting and curing ED.pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 123-124 http://dx.doi.org/10.5534/wjmh.2015.33.3.123",Non-OADS,/arxiv_data1/oa_pdf/7c/ee/wjmh-33-123.PMC4709427.pdf
"In addition, investigators have studied whether testosterone supple-mentation is associated with risk of prostate cancer in-cidence, progression, or recurrence.pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 125-129 http://dx.doi.org/10.5534/wjmh.2015.33.3.125",Non-OADS,/arxiv_data1/oa_pdf/bc/af/wjmh-33-125.PMC4709428.pdf
"In this large cohort, T or other androgen prescriptions increased more than threefold, from 0.81% in 2001 to 2.91% in pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 130-142 http://dx.doi.org/10.5534/wjmh.2015.33.3.130",Non-OADS,/arxiv_data1/oa_pdf/95/dd/wjmh-33-130.PMC4709429.pdf
Available from:  http://www.fda.gov/Drugs/DrugSafety/ucm436259.htm.,Non-OADS,/arxiv_data1/oa_pdf/95/dd/wjmh-33-130.PMC4709429.pdf
"While many studies have reported a negative impact of smoking on se-men analysis parameters and male infertility [7-10], others have found no such effects, and in some cases, have even pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 143-160  http://dx.doi.org/10.5534/wjmh.2015.33.3.143",Non-OADS,/arxiv_data1/oa_pdf/ea/76/wjmh-33-143.PMC4709430.pdf
"Therefore, we per- formed a literature review to identify individualized treat-pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 161-166 http://dx.doi.org/10.5534/wjmh.2015.33.3.161",Non-OADS,/arxiv_data1/oa_pdf/1e/37/wjmh-33-161.PMC4709431.pdf
Dyslipidemia has been estab-pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 167-173 http://dx.doi.org/10.5534/wjmh.2015.33.3.167,Non-OADS,/arxiv_data1/oa_pdf/d8/2b/wjmh-33-167.PMC4709432.pdf
"Key Words:  Endothelium; Erectile dysfunction; Plethysmography INTRODUCTION 　Endothelial function is known to be impaired in patients with chronic pathologic conditions, including coronary  artery disease, diabetes mellitus, hypertension, obesity, renal failure, impaired lipid profiles, and erectile dysfunc-pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 174-181 http://dx.doi.org/10.5534/wjmh.2015.33.3.174",Non-OADS,/arxiv_data1/oa_pdf/6c/c4/wjmh-33-174.PMC4709433.pdf
Acute urinary retention (AUR) is a serious and common pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 182-187 http://dx.doi.org/10.5534/wjmh.2015.33.3.182,Non-OADS,/arxiv_data1/oa_pdf/5e/cf/wjmh-33-182.PMC4709434.pdf
Prostate biopsy is the most common procedure used to pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 188-193 http://dx.doi.org/10.5534/wjmh.2015.33.3.188,Non-OADS,/arxiv_data1/oa_pdf/05/ba/wjmh-33-188.PMC4709435.pdf
In addition to the oncologic outcome after radical prostatec-pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 194-201 http://dx.doi.org/10.5534/wjmh.2015.33.3.194,Non-OADS,/arxiv_data1/oa_pdf/5b/c6/wjmh-33-194.PMC4709436.pdf
Key Words:  Cross-linked dextran; Filler; Penile  enhancement; Polymethyl methacrylatepISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 202-208 http://dx.doi.org/10.5534/wjmh.2015.33.3.202,Non-OADS,/arxiv_data1/oa_pdf/fb/96/wjmh-33-202.PMC4709437.pdf
Available  from: http://www.artefil.,Non-OADS,/arxiv_data1/oa_pdf/fb/96/wjmh-33-202.PMC4709437.pdf
"In this regard, the lack of data obtained di-pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2015 December 33(3): 209-213 http://dx.doi.org/10.5534/wjmh.2015.33.3.209",Non-OADS,/arxiv_data1/oa_pdf/5a/be/wjmh-33-209.PMC4709438.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/3d/rjv173.PMC4709458.pdf
Trial registration: http://clinicaltrials.gov (identi ﬁer NCT00135551) and http://www.umin.ac.jp/ ctr/index-j.htm (UMIN000001152).,Non-OADS,/arxiv_data1/oa_pdf/74/b7/hr2015104a.PMC4709460.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/4.0/ Supplementary Information accompanies the paper on Hyp ertension Research website (http://www.nature.com/hr)CCB-based combinations and BP variability SU m e m o t o et al 53 Hypertension Research",Non-OADS,/arxiv_data1/oa_pdf/74/b7/hr2015104a.PMC4709460.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ca/56/tom85.PMC4709465.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2015.00157 TOMOGRAPHY.ORG | VOLUME 1 NUMBER 2 |DECEMBER 2015 85,Non-OADS,/arxiv_data1/oa_pdf/ca/56/tom85.PMC4709465.pdf
Supplemental Materials: Video: http://tiny.cc/tom-01-02-s003 ACKNOWLEDGMENTS This study was supported by National Institutes of Health grants P41EB015894 and S10RR026783 and the W.M.,Non-OADS,/arxiv_data1/oa_pdf/ca/56/tom85.PMC4709465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/db/main.PMC4709468.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.12.050 2049-0801/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/17/db/main.PMC4709468.pdf
Available at: http://www.jco.org/cgi/doi/10.1200/JCO.2006.08.8575 .,Non-OADS,/arxiv_data1/oa_pdf/17/db/main.PMC4709468.pdf
"(2012), http://dx.doi.org/10.1136/amiajnl-2011-000607 .",Non-OADS,/arxiv_data1/oa_pdf/17/db/main.PMC4709468.pdf
"(2010), http://dx.doi.org/10.1245/s10434- 009-0792-y .",Non-OADS,/arxiv_data1/oa_pdf/17/db/main.PMC4709468.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Minimally invasive infrapubic in ﬂatable penile prosthesis implant for ED G Antonini et al 8 International Journal of Impotence Research (2016), 4 –8 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/29/c9/ijir201533a.PMC4709472.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc- nd/4.0/Aﬂibercept for myopic choroidal neovascularisation C Bruè et al 145 Eye",Non-OADS,/arxiv_data1/oa_pdf/4a/3d/eye2015199a.PMC4709541.pdf
"Open AccessR Mazzilli and others Testosterone replacement in 49,XXXXY syndromeID: 15-0114; January 2016 DOI: 10.1530/EDM-15-0114 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2016 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd",Non-OADS,/arxiv_data1/oa_pdf/a0/16/edmcr-2016-150114.PMC4709582.pdf
"R Mazzilli and others Testosterone replacement in 49,XXXXY syndromeID: 15-0114; January 2016 DOI: 10.1530/EDM-15-0114 http://www.edmcasereports.com 2",Non-OADS,/arxiv_data1/oa_pdf/a0/16/edmcr-2016-150114.PMC4709582.pdf
"R Mazzilli and others Testosterone replacement in 49,XXXXY syndromeID: 15-0114; January 2016 DOI: 10.1530/EDM-15-0114 http://www.edmcasereports.com 3",Non-OADS,/arxiv_data1/oa_pdf/a0/16/edmcr-2016-150114.PMC4709582.pdf
"( doi:10.5534/wjmh.2013.31.2.103 ) Received in ﬁnal form 13 December 2015 Accepted 23 December 2015 R Mazzilli and others Testosterone replacement in 49,XXXXY syndromeID: 15-0114; January 2016 DOI: 10.1530/EDM-15-0114 http://www.edmcasereports.com 4",Non-OADS,/arxiv_data1/oa_pdf/a0/16/edmcr-2016-150114.PMC4709582.pdf
Retrieved from  http://www.who.int/mediacentre/factsheets/fs330/e n/ April 2013.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved from  http://www.who.int/mediacentre/factsheets/fs330/e n/ April 2013.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved from   http://globalnation.inquirer.net/70149/lack -of- sanitation-clean -water -killing -kids -says-unicef   4.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved from  http://siteresources.worldbank.org/HEALTHNUTRI TIONANDPOPULATION/Resources/281627- 1095698140167/Fewtrell&ColfordJuly2004.pdf   6.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved from  http://siteresources.worldbank.org/INTPHILIPPINES/Resources/EconomicImpactsofSanitationintheP hils_Summary.pdf   7.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved from  http://siteresources.worldbank.org/INTPHILIPPINE S/Resources/EconomicImpactsofSanitationintheP hils_Summary.pdf   9.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved from  http://www.ajtmh.org/content/89/5/875.abstract   10.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved from  http://siteresources.worldbank.org/INTPHILIPPINE S/Resources/EconomicImpactsofSanitationintheP hils_Summary.pdf   11. International Committee of the Red Cross  ICRC  2011.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved from  http://www.sciencedirect.com/science/article/pii/S0 277953605001759   13.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved from  http://www.ajtmh.org/content/89/5/875.abstract   14.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
"Fewtrell, Lorna and Colford, John M. (2004)  .Water, Sanitation and Hygiene: Interventions  and Diarrhoea.A Systematic Review and Meta- analysis.Retrieved fromhttp://siteresources.worldbank.org/HEALTHN UTRITIONANDPOPULATION/Resources/281627- 1095698140167/Fewtrell&ColfordJuly2004.pdf   18.",Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved  from http://www.sciencedirect.com/science/article/pii/S0 033350695800719.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved from   http://www.ajol.info/index.php/ahs/article/view/689 3  21.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
"Yeager  B, Huttly  S , Bartolini,R ,  Rojas M,  Lanata  C.(1999)  Defecation Practices of Young  Children In A Peruvian Shanty Town Retrieved  from  http://www.sciencedirect.com/science/article/pii/S0 277953699001197.",Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Retrieved from  http://www.sciencedirect.com/science/article/pii/S1 473309902001846.,Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
"Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/3812435     Corresponding Author: Joseph Uy Almazan,  RN, MPM, MAN, Clinical Instructor ,   College of Nursing an d Health Sciences, Samar State University, Philippines ;   e-mail: almazanjoseph93@yahoo.com        240  DOI: 10.12865/CHSJ.40.04.01",Non-OADS,/arxiv_data1/oa_pdf/6a/5a/CHSJ-40-4-233.PMC4709702.pdf
Available at  http://www.who.int/diabetes/facts/world_figures/en   DOI: 10.12865/CHSJ.40.04.,Non-OADS,/arxiv_data1/oa_pdf/ae/03/CHSJ-40-4-265.PMC4709704.pdf
"Tofferi JK, Gilliland W , Avascular necrosis,  available at  http://emedicine.medscape.com/article/333364,  updated: Jun, 2014.",Non-OADS,/arxiv_data1/oa_pdf/66/85/CHSJ-40-4-289.PMC4709710.pdf
"Kelly JD, Sherwin SW, Femoral head avascular  necrosis, available at  http://emedicine.medscape.com/article/86568,  updated: Feb 28, 2010.",Non-OADS,/arxiv_data1/oa_pdf/66/85/CHSJ-40-4-289.PMC4709710.pdf
"Schoenstadt A, Avas cular necrosis, avail able at  http://bones.emedtv.com/avscular  necrosis/avascular -necrosis.html, last updated  Nov 5, 2008.",Non-OADS,/arxiv_data1/oa_pdf/66/85/CHSJ-40-4-289.PMC4709710.pdf
"Aiello MR, Chew FS, Imaging in avascular necrosis of the femoral head, available at  http://emedicine.medscape.com/article/386808,  updated: May 25, 2011.",Non-OADS,/arxiv_data1/oa_pdf/66/85/CHSJ-40-4-289.PMC4709710.pdf
"Terapeutică,  Farmacologie şi Toxicologie Clinică, 2008 ,  12(1):137-40 A vailable online:  http://www.terapeutica.ro/img/art/pdf/293/17_Gaman.pdf   2.",Non-OADS,/arxiv_data1/oa_pdf/49/5f/CHSJ-40-4-274.PMC4709713.pdf
"Available from: http://apps.searo.who.int/PDS_DOCS/B4816.pdf 2  Rajabi F, Esmailzadeh H, Rostamigooran N, et al.",OADS,/arxiv_data1/oa_pdf/ce/75/IJCBNM-4-98.PMC4709815.pdf
"Available from: http://mbs.behdasht.gov.ir/uploads/ KAN_ParastariSalamatJameah91.pdf 6 Karimi Moonaghi H, Heydari A, Taghipour A, Ildarabadi E. Challenges of Community  Health Nursing Education in Iran.",Non-OADS,/arxiv_data1/oa_pdf/ce/75/IJCBNM-4-98.PMC4709815.pdf
"[cited 17 Jul  2015] available from:  http://treatment.sbmu.ac.ir/uploads/Emergency_ measures.pdf   2 Gill JM, Riley AW.",Non-OADS,/arxiv_data1/oa_pdf/74/ee/IJCBNM-4-11.PMC4709818.pdf
[cited 17 Jul  2015] available from:http://cg.kmu.ac.ir/ Images/UserUpload/Document/CG/ Hakemiyat%20Balini/shakhes.doc 13 Sargent RG.,Non-OADS,/arxiv_data1/oa_pdf/74/ee/IJCBNM-4-11.PMC4709818.pdf
[cited  17 Jul  2015] available from: https://www.doctorsofbc.,Non-OADS,/arxiv_data1/oa_pdf/74/ee/IJCBNM-4-11.PMC4709818.pdf
Available from: http://www.cancer.org/research/cancerfactsstatistics/ cancerfactsfigures2013/index 3 Matsumoto K. Supporting Cancer  Patients and Families: A Workbook for  Psychotherapist [thesis].,Non-OADS,/arxiv_data1/oa_pdf/c3/b8/IJCBNM-4-90.PMC4709819.pdf
"Retrieved  from http://mediacenter.laprensagrafica.com/infografias/i/eua-el-pais-con-mas-salvadorenos-en-el-mundo Schön, D. A.",Non-OADS,/arxiv_data1/oa_pdf/66/aa/10.1177_1049732315609573.PMC4709820.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Attribution- NonCommercial- NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reprodu ction in any medium, provided the original work is unaltered and is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/cb/S204867901500035Xa.PMC4709836.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/7d/f9/tom115.PMC4710058.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2015.00163 TOMOGRAPHY.ORG | VOLUME 1 NUMBER 2 |DECEMBER 2015 115,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/tom115.PMC4710058.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2014 |  90  | e51859 | Page 1 of 5Video Article Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells Christian Schütz1, Martin Fleck2,3, Jonathan P. Schneck1, Mathias Oelke1 1Department of Pathology, Institute of Cell Engineering, Johns Hopkins University 2Department of Internal Medicine I, University of Regensburg 3Department of Rheumatology, Asklepios Medical Center Correspondence to: Mathias Oelke at moelke1@jhmi.edu URL: http://www.jove.com/video/51859 DOI: doi:10.3791/51859 Keywords: Immunology, Issue 90, Autoimmunity, Apoptosis, antigen-specific CD8+ T cells, HLA-A2-Ig, Fas/FasL, KaAPC Date Published: 8/11/2014 Citation: Schütz, C., Fleck, M., Schneck, J.P., Oelke, M. Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells.",Non-OADS,/arxiv_data1/oa_pdf/a3/71/jove-90-51859.PMC4710085.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51859/ Introduction Over the last two decades much progress has been made in understanding the pathogenic mechanisms of autoimmune diseases.,Non-OADS,/arxiv_data1/oa_pdf/a3/71/jove-90-51859.PMC4710085.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/62/0e/10.1177_2325967115621882.PMC4710110.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 0(0) 1–10 DOI: 10.1177/2054270415616548",Non-OADS,/arxiv_data1/oa_pdf/75/6c/10.1177_2054270415616548.PMC4710114.pdf
"27The current UK Health Secretary is quoted as stating in June 2015, ‘Theperformance of the NHS is only as good as the sup-port we give to the staﬀ’ (https://abetternhs.word press.com/2015/06/10/supervision/), and thisneeds to be translated into practical changes on the ground.",Non-OADS,/arxiv_data1/oa_pdf/75/6c/10.1177_2054270415616548.PMC4710114.pdf
"BBC News, December 12, 2012. http://www.bbc.co.uk/ news/uk-20696610 (accessed 2 November 2015).",Non-OADS,/arxiv_data1/oa_pdf/75/6c/10.1177_2054270415616548.PMC4710114.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ec/52/10.1177_2325967115621024.PMC4710116.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ad/ff/10.1177_2325967115617905.PMC4710117.pdf
"7) Use of techniques and substances to increase oxygen supply ; if so,  please specify   8) Use of ther motherap y techniques  9) Massage   10) Semi-invasive techniques (dry puncture, IPE, etc)   11) Pain-free stretching   12) Stretching with pain   13) Administration of vascularization-enhancing substances   14) Start isometric drills   15) Maintain aerobic capacitie s (eg, water  exercises )  16) Gradual increase of sport techniqu e avoiding use of affected area   17) Echography test     C) Cell-stimulating, proliferative and fibrotic phase , until day 28 after  injury onset:   1) Maint ain previously adopted measures:   • Complete  immobilization   • Elastic bandage   • Cryotherapy   • Inflammation bioregulators   • NSAIDs   • Drain all hematomas  • Drain hematoma if intense pain or compression is present:   • Analgesics   • No weightbearing  2) Reinforce use of antifibrotic substances  and techniques   3) Stretching as tolerated   4) Increase metabolic supply (proteins, food supplements, etc)   5) Increase mechanic al demand on muscle as tolerated (isometric,  conce ntric, excentric contractions, etc )  6) Begin basic sport technique movements as tolerated   7) Gradual increase of specific sport technique for each sport   8) Echography study    D) Remodeling  phase   1) Maint ain previously adopted measures   2) Decision on return to sports activity, when   • Pain-free stretching  • Pain-free contractions  • Pain-free basic sport technique movements   This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (http://creativecommons.org/ licenses/by-nc-nd/3.0/), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/b8/dd/10.1177_2325967115622434.PMC4710119.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine, 3(12), 232596711562 DOI: 10.1177/232596711562 ªThe Author(s) 20152434 2434",Non-OADS,/arxiv_data1/oa_pdf/b8/dd/10.1177_2325967115622434.PMC4710119.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/00/a7/10.1177_2325967115617932.PMC4710122.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/9b/99/10.1177_2325967115618161.PMC4710124.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/fa/d8/10.1177_2325967115621494.PMC4710125.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://uk.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Open; 0(0) 1–12 DOI: 10.1177/2054270415593717",Non-OADS,/arxiv_data1/oa_pdf/72/71/10.1177_2054270415593717.PMC4710126.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/6d/17/10.1177_2325967115623212.PMC4710128.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/ca/e6/10.1177_2058460115608660.PMC4710132.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c5/08/10.1177_2325967115623944.PMC4710143.pdf
"Variants were further selected if they were less than 1% of 1) the 1,000 Genome database (http://www.1000geno- mes.org/) (13), 2) the 6,500 exome variants in the Exome Variant Server (http://evs.gs.washington.edu/EVS/) (14), 3) the dataset of 1,208 Japanese exome variants in the Human Genetic Variation Database (http://www.genome.med.kyoto- u.ac.jp/SnpDB/index.html) (15), and 4) 269 in-house Japanese normal hearing controls.",OADS,/arxiv_data1/oa_pdf/9e/d9/mao-37-e126.PMC4710159.pdf
http://evs.gs.washington.edu/EVS/.,Non-OADS,/arxiv_data1/oa_pdf/9e/d9/mao-37-e126.PMC4710159.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/54/ppa-10-009.PMC4710167.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2016:10 9–18Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  9Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9516 3A review of immediacy and implications for  provider–patient relationships to support  medication management Rebecca J Bartlett ellis1 Anna F Carmon2 Caitlin Pike3 1Science of Nursing Care, indiana  University School of Nursing,   indianapolis, 2Communication Studies,   indiana University Purdue University  Columbus, Columbus, iN, 3iUPUi  University Library, indianapolis,   iN, USAObjectives:  This review is intended to 1) describe the construct of immediacy by analyzing  how immediacy is used in social relational research and 2) discuss how immediacy behaviors  can be incorporated into patient–provider interventions aimed at supporting patients’ medica - tion management.",Non-OADS,/arxiv_data1/oa_pdf/ab/54/ppa-10-009.PMC4710167.pdf
"Patient factors, such as not understanding medications and instructions, can  lead to unintentional non-adherence.4 In the USA, surveys of patients discharged from  acute care hospitals have found that when a new medicine was being explained to them,  only 65% reported that they had “always” been told what the medicine was for and  what side-effects might be experienced.5 When patients do not adequately understand  how to care for themselves after discharge, they are more likely to experience hospital  Correspondence: Rebecca J Bartlett ellis Science of Nursing Care Department,  indiana University School of Nursing,  1111 Middle Drive, e423, indianapolis,  iN 46202, USA Tel +1 317 274 0047 Fax +1 317 278 2021 email rjbartle@iu.ed u Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Bartlett Ellis et al Running head recto: A review of immediacy DOI: http://dx.doi.org/10.2147/PPA.S95163",Non-OADS,/arxiv_data1/oa_pdf/ab/54/ppa-10-009.PMC4710167.pdf
"Available from: http://files.eric.ed.gov/ fulltext/ED490540.pd f. Accessed October 15, 2014.",OADS,/arxiv_data1/oa_pdf/ab/54/ppa-10-009.PMC4710167.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ab/54/ppa-10-009.PMC4710167.pdf
Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20150235/DC1 .,Non-OADS,/arxiv_data1/oa_pdf/59/74/JEM_20150235.PMC4710198.pdf
Online supplemental material is available at http://www.jem .org/cgi/content/full/jem.20150567/DC1.,Non-OADS,/arxiv_data1/oa_pdf/57/d7/JEM_20150567.PMC4710201.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/ licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/27/ntv077.PMC4710206.pdf
International Network of Women  Against Tobacco—Europe (INWAT-Europe) and the European Network  for Smoking Prevention (ENSP); 2008. http://old.ensp.org/files/shsreport_ final_pdf__2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/25/27/ntv077.PMC4710206.pdf
1990;6(3):223-239. http://www.jos.nu/Articles/abstract.asp?,Non-OADS,/arxiv_data1/oa_pdf/25/27/ntv077.PMC4710206.pdf
http://journal.cpha.ca/index.php/cjph/ article/view/4119 .,Non-OADS,/arxiv_data1/oa_pdf/25/27/ntv077.PMC4710206.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/ 4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed inany way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/32/mjv059.PMC4710210.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/56/dkv360.PMC4710215.pdf
"An isolate was deﬁned as heteroresistant if both WT and mutant nucleotides conferring resistance at a speciﬁc locus were detected.Data analysis The primary data were read into an EpiData ﬁle for analysis (EpiData Analysis, version 2.2.2.183, freely available at http://www.epidata.dk).",OADS,/arxiv_data1/oa_pdf/15/56/dkv360.PMC4710215.pdf
Additional analyses were done with R software (R Core Team 2015; http://www.R-project.org).,OADS,/arxiv_data1/oa_pdf/15/56/dkv360.PMC4710215.pdf
http://apps.who.int/iris/bitstream/10665/43965/1/978924154 7581_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/56/dkv360.PMC4710215.pdf
http://apps.who.int/iris/bitstream/10665/83807/1/WHO_CDS_TB_2001.,OADS,/arxiv_data1/oa_pdf/15/56/dkv360.PMC4710215.pdf
"http://apps.who.int/ iris/bitstream/10665/44206/1/9789241598675_eng.pdf.39Piton J, Petrella S, Delarue M et al.",OADS,/arxiv_data1/oa_pdf/15/56/dkv360.PMC4710215.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a9/1b/3893.PMC4710218.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/50/24/3894.PMC4710219.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/73/3a/3898.PMC4710220.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/eb/61/3904.PMC4710221.pdf
http://exac.broadinstitute.org (accessed 25 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/eb/61/3904.PMC4710221.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/74/70/3909.PMC4710222.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4b/6f/3915.PMC4710223.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5b/5a/3920.PMC4710224.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f9/81/3926.PMC4710225.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/85/e0/3932.PMC4710226.pdf
", 2003; http://globplot.embl.de/); protein  kinases, 114 proteins (Breitkreutz et al.",OADS,/arxiv_data1/oa_pdf/85/e0/3932.PMC4710226.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/24/fe/3946.PMC4710228.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/aa/c5/3954.PMC4710229.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/47/29/3966.PMC4710230.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/44/b5/3985.PMC4710231.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0d/40/3999.PMC4710232.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8e/ce/4015.PMC4710233.pdf
"Seven antibodies were examined  by LM-IF.National Center for Biotechnology Information nonredundant data - base (ftp://ftp.ncbi.nih.gov/blast/db/FASTA/nr.gz, release: NCBI  nrdb 2008).",OADS,/arxiv_data1/oa_pdf/8e/ce/4015.PMC4710233.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/fa/8d/4033.PMC4710234.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/28/7e/4046.PMC4710235.pdf
", 2012;  Murphy, 2012; http://cellorganizer.org/).",Non-OADS,/arxiv_data1/oa_pdf/28/7e/4046.PMC4710235.pdf
"For  analysis of 3D shapes, we used a previously described (Velliste and  Murphy, 2002) collection of 3D images of HeLa cells obtained via  confocal microscopy (available from http://murphylab.web.cmu   .edu/data/3Dhela_images.html).",OADS,/arxiv_data1/oa_pdf/28/7e/4046.PMC4710235.pdf
Available at http://pages.pomona.edu/ ∼vds04747/public/papers/   landmarks.pdf (accessed 15 June 2015).,Non-OADS,/arxiv_data1/oa_pdf/28/7e/4046.PMC4710235.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/cd/ca/4057.PMC4710236.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f2/33/4063.PMC4710237.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f5/77/4075.PMC4710238.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/aa/52/4087.PMC4710239.pdf
Use of the University of New Mexico Cancer Center Micros - copy and Flow Cytometry facilities and NIH support for these cores is  acknowledged (http://hsc.unm.edu/crtc/microscopy/acknowledge - ment.shtml).,Non-OADS,/arxiv_data1/oa_pdf/aa/52/4087.PMC4710239.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/46/14/4100.PMC4710240.pdf
Available at https://circle.ubc.ca/handle/2429/44784  (accessed 1 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/46/14/4100.PMC4710240.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ee/e7/4124.PMC4710242.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/04/04/4135.PMC4710243.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/34/fb/4163.PMC4710245.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/eb/52/4171.PMC4710246.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/78/main.PMC4710377.pdf
Sato  and http://dx.doi.org/10.1016/j.toxrep.2015.12.001 2214-7500/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/78/main.PMC4710377.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/78/main.PMC4710377.pdf
"Supplementary  data Supplementary data  associated  with  this  article  can  be  found, in the  online  version,  at  http://dx.doi.org/10.1016/j.toxrep.2015.11.",OADS,/arxiv_data1/oa_pdf/e4/78/main.PMC4710377.pdf
"It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.14-09-0141 “ASCB®”and “The American Society for Cell Biology®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ September 2, 2015 14:ar26",Non-OADS,/arxiv_data1/oa_pdf/eb/1f/ar26.PMC4710384.pdf
http://dx.doi.org/10.1080/14703297.2013.796725  (accessed May 2015).,Non-OADS,/arxiv_data1/oa_pdf/eb/1f/ar26.PMC4710384.pdf
"It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.15-04-0081 “ASCB®”and “The American Society for Cell Biology®” are regis-   tered trademarks of The American Society for Cell Biology.INTRODUCTION Integration of inquiry-based approaches into curriculum is  transforming the way science is taught and studied in un - dergraduate classrooms (National Research Council [NRC],  2003; American Association for the Advancement of Science  [AAAS], 2011).",Non-OADS,/arxiv_data1/oa_pdf/91/73/ar27.PMC4710385.pdf
"The DNA Learning Center  in collaboration with iPlant (Goff et  al., 2011) developed a  Green Line of the DNA Subway, a tool aimed at providing  students with the opportunities to conduct research-grade  RNA-seq analysis (http://dnasubway.iplantcollaborative   .org).",Non-OADS,/arxiv_data1/oa_pdf/91/73/ar27.PMC4710385.pdf
"An instruc - tor-created public project (“Maize Abiotic Stress,” DNA  Subway Green Line), which students could access from their  computers, pre-ran quality-control analysis (Supplemental  Figure 1; FastQC; http://dnasubway.iplantcollaborative   .org).",Non-OADS,/arxiv_data1/oa_pdf/91/73/ar27.PMC4710385.pdf
http://people.vanderbilt.edu/ ∼keivan.stassun/pubs.htm (accessed  14 August 2009).,Non-OADS,/arxiv_data1/oa_pdf/47/9d/ar28.PMC4710386.pdf
"It is available to the public under an Attribu - tion–Noncommercial–Share Alike 3.0 Unported Creative Commons  License (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI:10.1187/ cbe-14-11-0209 “ASCB®”and“ The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ September 2, 2015 14:ar29",Non-OADS,/arxiv_data1/oa_pdf/08/09/ar29.PMC4710387.pdf
It is available to the public under an Attribu - tion–Noncommercial–Share Alike 3.0 Unported Creative Commons  License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/22/02/ar30.PMC4710388.pdf
https://stemedhub.org/groups/aau (ac - cessed 10 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/46/d3/ar31.PMC4710389.pdf
http://www.Research-Training.net/ Manchester (accessed 9 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/46/d3/ar31.PMC4710389.pdf
"Two months after publication it is available to the public under an  Attribution–Noncommercial–Share Alike 3.0 Unported Creative  Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).DOI:10.1187/ cbe.14-09-0153 “ASCB®” and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ September 2, 2015 14:ar32",Non-OADS,/arxiv_data1/oa_pdf/15/fc/ar32.PMC4710390.pdf
http://arizona.openrepository.com/arizona/   handle/10150/194297 (accessed September 2010).,Non-OADS,/arxiv_data1/oa_pdf/15/fc/ar32.PMC4710390.pdf
http://scholarworks.gsu.edu/ msit_diss/133 (accessed August 2014).,Non-OADS,/arxiv_data1/oa_pdf/15/fc/ar32.PMC4710390.pdf
http://digitalcommons.unl.edu/dissertations/ AAI9903770 (accessed November 2013).,Non-OADS,/arxiv_data1/oa_pdf/15/fc/ar32.PMC4710390.pdf
"Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0   Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.14-11-0206 “ASCB®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.Undergraduate research (UR) experiences have long been  an important component of science education at universi - ties and colleges but have received greater attention in re - cent years, as they have been identified as important ways  to strengthen preparation for advanced study and work in  CBE Life Sci Educ September 2, 2015 14:ar33",Non-OADS,/arxiv_data1/oa_pdf/64/a1/ar33.PMC4710391.pdf
"One example is the NSF’s BIO-REU program  (http://bioreu.org), a consortium of all funded REU sites in  the life sciences; BIO-REU leaders have used the URSSA for  the past 4 years, with encouragement from their NSF pro - gram officers.",Non-OADS,/arxiv_data1/oa_pdf/64/a1/ar33.PMC4710391.pdf
"Two months after publication it is available to the  public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/ licenses/by-nc-sa/3.0).DOI:10.1187/ cbe.14-10-0180 “ASCB®” and “The American Society for Cell Biology®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ September 2, 2015 14:ar34",Non-OADS,/arxiv_data1/oa_pdf/74/36/ar34.PMC4710392.pdf
http://visionandchange.org/files/2011/03/Revised-Vision-and   -Change-Final-Report.pdf (accessed 11 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/74/36/ar34.PMC4710392.pdf
http://economics.mit.edu/files/9758  (accessed 28 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/74/36/ar34.PMC4710392.pdf
http://q4b.biology.ubc.ca/concept-inventories  (accessed 20 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/74/36/ar34.PMC4710392.pdf
"It is available to the public under an Attribution–Non-commercial–Share Alike 3.0 Unported Creative Commons License ( http://creativecommons.org/licenses/by-nc-sa/3.0 ).DOI:10.1187/cbe.14-12-0231 “ASCB®”and “The American Society for Cell Biology®” are regis- tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ September 2, 2015 14:ar35",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/ar35.PMC4710393.pdf
http://books.google.com/books?hl  = en&lr = &id = C04rAAAAYAAJ&oi = fnd&pg = PA1&dq = dix+scientist+role+models&ots = 4Ft2OxP7QL&sig = oOXKbxjmoCE0aJtZ7A6ODpzGxFA (accessed 18 December 2014)   .,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/ar35.PMC4710393.pdf
http://www.oxforddictionaries.com/us/defi  nition/american_english/stereotype  (accessed 16 Sep- tember 2014)   .,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/ar35.PMC4710393.pdf
http://genderandset.open.ac.uk/index.php/genderandset/ article/viewArticle/78  (accessed 18 December 2014)   .,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/ar35.PMC4710393.pdf
"It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.14-11-0210 “ASCB®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.INTRODUCTION Given today’s reliance on science and technology in almost  all sectors of the world economy and the need to solve seri - ous global problems, the low percentage (24%) of U.S. col - lege graduates who earned degrees in science, technology,  engineering, and mathematics (STEM), 27th in the devel - oped world, is alarming (National Academy of Sciences,  National Academy of Engineering, Institute of Medicine,  2010).",Non-OADS,/arxiv_data1/oa_pdf/39/3c/es5.PMC4710394.pdf
http://changetheequation.org/sites/default/files/ CTEq_VitalSigns_Supply%20%282%29.pdf (accessed 9 March 2015).,OADS,/arxiv_data1/oa_pdf/39/3c/es5.PMC4710394.pdf
http://nces.ed.gov/pubs2014/2014001rev.pdf (accessed  9 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/39/3c/es5.PMC4710394.pdf
http://www.nextscientist.com/alternative-careers-for-phd-students/  (accessed 25 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/39/3c/es5.PMC4710394.pdf
http://studyofwork.com/ files/2011/03/NSF_Women-Full-Report-0314.pdf (accessed 29  October 2014).,Non-OADS,/arxiv_data1/oa_pdf/39/3c/es5.PMC4710394.pdf
https://cdn.americanprogress.org/ wp-content/uploads/issues/2009/11/pdf/women_and_sciences   .pdf (accessed 5 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/39/3c/es5.PMC4710394.pdf
http://issues.org/20-4/preston (accessed 9 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/39/3c/es5.PMC4710394.pdf
http://ugr.ue.ucsc.edu/CLB (accessed 9 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/39/3c/es5.PMC4710394.pdf
http://tucsonvaluesteachers.org/pdf/TVT-2013   -teacher-survey-summary.pdf (accessed 17 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/39/3c/es5.PMC4710394.pdf
"It is available to the public under an Attribu - tion–Noncommercial–Share Alike 3.0 Unported Creative Commons  License (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.15-04-0102 “ASCB®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ September 2, 2015 14:fe 3Review of: Integrating Concepts in Biology , by A. Malcolm Campbell, Laurie J. Heyer,  and Christopher J. Paradise; 2014; Trunity.com eBook; www.trunity.com/products/ digital-textbooks/integrating-concepts-in-biology; ISBN-13: 978-1-63097-008-6",Non-OADS,/arxiv_data1/oa_pdf/ae/22/fe3.PMC4710395.pdf
"It is available  to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/ licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.15-02-0040 “ASCB®”and “The American Society for Cell Biology®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ December 1, 2015 14:ar36",Non-OADS,/arxiv_data1/oa_pdf/1d/c3/ar36.PMC4710397.pdf
"It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.15-03-0073 “ASCB ®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ December 1, 2015 14:ar37",Non-OADS,/arxiv_data1/oa_pdf/9b/40/ar37.PMC4710398.pdf
Instructors were recruited from the authors’ personal net - works and from the CUREnet website (https://curenet.cns   .utexas.edu).,Non-OADS,/arxiv_data1/oa_pdf/9b/40/ar37.PMC4710398.pdf
http://visionandchange.org/files/2011/   03/Revised-Vision-and-Change-Final-Report.pdf2011/03/Revised   -Vision-and-Change-Final-Report.pdf (accessed 10 January 2014).,Non-OADS,/arxiv_data1/oa_pdf/9b/40/ar37.PMC4710398.pdf
"It is available to the public under an Attribu - tion–Noncommercial–Share Alike 3.0 Unported Creative Commons  License (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.15-03-0061 “ASCB ®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ December 1, 2015 14:ar38",Non-OADS,/arxiv_data1/oa_pdf/8f/99/ar38.PMC4710399.pdf
"It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.15-06-0138 “ASCB ®”and “The American Society for Cell Biology®” are regis-   tered trademarks of The American Society for Cell Biology..CBE Life Sci Educ December 1, 2015 14:ar39",Non-OADS,/arxiv_data1/oa_pdf/44/6f/ar39.PMC4710400.pdf
http://eric.ed.gov/?id =ED408955.,OADS,/arxiv_data1/oa_pdf/44/6f/ar39.PMC4710400.pdf
"We  have developed two new online apps as part of the online  materials, one on confirmation bias (http://bias.oia.arizona   .edu/index.html) and one on the mathematics of power  (http://power.oia.arizona.edu/index.html).",Non-OADS,/arxiv_data1/oa_pdf/d9/fb/ar42.PMC4710403.pdf
"Customizable options (at http://bias.oia.arizona.edu/   options.html and http://power.oia.arizona.edu/options   .html for confirmation bias and power, respectively) allow the  staged introduction of elements of the apps.",OADS,/arxiv_data1/oa_pdf/d9/fb/ar42.PMC4710403.pdf
http://plato.stanford.edu/archives/win2012/entries/probability   -interpret.,Non-OADS,/arxiv_data1/oa_pdf/d9/fb/ar42.PMC4710403.pdf
http://commonfund.nih.gov/diversity/initiatives (accessed  1 December 2014).,Non-OADS,/arxiv_data1/oa_pdf/ff/93/ar44.PMC4710405.pdf
http://grants.nih.gov/grants/guide/rfa   -files/RFA-RM-12-022.html (accessed 15 January 2015).,Non-OADS,/arxiv_data1/oa_pdf/ff/93/ar44.PMC4710405.pdf
"It is available to the public under an Attribu - tion–Noncommercial–Share Alike 3.0 Unported Creative Commons  License (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.15-05-0108 “ASCB ®”and “The American Society for Cell Biology®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ December 1, 2015 14:ar45",Non-OADS,/arxiv_data1/oa_pdf/b0/3a/ar45.PMC4710406.pdf
R package version  1.15.1. http://CRAN.R-project.org/package=MuMIn.,Non-OADS,/arxiv_data1/oa_pdf/b0/3a/ar45.PMC4710406.pdf
"It is available to the public under an Attribution–Non - commercial–Share Alike 3.0 Unported Creative Commons License  (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.14-09-0152 “ASCB ®”and “The American Society for Cell Biology ®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ December 1, 2015 14:ar46",Non-OADS,/arxiv_data1/oa_pdf/2b/13/ar46.PMC4710407.pdf
"It is available to the public under an Attribution– Noncommercial–Share Alike 3.0 Unported Creative Commons  License (http://creativecommons.org/licenses/by-nc-sa/3.0).DOI: 10.1187/cbe.15-09-0194 “ASCB ®”and “The American Society for Cell Biology®” are regis-   tered trademarks of The American Society for Cell Biology.CBE Life Sci Educ December 1, 2015 14:fe4",Non-OADS,/arxiv_data1/oa_pdf/f9/87/fe4.PMC4710409.pdf
"14, Winter 2015 14:fe4, 3The Nuffield Council on Bioethics in the United Kingdom  examines and reports on ethical issues in biology and medi - cine (http://nuffieldbioethics.org).",Non-OADS,/arxiv_data1/oa_pdf/f9/87/fe4.PMC4710409.pdf
The film is available at http://nuffieldbioethics.org/project/   children-research/films-young-peoples-perspectives   -clinical-ethics-reviews/.,Non-OADS,/arxiv_data1/oa_pdf/f9/87/fe4.PMC4710409.pdf
The previously mentioned Nuffield  Council on Bioethics website also has a blog that is updated  regularly (http://nuffieldbioethics.org/blog).,Non-OADS,/arxiv_data1/oa_pdf/f9/87/fe4.PMC4710409.pdf
"In 2014, the  Nuffield blog did a series of posts that focused specifically  on bioethics and education (http://nuffieldbioethics.org/   education/materials-resources-educators/blog-series   -bioethics-education).",Non-OADS,/arxiv_data1/oa_pdf/f9/87/fe4.PMC4710409.pdf
"The Bioethics Blog Tracker on the Georgetown Univer - sity bioethics website (https://bioethics.georgetown.edu/ explore-bioethics/bioethics-blogs) functions as an aggrega - tor, republishing current posts from more than 30 separate  bioethics blogs.",Non-OADS,/arxiv_data1/oa_pdf/f9/87/fe4.PMC4710409.pdf
"Elliott is  also the author of a lengthy 2014 article about how the home - less population, particularly in Philadelphia, is exploited  in healthy human participant research: “The Best-Selling,  Billion-Dollar Pills Tested on Homeless People: How the  Destitute and the Mentally Ill Are Being Used as Human Lab  Rats” (https://medium.com/matter/did-big-pharma-test   -your-meds-on-homeless-people-a6d8d3fc7dfe).",Non-OADS,/arxiv_data1/oa_pdf/f9/87/fe4.PMC4710409.pdf
http://ccliconference.org/ files/2013/11/Measuring-STEM-Teaching-Practices.pdf (accessed  13 August 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/23/le3.PMC4710410.pdf
http://buros.org/mental-measurements-yearbook (accessed 13  August 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/23/le3.PMC4710410.pdf
http://ncse.com (accessed 13 August 2015).Network for Integrating Bioinformatics into Life Sciences Education  (NIBLSE) (2014).,Non-OADS,/arxiv_data1/oa_pdf/ef/23/le3.PMC4710410.pdf
http://niblse.unomaha.edu  (accessed 13 August 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/23/le3.PMC4710410.pdf
https://dinsdalelab.sdsu   .edu/newsite/index.php/faculty-workshop (accessed 13 August   2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/23/le3.PMC4710410.pdf
http://ase.tufts.edu/tuftssummerstudy/bioseq.asp  (accessed 13 August 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/23/le3.PMC4710410.pdf
http://bioquest.org/esteem/ esteem_about.php (accessed 13 August 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/23/le3.PMC4710410.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.For commercial re-use, please contact journals.permissions@oup.com 337",Non-OADS,/arxiv_data1/oa_pdf/41/dd/dfu027.PMC4710459.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2014 |  90  | e51087 | Page 1 of 15Video Article Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy Matthew Rames1, Yadong Yu1, Gang Ren1 1Lawrence Berkeley National Laboratory, The Molecular Foundry Correspondence to: Gang Ren at gren@lbl.gov URL: http://www.jove.com/video/51087 DOI: doi:10.3791/51087 Keywords: Environmental Sciences, Issue 90, small and asymmetric protein structure, electron microscopy, optimized negative staining Date Published: 8/15/2014 Citation: Rames, M., Yu, Y., Ren, G. Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy.",Non-OADS,/arxiv_data1/oa_pdf/fd/f0/jove-90-51087.PMC4710468.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51087/ Introduction Understanding protein function requires knowledge of protein structure.,Non-OADS,/arxiv_data1/oa_pdf/fd/f0/jove-90-51087.PMC4710468.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/86/main.PMC4710578.pdf
"http://dx.doi.org/10.1016/j.tim.2015.03.005Corresponding  author:  Ryan,  R.P.",OADS,/arxiv_data1/oa_pdf/dd/86/main.PMC4710578.pdf
"2013,  http://dx.doi.org/10.1155/2013/23197975  Abrahamsson,  T.R.",Non-OADS,/arxiv_data1/oa_pdf/dd/86/main.PMC4710578.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/28/emss-65498.PMC4710676.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/16/main.PMC4710706.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.12.047 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/75/16/main.PMC4710706.pdf
"Developmental  Cognitive  Neuroscience  15  (2015)  48–57 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience jo  ur  nal  ho  me  pag  e:  http://www.elsevier.com/locate/dcn Brain  structural correlates of  complex  sentence  comprehension in  children Anja  Fengler∗,  Lars  Meyer,  Angela  D.  Friederici Department  of  Neuropsychology,  Max  Planck  Institute  for  Human  Cognitive  and  Brain  Sciences,  Stephanstraße  1A,  04103,  Leipzig,  Germany a  r  t  i  c  l  e  i  n  f  o Article  history: Received  5 February 2015 Received in  revised  form  26  August  2015 Accepted  15 September  2015 Available online  25  September  2015 Keywords:Sentence comprehension VBMBrain development Language-relevant  brain  areas Verbal  working  memorya  b  s  t  r  a  c  t Prior  structural  imaging  studies  found  initial  evidence  for  the  link  between  structural  gray  matter  changes and the  development  of  language  performance  in  children.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"While  progressive changes  in  the  cortical  development  are  assumed  to  provide  the basis  for  neural  plasticity  and  thus  maximal  learning  opportu- nities  (Johnson,  2001;  Simonds  and  Scheibel,  1989 ),  regressive changes  in  the  cortex,  such  as  synaptic  pruning  (Rakic  et  al., http://dx.doi.org/10.1016/j.dcn.2015.09.004 1878-9293/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  38,  95–113,  http://dx.doi.org/10.1016/j.neuroimage.2007.07.",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"14,  433–440,  http://dx.doi.org/10.1111/1467- 9280.01459 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  21, 1320–1336,  http://dx.doi.org/10.1016/j.neuroimage.2003.11.027 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Bildungsbericht  2014,  n.d.  Retrieved  from  http://www.bildungsbericht.de (15.05.15).",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  26,  221–233,  http://dx.doi.org/10.1016/ j.neuroimage.2005.01.032 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"113,  787–821,  http://dx.doi.org/10.1037/0033-295x.113.4.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Cortex  22,  1–12,  http://dx.doi.org/10.1093/ cercor/bhr018 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"44,  257–275,  http://dx.doi.org/10.1016/j.cortex.2006.06.",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  22,  11–21,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"15, 80–94,  http://dx.doi.org/10.1002/hbm.10006 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Brain 126,  1193–1201,  doi:http://dx.doi.org/10.1093/brain/awg104.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"123, 111–119,  http://dx.doi.org/10.1002/cne.901230110 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Neuron  24,  427–432,  http://dx.doi.org/ 10.1016/s0896-6273(00)80855-7 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"124,  34–44,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"79,  1152–1167,  http://dx.doi.org/10.1111/j.1467-8624.2008.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Neuropsychologia  44,  622–636,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"19,  2035–2049,  http://dx.doi.org/10.1162/jocn.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"24,  79–91,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage 54,  313–327,  http://dx.doi.org/10.1016/j.neuroimage.2010.07.033 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"28,  11435–11444,  http://dx.doi.org/10.1523/JNEUROSCI.2388-08.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"91,  1357–1392,  http://dx.doi.org/10.1152/physrev.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Cortex  16,  1709–1717,  http://dx.doi.org/10.1093/cercor/ bhj106 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  20,  S8–S17,  http://dx.doi.org/10.1016/ j.neuroimage.2003.09.003 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"101,  8174–8179,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"72,  6–15,  http://dx.doi.org/10.1016/j.bandc.2009.08.009 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"32,  1304–1321,  http://dx.doi.org/10.1037/ 0278-7393.32.6.1304 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"26,  178–190, http://dx.doi.org/10.1002/hbm.20154 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"16,  240–246,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Cognition  92, 67–99, http://dx.doi.org/10.1016/j.cognition.2003.10.011 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"8,  393–402,  http://dx.doi.org/10.1038/nrn2113 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  48,  371–380,  http://dx.doi.org/10.1016/j.neuroimage.2009.06.",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"2, 475–483, http://dx.doi.org/10.1038/35081509 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"29,  1015–1027,  http://dx.doi.org/10.1002/hbm.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"132,  3401–3410,  http://dx.doi.org/10.1093/brain/ awp273 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"28,  13209–13215, http://dx.doi.org/10.1523/JNEUROSCI.2903-08.2008 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"30,  718–729,  http://dx.doi.org/10.1016/j.neubiorev.2006.06.001 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  36,  1065–1073,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Linguistics  41,  213–254,  http://dx.doi.org/10.1515/ling.2003.008.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Cortex  17,  1092–1099,  http://dx.doi.org/10.1093/cercor/ bhl019 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  19,  1233–1239,  http://dx.doi.org/10.1016/S1053- 8119(03)00169-1 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Cortex  11,  335–342,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"1, 105–113,  http://dx.doi.org/10.2174/1573405054038726 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  62,  1987–1998,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"113,  51–58,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  37,  361–378,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"9,  60–68,  http://dx.doi.org/10.1016/j.tics.2004.",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Cortex  18,  915–929,  http://dx.doi.org/10.1093/ cercor/bhm124 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"31,  7174–7177, http://dx.doi.org/10.1523/JNEUROSCI.0054-11.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"22,  943–954,  http://dx.doi.org/10.1162/jocn.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Cortex  15, 1261–1269,  http://dx.doi.org/10.1093/cercor/bhi009 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  15,  1003–1014,  http://dx.doi.org/10.1006/nimg.2001.1026 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  37,  8–17,  http://dx.doi.org/10.1016/j.neuroimage.2007.04.",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  51,  1285–1293,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"13,  272–281,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"15,  762–774,  http://dx.doi.org/10.1111/j.1467-7687.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"Nature  440,  676–679,  http://dx.doi.org/10.1038/ nature04513 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"28,  3586–3594,  http://dx.doi.org/10.1523/JNEUROSCI.5309-07.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"6,  309–315,  http://dx.doi.org/10.1038/nn1008 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"24,  8223–8231,  http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"52,  452–473, http://dx.doi.org/10.1006/brln.1996.0024 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"34,  1857–1871,  http://dx.doi.org/10.1002/ hbm.22033 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"34,  477–487,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"363, 1037–1054,  http://dx.doi.org/10.1098/rstb.2007.2158 .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"18,  259–263,  http://dx.doi.org/10.1111/ j.1467-8721.2009.01648.x .",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"55,  157–166,  http://dx.doi.org/10.1016/j.jml.2006.03.007 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"NeuroImage  87,  120–126, http://dx.doi.org/10.1016/j.neuroimage.2013.11.010 .",OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
"107,  99–115,  http://dx.doi.org/10.1016/S0925-4927(01) 00087-7.",Non-OADS,/arxiv_data1/oa_pdf/8e/2c/main.PMC4710708.pdf
e-mail: aohno@mail.ecc.u-tokyo.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a4/20/jvms-77-1549.PMC4710709.pdf
e-mail: yongjunli23@163.com ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/11/fb/jvms-77-1555.PMC4710710.pdf
e-mail: sugiyama@muses.tottori-u.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/56/06/jvms-77-1565.PMC4710711.pdf
e-mail: Oriel.Thekisoe@nwu.ac.za ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b2/07/jvms-77-1573.PMC4710712.pdf
"The sequence data  of the PCR products were analyzed using BLAST 2.0 (Na- tional Center for Biotechnology Information, Bethesda, MA, U.S.A.; http://www.ncbi.nlm.nih.gov/blast/) for homology  searching.",OADS,/arxiv_data1/oa_pdf/b2/07/jvms-77-1573.PMC4710712.pdf
The sequences used in the  alignment were obtained from the NCBI GenBank Database  (http://www.ncbi.nlm.nih.gov/genbank/).,OADS,/arxiv_data1/oa_pdf/b2/07/jvms-77-1573.PMC4710712.pdf
e-mail: hikeda@nvlu.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5d/61/jvms-77-1581.PMC4710713.pdf
e-mail: nobhoshi@kobe-u.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/60/4d/jvms-77-1587.PMC4710714.pdf
©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/83/9f/jvms-77-1599.PMC4710715.pdf
e-mail: t-yamamoto-jc@morinaga.co.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2b/98/jvms-77-1605.PMC4710716.pdf
http://www.iso.org/iso/catalogue_detail.htm?csnumber=11834.,Non-OADS,/arxiv_data1/oa_pdf/2b/98/jvms-77-1605.PMC4710716.pdf
Handbook for Introduction of Food Traceability System http://www.maff.go.jp/j/syouan/seisaku/trace/pdf/hand-book_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2b/98/jvms-77-1605.PMC4710716.pdf
e-mail:	r.nabewo@gmail.com ©2015 The Japanese Society of Veterinary Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/jvms-77-1611.PMC4710717.pdf
http://www.r-project.org.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/jvms-77-1611.PMC4710717.pdf
http://imagej.nih.gov/ij/.,OADS,/arxiv_data1/oa_pdf/ec/21/jvms-77-1611.PMC4710717.pdf
"Since the first miRNA (Lin-4) was identified  [13, 32], more than 28,645 miRNAs have been discovered in the eukaryote using various experimental approaches and  computational predictions (http://www.mirbase.org/index.",OADS,/arxiv_data1/oa_pdf/c2/07/jvms-77-1617.PMC4710718.pdf
mirbase.org/) or GEO (http://www.ncbi.nlm.nih.gov/geo/).,OADS,/arxiv_data1/oa_pdf/c2/07/jvms-77-1617.PMC4710718.pdf
"e-mail: hejianzhong112@163.com, scq926@163.com ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/c2/07/jvms-77-1617.PMC4710718.pdf
"Of these, 7,240,262 ovary sequences, which accounted for  75.42% of the total reads (Table 3), were perfectly mapped  to the Ovis aries genome (http://www.ncbi.nlm.nih.gov/proj- ects/mapview/map_search.cgi?taxid=9940&query=January  2013).",OADS,/arxiv_data1/oa_pdf/c2/07/jvms-77-1617.PMC4710718.pdf
BMC Genomics 14: 801 http://www.biomedcen- tral.com/1471–2164/14/801.,Non-OADS,/arxiv_data1/oa_pdf/c2/07/jvms-77-1617.PMC4710718.pdf
e-mail: hsst56@vet.osakafu-u.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/78/6e/jvms-77-1625.PMC4710719.pdf
8.8 (http://www.chiringi.or.jp/soft/soft.html) [25].,Non-OADS,/arxiv_data1/oa_pdf/78/6e/jvms-77-1625.PMC4710719.pdf
e-mail: torisu@cc.miyazaki-u.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/56/e2/jvms-77-1633.PMC4710720.pdf
©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2b/c3/jvms-77-1639.PMC4710721.pdf
